WO2014081131A1 - Organic compound, and organic electro-luminescence device comprising same - Google Patents

Organic compound, and organic electro-luminescence device comprising same Download PDF

Info

Publication number
WO2014081131A1
WO2014081131A1 PCT/KR2013/009778 KR2013009778W WO2014081131A1 WO 2014081131 A1 WO2014081131 A1 WO 2014081131A1 KR 2013009778 W KR2013009778 W KR 2013009778W WO 2014081131 A1 WO2014081131 A1 WO 2014081131A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
substituted
unsubstituted
compound
aryl
Prior art date
Application number
PCT/KR2013/009778
Other languages
French (fr)
Korean (ko)
Inventor
백영미
김성무
이용환
신진용
박호철
이창준
김태형
Original Assignee
주식회사 두산
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020130105613A external-priority patent/KR101571600B1/en
Application filed by 주식회사 두산 filed Critical 주식회사 두산
Publication of WO2014081131A1 publication Critical patent/WO2014081131A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/16Peri-condensed systems
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05BELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B33/00Electroluminescent light sources
    • H05B33/10Apparatus or processes specially adapted to the manufacture of electroluminescent light sources
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1014Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1088Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1092Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1096Heterocyclic compounds characterised by ligands containing other heteroatoms
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers

Definitions

  • the present invention relates to an organic compound that can be used as a material for an organic electroluminescent device and an organic electroluminescent device comprising the same, and more specifically, to include an organic compound having excellent thermal stability and luminescence ability and the organic compound as a material of an organic material layer.
  • the present invention relates to an organic EL device having improved luminous efficiency, driving voltage, and lifetime.
  • the material used as the organic material layer may be classified into a light emitting material, a hole injection material, a hole transport material, an electron transport material, an electron injection material and the like according to its function.
  • the light emitting material may be classified into blue, green, and red light emitting materials, and yellow and orange light emitting materials required to realize a better natural color according to the light emitting color.
  • a host / dopant system may be used as a light emitting material.
  • the dopant material may be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt.
  • a metal complex compound containing heavy atoms such as Ir and Pt.
  • NPB hole blocking layer
  • BCP hole blocking layer
  • Alq 3 and the like are widely known as the hole blocking layer and the electron transport layer
  • anthracene derivatives have been reported as fluorescent dopant / host materials as light emitting materials.
  • phosphorescent materials having great advantages in terms of efficiency improvement among the light emitting materials include metal complex compounds including Ir such as Firpic, Ir (ppy) 3 , (acac) Ir (btp) 2, and the like. Green and red dopant materials are used, and CBP is a phosphorescent host material.
  • the conventional luminescent materials are good in terms of luminescence properties, but due to low glass transition temperature and very poor thermal stability, they are not satisfactory in terms of lifespan in organic EL devices. Therefore, there is a demand for development of a light emitting material having excellent performance.
  • an object of the present invention is to provide an organic electroluminescent device having improved driving voltage, luminous efficiency and the like by including the novel organic compound.
  • the present invention provides a compound represented by Formula 1:
  • R 1 to R 5 are the same as or different from each other, and each independently hydrogen, deuterium, halogen, cyano, a substituted or unsubstituted C 1 -C 40 alkyl group, a substituted or unsubstituted C 2 -C 40 alkenyl group , Substituted or unsubstituted C 2 -C 40 alkynyl group, substituted or unsubstituted C 6 -C 40 aryl group, substituted or unsubstituted heteroaryl group having 5 to 40 nuclear atoms, substituted or unsubstituted C 6 ⁇ C 40 aryloxy group, substituted or unsubstituted C 1 ⁇ C 40 Alkyloxy group, substituted or unsubstituted C 6 ⁇ C 40 arylamine group, substituted or unsubstituted C 3 ⁇ C 40 A cycloalkyl group, a substituted or unsubstituted heterocycloalkyl group having 3 to 40
  • R 1 and R 2 may be condensed together to form a condensed ring represented by one of Formulas 2 to 4, or one of R 3 to R 5 may be condensed with an adjacent group to form a condensed ring represented by Formula 5 below.
  • R 6 to R 11 are the same as or different from each other, and each independently hydrogen, deuterium, halogen, cyano, a substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted C 2 to C 40 alkenyl group , Substituted or unsubstituted C 2 -C 40 alkynyl group, substituted or unsubstituted C 6 -C 40 aryl group, substituted or unsubstituted heteroaryl group having 5 to 40 nuclear atoms, substituted or unsubstituted C 6 ⁇ C 40 aryloxy group, substituted or unsubstituted C 1 ⁇ C 40 Alkyloxy group, substituted or unsubstituted C 6 ⁇ C 40 arylamine group, substituted or unsubstituted C 3 ⁇ C 40 A cycloalkyl group, a substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear
  • Ar 1 is a substituted or unsubstituted C 1 ⁇ C 40 alkyl group, a substituted or unsubstituted C 2 ⁇ C 40 alkenyl group, a substituted or unsubstituted C 2 ⁇ C 40 alkynyl group, a substituted or unsubstituted C 6 to C 40 aryl group, substituted or unsubstituted heteroaryl group having 5 to 40 nuclear atoms, substituted or unsubstituted C 6 to C 40 aryloxy group, substituted or unsubstituted C 1 to C 40 Alkyloxy group, substituted or unsubstituted C 6 to C 40 arylamine group, substituted or unsubstituted C 3 to C 40 cycloalkyl group, substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear atoms, substituted Or an unsubstituted C 1 to C 40 alkylsilyl group, a substituted or unsubstit
  • n is an integer from 0 to 4, and if n is an integer from 1 to 4, at least one Ra is each independently deuterium, halogen, cyano, substituted or unsubstituted C 1 -C 40 alkyl group, substituted or unsubstituted C Alkenyl group of 2 to C 40 , substituted or unsubstituted alkynyl group of C 2 to C 40 , substituted or unsubstituted C 6 to C 40 aryl group, substituted or unsubstituted heteroaryl of 5 to 40 nuclear atoms Groups, substituted or unsubstituted C 6 -C 40 aryloxy group, substituted or unsubstituted C 1 -C 40 alkyloxy group, substituted or unsubstituted C 6 -C 40 arylamine group, substituted or unsubstituted A substituted C 3 to C 40 cycloalkyl group, a substituted or unsubstituted heterocycloalkyl group
  • X is a single bond or is selected from the group consisting of C (R 21 ) (R 22 ), N (R 23 ), O, and S;
  • R 21 to R 23 are each independently hydrogen, deuterium, a substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted C 6 to C 40 aryl group, or a substituted or unsubstituted nuclear atom 5 to 5 40 heteroaryl group and substituted or unsubstituted C 6 ⁇ C 40 arylamine group;
  • alkyl group alkenyl group, alkynyl group, aryl group, heteroaryl group, aryloxy group, alkyloxy group, arylamine group, arylalkyl group, cycloalkyl group, heterocycloalkyl group, alkyl of R 1 to R 11, Ra and Ar 1
  • a silyl group an alkyl boron group, an aryl boron group, an aryl phosphine group, an aryl phosphine oxide group and an aryl silyl group; and one or more substituents respectively introduced to the alkyl, aryl, heteroaryl and arylamine groups of R 21 to R 23 .
  • C 1 ⁇ C 40 alkyl group C 2 ⁇ C 40 alkenyl group, C 2 ⁇ C 40 alkynyl group, C 6 ⁇ C 40 aryl group, nuclear atom 5 To 40 heteroaryl group, C 6 to C 40 aryloxy group, C 1 to C 40 alkyloxy group, C 6 to C 40 arylamine group, C 3 to C 40 cycloalkyl group, nuclear atom number 3 to 40 heterocycloalkyl group, C 1 ⁇ C 40 alkyl silyl group, C 1 ⁇ C 40 alkyl group of boron, C 6 ⁇ C 40 aryl group of boron, C 6 ⁇ C 40 aryl group Is selected from the spin group, C 6 ⁇ C 40 aryl phosphine oxide group, and a C 6 ⁇ C 40 aryl silyl group of the group consisting of, wherein if the plurality of substituents, the same or different from each
  • the present invention is an organic electroluminescent device comprising an anode, a cathode, and at least one organic layer interposed between the anode and the cathode, wherein at least one of the at least one organic layer comprises the compound.
  • an organic electroluminescent device comprising an anode, a cathode, and at least one organic layer interposed between the anode and the cathode, wherein at least one of the at least one organic layer comprises the compound.
  • the compound represented by Formula 1 of the present invention is excellent in thermal stability and phosphorescence properties, it may be applied to the light emitting layer of the organic EL device.
  • the compound represented by Chemical Formula 1 may have a wide bandgap in which an indole moiety having a large electron donor is bonded to a terminal of a pyrroloacridine moiety.
  • the compound has a bipolar characteristic of the entire molecule due to the various aromatic ring substituents in which the electron withdrawal group (EWG) having high electron absorption is bonded to the basic skeleton, and thus the bonding force between the holes and the electrons is improved. It can increase.
  • the compound when the compound is applied to the organic EL device, since it can exhibit excellent properties as a host material of the light emitting layer compared to the conventional CBP, the phosphorescence property of the device is improved, and at the same time, the hole injection capacity and / or transport capacity, luminous efficiency, Driving voltage, lifespan characteristics and the like can be improved.
  • the energy level may be adjusted according to the substituents to have a wide band gap (sky blue to red), and thus may be applied to not only the light emitting layer but also a hole transport layer, a hole injection layer, and the like.
  • the host material should have a triplet energy gap of the host higher than the dopant. That is, in order to effectively provide phosphorescence from the dopant, the lowest excited state of the host must be higher in energy than the lowest emitted state of the dopant.
  • the compound represented by Formula 1 of the present invention has an indole moiety as a central skeleton and has triplet energy suitable for phosphorescence emission.
  • the molecular weight of the compound is significantly increased due to the various aromatic ring substituents introduced into the indole moiety, so that the glass transition temperature can be improved, thereby having higher thermal stability than the conventional CBP. Can be.
  • the device including the compound of formula 1 according to the present invention can greatly improve the durability and life characteristics.
  • the compound of Chemical Formula 1 according to the present invention when adopted as a hole injection / transport layer material of an organic EL device, a phosphorescent host material of blue, green and / or red color, the compound having the excellent efficiency and lifespan may be superior to the conventional CBP. Can be. Therefore, the compound according to the present invention can greatly contribute to improving the performance and lifespan of the organic EL device, and in particular, the device life improvement has a great effect on maximizing the performance in the full color organic light emitting panel.
  • R 1 to R 5 are the same as or different from each other, each independently hydrogen, deuterium, halogen, cyano, substituted or unsubstituted C 1 ⁇ C 40 alkyl group, substituted Or an unsubstituted C 2 -C 40 alkenyl group, a substituted or unsubstituted C 2 -C 40 alkynyl group, a substituted or unsubstituted C 6 -C 40 aryl group, a substituted or unsubstituted nuclear atom 5 To 40 heteroaryl groups, substituted or unsubstituted C 6 to C 40 aryloxy groups, substituted or unsubstituted C 1 to C 40 alkyloxy groups, substituted or unsubstituted C 6 to C 40 arylamines Groups, substituted or unsubstituted C 3 to C 40 cycloalkyl group, substituted or unsubstituted heterocycloalkyl group having
  • One or more substituents each introduced into an alkylboron group, an arylboron group, an arylphosphine group, an arylphosphine oxide group and an arylsilyl group are each independently deuterium, halogen, cyano group, C 1 -C 40 alkyl group, C 2 -C 40 alkenyl group, C 2 to C 40 alkynyl group, C 6 to C 40 aryl group, nuclear atom 5 to 40 heteroaryl group, C 6 to C 40 aryloxy group, C 1 to C 40 Alkyloxy group, C 6 -C 40 arylamine group, C 3 -
  • R 1 and R 2 may be fused to each other in R 1 to R 5 to form a fused ring represented by one of Formulas 2 to 4, or one of R 3 to R 5 may be adjacent to each other. It should be combined with the group to form a condensed ring represented by the formula (5).
  • R 3 is condensed with an adjacent group R 4 in the R 1 to R 5 to form a condensed ring represented by Chemical Formula 5
  • a compound represented by the following Chemical Formula 6 or 8 is formed.
  • R 1 and R 2 are condensed in the R 1 to R 5 to form a condensed ring represented by one of Formulas 2 to 4
  • a compound represented by one of Formulas 10 to 15 is formed.
  • R 6 to R 11 are the same as or different from each other, and each independently hydrogen, deuterium, halogen, cyano, a substituted or unsubstituted C 1 -C 40 alkyl group, a substituted or unsubstituted C 2 -C 40 alkene Nyl group, substituted or unsubstituted C 2 to C 40 alkynyl group, substituted or unsubstituted C 6 to C 40 aryl group, substituted or unsubstituted heteroaryl group having 5 to 40 nuclear atoms, substituted or unsubstituted C 6 ⁇ C 40 aryloxy group, substituted or unsubstituted C 1 ⁇ C 40 Alkyloxy group, substituted or unsubstituted C 6 ⁇ C 40 arylamine group, substituted or unsubstituted C 3 ⁇ C 40 cycloalkyl groups, substituted or unsubstituted heterocycloalkyl groups having 3 to 40 nuclear atoms, substituted or
  • One or more substituents each introduced into an alkylboron group, an arylboron group, an arylphosphine group, an arylphosphine oxide group and an arylsilyl group are each independently deuterium, halogen, cyano group, C 1 -C 40 alkyl group, C 2 -C 40 alkenyl group, C 2 to C 40 alkynyl group, C 6 to C 40 aryl group, nuclear atom 5 to 40 heteroaryl group, C 6 to C 40 aryloxy group, C 1 to C 40 Alkyloxy group, C 6 -C 40 arylamine group, C 3 -C
  • Ar 1 is a substituted or unsubstituted C 1 ⁇ C 40 Alkyl group, a substituted or unsubstituted C 2 ⁇ C 40 Alkenyl group, a substituted or unsubstituted C 2 ⁇ C 40 Alkynyl group, a substituted or unsubstituted C 6 ⁇ C 40 aryl group, substituted or unsubstituted heteroaryl group having 5 to 40 nuclear atoms, substituted or unsubstituted C 6 ⁇ C 40 aryloxy group, substituted or unsubstituted C 1 ⁇ C 40 An alkyloxy group, a substituted or unsubstituted C 6 -C 40 arylamine group, a substituted or unsubstituted C 3 -C 40 cycloalkyl group, a substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear atoms, Substituted or unsubstituted C 1 to C 40 alkyl
  • At least one substituent introduced into each of the aryl boron group, aryl phosphine group, aryl phosphine oxide group and aryl silyl group is each independently deuterium, halogen, cyano group, C 1 ⁇ C 40 alkyl group, C 2 ⁇ C 40 alkenes group, C 2 ⁇ C 40 alkynyl group, C 6 ⁇ C 40 aryl group, an aryloxy group of nuclear atoms aryl of from 5 to 40 heteroaryl group, a C 6 ⁇ C 40, alkyloxy group of C
  • n is an integer of 0 to 4.
  • n is 0, it means that hydrogen is not substituted by the substituent Ra.
  • Ra is substituted with a substituent Ra, and at least one Ra is each independently deuterium, halogen, cyano, substituted or unsubstituted C 1 to C 40 alkyl group, substituted or Unsubstituted C 2 to C 40 alkenyl group, substituted or unsubstituted C 2 to C 40 alkynyl group, substituted or unsubstituted C 6 to C 40 aryl group, substituted or unsubstituted nuclear atom 5 to 5 40 heteroaryl groups, substituted or unsubstituted C 6 -C 40 aryloxy groups, substituted or unsubstituted C 1 -C 40 alkyloxy groups, substituted or unsubstituted C 6 -C 40 arylamine groups , Substituted or unsubstituted
  • One or more substituents introduced into the arylborone group, the arylphosphine group, the arylphosphine oxide group and the arylsilyl group are each independently deuterium, halogen, cyano group, C 1 -C 40 alkyl group, C 2 -C 40 alkenyl group , C 2 ⁇ C 40 alkynyl group, C 6 ⁇ C 40 aryl group, an aryloxy group of nuclear atoms aryl of from 5 to 40 heteroaryl group, a C 6 ⁇ C 40, alkyloxy group of C 1 ⁇ C 40 of, C 6 ⁇ C
  • X is a single bond directly connected or is selected from the group consisting of C (R 21 ) (R 22 ), N (R 23 ), O and S, preferably a single bond, or C (R 21 ) ( R 22 ).
  • R 21 to R 23 are each independently hydrogen, deuterium, a substituted or unsubstituted C 1 -C 40 alkyl group, a substituted or unsubstituted C 6 -C 40 aryl group, a substituted or unsubstituted nuclear atom 5 To 40 heteroaryl groups, and a substituted or unsubstituted C 6 ⁇ C 40 arylamine group.
  • R 21 and R 22 are hydrogen, a substituted or unsubstituted C 1 -C 40 alkyl group, or a substituted or unsubstituted group. preferably C 6 ⁇ C 40 aryl group in it, and it is more preferred that the methyl group or a phenyl group.
  • one or more substituents introduced into each of the alkyl group, aryl group, heteroaryl group and arylamine group of R 21 to R 23 are each independently deuterium, halogen, cyano group, C 1 ⁇ C 40 alkyl group, C 2 ⁇ C 40 alkenyl group, C 2 to C 40 alkynyl group, C 6 to C 40 aryl group, nuclear atom 5 to 40 heteroaryl group, C 6 to C 40 aryloxy group, C 1 to C 40 Alkyloxy group, C 6 -C 40 arylamine group, C 3 -C 40 cycloalkyl group, nuclear atom 3-40 heterocycloalkyl group, C 1 -C 40 alkylsilyl group, C 1 -C 40 alkyl boron group, C 6 ⁇ C group 60 arylboronic of, C 6 ⁇ C 40 aryl phosphine group, C 6 ⁇ C 40 aryl phosphine oxide group, and a C 6 ⁇ C 40
  • Ra and Ar 1 may be each independently selected from the group consisting of hydrogen or the following substituents S1 to S206, but is not limited thereto.
  • Ar 1 may be preferably selected from the group consisting of the following substituents A1 to A64.
  • Examples of the compound represented by Formula 1 according to the present invention include a compound represented by the following Formulas 6 to 15, but are not limited thereto.
  • R 1 to R 11 , Ra, Ar 1, X and n are the same as defined in Chemical Formula 1.
  • Specific examples of the compound represented by Formula 1 include compounds represented by the following formulas INV-1 to INV-20, but are not limited thereto.
  • R 1 to R 11 , Ra, Ar 1 and n are the same as defined in Chemical Formula 1.
  • Representative examples of the compound represented by Formula 1 include the following compounds, but are not limited thereto.
  • unsubstituted alkyl is a monovalent substituent derived from a straight or branched chain saturated hydrocarbon of 1 to 40 carbon atoms, examples of which are methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso -Amyl, hexyl and the like.
  • unsubstituted alkenyl is a monovalent substituent derived from a C2-C40 straight or branched chain unsaturated hydrocarbon having at least one carbon-carbon double bond, and examples thereof include vinyl. (vinyl), allyl, isopropenyl, 2-butenyl, and the like, but are not limited thereto.
  • unsubstituted alkynyl is a monovalent substituent derived from a C2-C40 straight or branched chain unsaturated hydrocarbon having at least one carbon-carbon triple bond, and examples thereof include eta. Ethynyl, 2-propynyl, and the like, but are not limited thereto.
  • unsubstituted aryl means a monovalent substituent derived from an aromatic hydrocarbon having 6 to 60 carbon atoms in which a single ring or two or more rings are combined. Two or more rings may be attached in a simple or fused form with one another.
  • aryl include, but are not limited to, phenyl, naphthyl, phenanthryl, anthryl, and the like.
  • unsubstituted heteroaryl means a monovalent substituent derived from monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 40 nuclear atoms. At least one carbon in the ring, preferably 1 to 3 carbons, is substituted with a heteroatom such as N, O, S or Se. It is understood that two or more rings may be attached in a simple or fused form to each other and further include a condensed form with an aryl group.
  • heteroaryl examples include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl; Polycyclics such as phenoxathienyl, indolinzinyl, indolyl, purinyl, quinolyl, benzothiazole, carbazolyl It is understood to include a ring and to include 2-furanyl, N-imidazolyl, 2-isoxazolyl, 2-pyridinyl, 2-pyrimidinyl, and the like.
  • unsubstituted aryloxy is a monovalent substituent represented by RO-, wherein R is aryl having 5 to 60 carbon atoms.
  • R is aryl having 5 to 60 carbon atoms.
  • aryloxy include phenyloxy, naphthyloxy, diphenyloxy and the like.
  • unsubstituted alkyloxy is a monovalent substituent represented by R'O-, wherein R 'means 1 to 40 alkyl, and is linear, branched or cyclic. It is interpreted as including a (cyclic) structure.
  • alkyloxy may include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy and the like.
  • unsubstituted arylamine means an amine substituted with aryl having 6 to 60 carbon atoms.
  • unsubstituted cycloalkyl means a monovalent substituent derived from a monocyclic or polycyclic non-aromatic hydrocarbon having 3 to 40 carbon atoms.
  • examples of such cycloalkyls include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine, and the like.
  • unsubstituted heterocycloalkyl means a monovalent substituent derived from a non-aromatic hydrocarbon having 3 to 40 nuclear atoms, and at least one carbon in the ring, preferably 1 to 3 carbons Substituted with a hetero atom such as N, O or S.
  • a hetero atom such as N, O or S.
  • Non-limiting examples thereof include morpholine, piperazine and the like.
  • alkylsilyl means silyl substituted with alkyl having 1 to 40 carbon atoms
  • arylsilyl means silyl substituted with aryl having 5 to 40 carbon atoms
  • fused ring means a condensed aliphatic ring, a condensed aromatic ring, a condensed heteroaliphatic ring, a condensed heteroaromatic ring, or a combination thereof.
  • the present invention provides an organic electroluminescent device comprising a compound represented by the formula (1), preferably a compound represented by the formula (6) to a compound represented by the formula (15).
  • the present invention is an organic electroluminescent device comprising an anode, a cathode, and at least one organic layer interposed between the anode and the cathode, wherein at least one of the at least one organic layer
  • the compound represented by Chemical Formula 1 preferably, the compound represented by Chemical Formula 6 to the compound represented by Chemical Formula 15 is included.
  • the compound of Formula 1 may be used alone or in combination of two or more.
  • the at least one organic material layer may be any one or more of a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer and an electron injection layer, at least one of the organic material layer may include a compound represented by the formula (1).
  • the organic material layer including the compound of Compound 1 may be a light emitting layer.
  • the light emitting layer of the organic electroluminescent device may include a host material, wherein the host material may include the compound of formula (1).
  • the compound of Formula 1 when included as a light emitting layer material of the organic electroluminescent device, preferably a blue, green or red phosphorescent host, the binding force between holes and electrons in the light emitting layer is increased, so that the efficiency of the organic electroluminescent device (Luminescence efficiency and power efficiency), lifetime, brightness and driving voltage can be improved.
  • the structure of the organic EL device according to the present invention described above is not particularly limited, and may be, for example, a structure in which a substrate, an anode, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and a cathode are sequentially stacked.
  • at least one of the hole injection layer, the hole transport layer, the light emitting layer, the electron transport layer and the electron injection layer may include a compound represented by the formula (1), preferably the light emitting layer comprises a compound represented by the formula (1) Can be.
  • the light emitting layer includes the compound of Formula 1, the compound may be used as a phosphorescent host.
  • An electron injection layer may be further stacked on the electron transport layer.
  • the structure of the organic electroluminescent device according to the present invention may be a structure in which an anode, one or more organic material layers and a cathode are sequentially stacked, and an insulating layer or an adhesive layer is inserted at an interface between the electrode and the organic material layer.
  • the organic electroluminescent device according to the present invention is formed by using materials and methods known in the art, except that at least one layer (eg, a light emitting layer) of the organic material layer is formed to include the compound represented by Chemical Formula 1. It may be prepared by forming another organic layer and an electrode.
  • at least one layer eg, a light emitting layer of the organic material layer is formed to include the compound represented by Chemical Formula 1. It may be prepared by forming another organic layer and an electrode.
  • the organic material layer may be formed by a vacuum deposition method or a solution coating method.
  • the solution coating method include, but are not limited to, spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer.
  • the substrate usable in the present invention is not particularly limited, and silicon wafers, quartz, glass plates, metal plates, plastic films, sheets, and the like may be used.
  • examples of the anode material include metals such as vanadium, chromium, copper, zinc and gold or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO); Combinations of metals and oxides such as ZnO: Al or SnO 2 : Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole or polyaniline; And carbon black, but are not limited thereto.
  • metals such as vanadium, chromium, copper, zinc and gold or alloys thereof.
  • Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO); Combinations of metals and oxides such as ZnO: Al or SnO 2 : Sb
  • Conductive polymers such as polythiophene, poly (3-methylthiophene
  • the negative electrode material may be a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, or lead or an alloy thereof; And multilayer structure materials such as LiF / Al or LiO 2 / Al, and the like.
  • step 1> of Preparation Example 1 Except for using 5,7-dibromo-1H-indole (24.2 g, 88.0 mmol) instead of 4,7-dibromo-1H-indole used in ⁇ step 1> of Preparation Example 1, ⁇ The procedure of step 1> was followed to yield 2-bromopyrrolo [3,2,1-jk] carbazole.
  • Compound C-3 was prepared by the same procedure as in Synthesis Example 1, except that 2-bromo-6-phenylpyridine (6.19 g, 26.57 mmol) was used instead of 2- (4-bromophenyl) triphenylene used in Synthesis Example 1. (4.42 g, yield: 70%) was obtained.
  • Compound C-17 was prepared by the same procedure as in Synthesis Example 10, except that Compound IC-2 (4.28 g, 13.29 mmol) synthesized in Preparation Example 2 was used instead of Compound IC-1 used in Synthesis Example 10. 5.02 g, yield: 60%).
  • Compound C-18 was prepared by the same procedure as in Synthesis Example 11, except that Compound IC-2 (4.28 g, 13.29 mmol) synthesized in Preparation Example 2 was used instead of Compound IC-1 used in Synthesis Example 11. 7.88 g, yield: 84%).
  • Compound C-19 was prepared by the same procedure as in Synthesis Example 12, except that Compound IC-2 (4.28 g, 13.29 mmol) synthesized in Preparation Example 2 was used instead of Compound IC-1 used in Synthesis Example 12. 7.69 g, yield: 82%) was obtained.
  • a compound C-20 was prepared by the same procedure as in Synthesis Example 10, except that Compound IC-3 (4.28 g, 13.29 mmol) synthesized in Preparation Example 2 was used instead of Compound IC-1 used in Synthesis Example 10. 7.45 g, yield: 89%).
  • Compound C-21 was prepared by the same procedure as in Synthesis Example 11, except that Compound IC-3 (4.28 g, 13.29 mmol) synthesized in Preparation Example 2 was used instead of Compound IC-1 used in Synthesis Example 11. 6.56 g, yield: 70%).
  • Compound C-22 was prepared by the same procedure as in Synthesis Example 12, except that Compound IC-3 (4.28 g, 13.29 mmol) synthesized in Preparation Example 2 was used instead of Compound IC-1 used in Synthesis Example 12. 7.32 g, yield: 78%).
  • Compound C-23 was prepared in the same manner as in Synthesis Example 10, except that Compound IC-4 (4.28 g, 13.29 mmol) synthesized in Preparation Example 3 was used instead of Compound IC-1 used in Synthesis Example 10. 7.28 g, yield: 87%).
  • a compound C-25 was prepared by the same procedure as in Synthesis Example 12, except that Compound IC-4 (4.28 g, 13.29 mmol) used in Preparation Example 3 was used instead of Compound IC-1 used in Synthesis Example 12. 6.19 g, yield: 66%).
  • Compound C-26 was prepared by the same procedure as in Synthesis Example 10, except that Compound IC-5 (4.28 g, 13.29 mmol) synthesized in Preparation Example 4 was used instead of Compound IC-1 used in Synthesis Example 10. 5.07 g, yield: 65%).
  • Compound C-27 was prepared by the same procedure as in Synthesis Example 11, except that Compound IC-5 (4.28 g, 13.29 mmol) synthesized in Preparation Example 4 was used instead of Compound IC-1 used in Synthesis Example 11. 5.82 g, yield: 66%).
  • Compound C-28 was prepared by the same procedure as in Synthesis Example 12, except that Compound IC-5 (4.28 g, 13.29 mmol) synthesized in Preparation Example 4 was used instead of Compound IC-1 used in Synthesis Example 12. 6.35 g, yield: 72%).
  • Compound C-29 was prepared by the same procedure as in Synthesis Example 10, except that Compound IC-6 (4.28 g, 13.29 mmol) synthesized in Preparation Example 5 was used instead of Compound IC-1 used in Synthesis Example 10. 4.45 g, yield: 57%).
  • Compound C-30 was prepared by the same procedure as in Synthesis Example 11, except that Compound IC-6 (4.28 g, 13.29 mmol) synthesized in Preparation Example 5 was used instead of Compound IC-1 used in Synthesis Example 11. 4.32 g, yield: 49%) was obtained.
  • a compound C-31 was prepared in the same manner as in Synthesis Example 12, except that Compound IC-6 (4.28 g, 13.29 mmol) synthesized in Preparation Example 5 was used instead of Compound IC-1 used in Synthesis Example 12. 5.55 g, yield: 63%).
  • Compound C-32 was prepared by the same procedure as in Synthesis Example 10, except that Compound IC-7 (4.28 g, 13.29 mmol) synthesized in Preparation Example 5 was used instead of Compound IC-1 used in Synthesis Example 10. 6.01 g, yield: 77%).
  • Compound C-33 was prepared by the same procedure as in Synthesis Example 11, except that Compound IC-7 (4.28 g, 13.29 mmol) synthesized in Preparation Example 5 was used instead of Compound IC-1 used in Synthesis Example 11. 7.67 g, yield: 87%).
  • a compound C-34 was prepared in the same manner as in Synthesis Example 12, except that Compound IC-7 (4.28 g, 13.29 mmol) synthesized in Preparation Example 5 was used instead of Compound IC-1 used in Synthesis Example 12. 6.53 g, yield: 74%).
  • Compound C-35 was prepared in the same manner as in Synthesis Example 10, except that Compound IC-8 (4.28 g, 13.29 mmol) synthesized in Preparation Example 6 was used instead of Compound IC-1 used in Synthesis Example 10. 6.71 g, yield: 86%).
  • Compound C-36 was prepared by the same procedure as in Synthesis Example 11, except that Compound IC-8 (4.28 g, 13.29 mmol) synthesized in Preparation Example 6 was used instead of Compound IC-1 used in Synthesis Example 11. 5.64 g, yield: 64%).
  • Compound C-37 was prepared by the same procedure as in Synthesis Example 12, except that Compound IC-8 (4.28 g, 13.29 mmol) synthesized in Preparation Example 6 was used instead of Compound IC-1 used in Synthesis Example 12. 6.88 g, yield: 78%).
  • Compound C-38 was prepared by the same procedure as in Synthesis Example 10, except that Compound IC-9 (4.28 g, 13.29 mmol) synthesized in Preparation Example 7 was used instead of Compound IC-1 used in Synthesis Example 10. 6.44 g, yield: 77%).
  • Compound C-39 was prepared by the same procedure as in Synthesis Example 11, except that Compound IC-9 (4.28 g, 13.29 mmol) synthesized in Preparation Example 7 was used instead of Compound IC-1 used in Synthesis Example 11. 5.63 g, yield: 60%).
  • a compound C-40 was prepared by the same procedure as in Synthesis Example 12, except that Compound IC-9 (4.28 g, 13.29 mmol) synthesized in Preparation Example 7 was used instead of Compound IC-1 used in Synthesis Example 12. 4.97 g, yield: 53%) was obtained.
  • a compound C-41 was prepared in the same manner as in Synthesis Example 10, except that Compound IC-10 (4.28 g, 13.29 mmol) synthesized in Preparation Example 7 was used instead of Compound IC-1 used in Synthesis Example 10. 6.27 g, yield: 75%).
  • Compound C-42 was prepared by the same procedure as in Synthesis Example 11, except that Compound IC-10 (4.28 g, 13.29 mmol) synthesized in Preparation Example 7 was used instead of Compound IC-1 used in Synthesis Example 11. 6.75 g, yield: 72%).
  • Compound C-43 was prepared by the same procedure as in Synthesis Example 12, except that Compound IC-10 (4.28 g, 13.29 mmol) synthesized in Preparation Example 7 was used instead of Compound IC-1 used in Synthesis Example 12. 5.90 g, yield: 63%).
  • Compound C-48 was prepared by the same procedure as in Synthesis Example 44, except that Compound IC-12 (3.49 g, 7.31 mmol) synthesized in Preparation Example 8 was used instead of Compound IC-11 used in Synthesis Example 44. 2.83 g, yield: 55%).
  • a compound C-49 was prepared in the same manner as in Synthesis Example 45, except that Compound IC-12 (3.49 g, 7.31 mmol) synthesized in Preparation Example 8 was used instead of Compound IC-11 used in Synthesis Example 45. 2.38 g, yield: 41%).
  • a compound C-50 was prepared in the same manner as in Synthesis Example 46, except that Compound IC-12 (3.49 g, 7.31 mmol) synthesized in Preparation Example 8 was used instead of Compound IC-11 used in Synthesis Example 46. 2.44 g, yield: 40%).
  • Compound C-51 was prepared by the same procedure as in Synthesis Example 47, except that Compound IC-12 (3.49 g, 7.31 mmol) synthesized in Preparation Example 8 was used instead of Compound IC-11 used in Synthesis Example 47. 2.01 g, yield: 33%).
  • a glass substrate coated with ITO (Indium tin oxide) to a thickness of 1500 ⁇ was washed with distilled water ultrasonically. After washing the distilled water, ultrasonic cleaning with a solvent such as isopropyl alcohol, acetone, methanol, dried and transferred to a UV OZONE cleaner (Power sonic 405, Hwasin Tech), and then wash the substrate using UV for 5 minutes The substrate was transferred to a vacuum evaporator.
  • ITO Indium tin oxide
  • Example 1 Except for using the compounds C-2 to C-51 synthesized in Synthesis Examples 2 to 51 instead of the compound C-1 used as a host material in the formation of the emission layer in Example 1, the same as in Example 1 To an organic EL device.
  • a green organic EL device was manufactured in the same manner as in Example 1, except that CBP was used instead of Compound C-1 used as a host material in forming the emission layer in Example 1.
  • the structure of CBP used is as follows.
  • Example 1 Sample Host Driving voltage (V) Current efficiency (cd / A) Example 1 Compound C-1 6.50 41.0 Example 2 Compound C-2 6.45 41.2 Example 3 Compound c-3 6.55 41.1 Example 4 Compound c-4 6.50 40.9 Example 5 Compound C-5 6.60 41.3 Example 6 Compound c-6 6.55 41.0 Example 7 Compound c-7 6.50 41.4 Example 8 Compound c-8 6.46 41.9 Example 9 Compound c-9 6.55 41.5 Example 10 Compound C-10 6.45 41.3 Example 11 Compound C-11 6.60 41.8 Example 12 Compound c-12 6.55 42.1 Example 13 Compound C-13 6.60 41.2 Example 14 Compound c-14 6.54 41.7 Example 15 Compound c-15 6.65 42.1 Example 16 Compound c-16 6.60 41.5 Example 17 Compound c-17 6.59 41.8 Example 18 Compound c-18 6.50 41.7 Example 19 Compound c-19 6.45 41.8 Example 20 Compound C-20 6.51 41.3 Example 21 Compound c-21 6.55 40.9 Example 22 Compound c-22 6.60 4
  • the green organic EL devices of Examples 1 to 51 using the compounds represented by the formula (1) according to the present invention (Compounds C-1 to C-51) as the host material of the light emitting layer were comparative examples using conventional CBP. It was confirmed that the green organic EL device of 1 exhibited better performance in terms of current efficiency and driving voltage.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Manufacturing & Machinery (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The present invention relates to an organic compound, which can be used as a material for an organic electro-luminescence device, and to an organic electro-luminescence device comprising same. More particularly, the present invention relates to an organic compound having excellent thermal stability and light-emitting ability, and to an organic electro-luminescence device having improved luminescence efficiency, driving voltage, life span, and so forth by including the organic compound as a material of an organic layer.

Description

유기 화합물 및 이를 포함하는 유기 전계 발광 소자Organic compound and organic electroluminescent device comprising the same
본 발명은 유기 전계 발광 소자용 재료로서 사용될 수 있는 유기 화합물 및 이를 포함하는 유기 전계 발광 소자에 관한 것으로, 보다 구체적으로는 열적 안정성 및 발광능이 우수한 유기 화합물 및 상기 유기 화합물을 유기물층의 재료로서 포함하여 발광효율, 구동 전압, 수명 등의 특성이 향상된 유기 전계 발광 소자에 관한 것이다.The present invention relates to an organic compound that can be used as a material for an organic electroluminescent device and an organic electroluminescent device comprising the same, and more specifically, to include an organic compound having excellent thermal stability and luminescence ability and the organic compound as a material of an organic material layer. The present invention relates to an organic EL device having improved luminous efficiency, driving voltage, and lifetime.
1950년대 Bernanose의 유기 박막 발광 관측을 시점으로 하여, 1965년 안트라센 단결정을 이용한 청색 전기발광으로 이어진 유기 전계 발광(electroluminescent, EL) 소자(이하, 간단히 '유기 EL 소자'로 칭함)에 대한 연구가 이어져 오다가, 1987년 탕(Tang)에 의하여 정공층과 발광층의 기능층으로 나눈 적층구조의 유기 EL 소자가 제시되었다. 이후, 고효율, 고수명의 유기 EL 소자를 만들기 위하여, 소자 내 각각의 특징적인 유기물 층을 도입하는 형태로 발전하여 왔으며, 이에 사용되는 특화된 물질의 개발로 이어졌다. Based on Bernanose's observation of organic thin-film luminescence in the 1950s, the study of organic electroluminescent (EL) devices (hereinafter referred to simply as 'organic EL devices') led to blue electroluminescence using anthracene single crystals in 1965. In 1987, Tang proposed an organic EL device having a laminated structure divided into a functional layer of a hole layer and a light emitting layer. Since then, in order to make a high efficiency, long life organic EL device, it has evolved to introduce each characteristic organic material layer in the device, leading to the development of specialized materials used therein.
유기 전계 발광 소자는 두 전극 사이에 전압을 걸어 주면 양극에서는 정공이 유기물층으로 주입되고, 음극에서는 전자가 유기물층으로 주입된다. 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 바닥상태로 떨어질 때 빛이 나게 된다. 이때, 유기물층으로 사용되는 물질은 그 기능에 따라, 발광 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다. In the organic electroluminescent device, when a voltage is applied between two electrodes, holes are injected into the organic material layer at the anode, and electrons are injected into the organic material layer at the cathode. When the injected holes and electrons meet, excitons are formed, and when the excitons fall to the ground, they shine. In this case, the material used as the organic material layer may be classified into a light emitting material, a hole injection material, a hole transport material, an electron transport material, an electron injection material and the like according to its function.
발광 물질은 발광색에 따라 청색, 녹색, 적색 발광 물질과, 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색 발광 물질로 구분될 수 있다. 또한, 색순도의 증가와 에너지 전이를 통한 발광 효율을 증가시키기 위하여, 발광 물질로서 호스트/도판트 계를 사용할 수 있다. The light emitting material may be classified into blue, green, and red light emitting materials, and yellow and orange light emitting materials required to realize a better natural color according to the light emitting color. In addition, in order to increase luminous efficiency through an increase in color purity and energy transfer, a host / dopant system may be used as a light emitting material.
도판트 물질은 유기 물질을 사용하는 형광 도판트와 Ir, Pt 등의 중원자(heavy atoms)가 포함된 금속 착체 화합물을 사용하는 인광 도판트로 나눌 수 있다. 이때, 인광 재료의 개발은 이론적으로 형광에 비해 4배까지의 발광 효율을 향상시킬 수 있기 때문에, 인광 도판트 뿐만 아니라 인광 호스트 재료들에 대한 연구가 많이 진행되고 있다. The dopant material may be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. At this time, since the development of the phosphorescent material can theoretically improve the luminous efficiency up to 4 times compared to the fluorescence, research on phosphorescent host materials as well as phosphorescent dopants has been conducted.
현재까지 정공 주입층, 정공 수송층. 정공 차단층, 전자 수송층으로는 NPB, BCP, Alq3 등이 널리 알려져 있으며, 발광 재료로는 안트라센 유도체들이 형광 도판트/호스트 재료로서 보고되고 있다. 특히, 발광 재료 중 효율 향상 측면에서 큰 장점을 가지고 있는 인광 재료들은 Firpic, Ir(ppy)3, (acac)Ir(btp)2 등과 같은 Ir을 포함하는 금속 착체 화합물이 청색(blue), 녹색(green), 적색(red) 도판트 재료로 사용되고 있으며, 현재까지는 CBP가 인광 호스트 재료로 높은 특성을 나타내고 있다.Hole injection layer, hole transport layer to date. NPB, BCP, Alq 3 and the like are widely known as the hole blocking layer and the electron transport layer, and anthracene derivatives have been reported as fluorescent dopant / host materials as light emitting materials. In particular, phosphorescent materials having great advantages in terms of efficiency improvement among the light emitting materials include metal complex compounds including Ir such as Firpic, Ir (ppy) 3 , (acac) Ir (btp) 2, and the like. Green and red dopant materials are used, and CBP is a phosphorescent host material.
그러나, 종래 발광 물질들은 발광 특성 측면에서 양호하나, 유리전이온도가 낮아 열적 안정성이 매우 좋지 않기 때문에, 유기 EL 소자에서의 수명 측면에서 만족할만한 수준이 되지 못하고 있다. 따라서, 우수한 성능을 가지는 발광 물질의 개발이 요구되고 있다. However, the conventional luminescent materials are good in terms of luminescence properties, but due to low glass transition temperature and very poor thermal stability, they are not satisfactory in terms of lifespan in organic EL devices. Therefore, there is a demand for development of a light emitting material having excellent performance.
본 발명은 높은 유리 전이온도로 인해 열적 안정성이 우수하면서, 정공과 전자의 결합력을 향상시킬 수 있는 신규 유기 화합물을 제공하는 것을 목적으로 한다.It is an object of the present invention to provide a novel organic compound which is excellent in thermal stability due to a high glass transition temperature and can improve the binding force between holes and electrons.
또, 본 발명은 상기 신규 유기 화합물을 포함하여 구동전압, 발광효율 등이 향상된 유기 전계 발광 소자를 제공하는 것을 목적으로 한다.In addition, an object of the present invention is to provide an organic electroluminescent device having improved driving voltage, luminous efficiency and the like by including the novel organic compound.
본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다:The present invention provides a compound represented by Formula 1:
화학식 1
Figure PCTKR2013009778-appb-C000001
Formula 1
Figure PCTKR2013009778-appb-C000001
상기 화학식 1에서,In Chemical Formula 1,
R1 내지 R5는 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고, 또는 인접하는 기와 결합하여 축합 고리를 형성할 수 있으며,R 1 to R 5 are the same as or different from each other, and each independently hydrogen, deuterium, halogen, cyano, a substituted or unsubstituted C 1 -C 40 alkyl group, a substituted or unsubstituted C 2 -C 40 alkenyl group , Substituted or unsubstituted C 2 -C 40 alkynyl group, substituted or unsubstituted C 6 -C 40 aryl group, substituted or unsubstituted heteroaryl group having 5 to 40 nuclear atoms, substituted or unsubstituted C 6 ~ C 40 aryloxy group, substituted or unsubstituted C 1 ~ C 40 Alkyloxy group, substituted or unsubstituted C 6 ~ C 40 arylamine group, substituted or unsubstituted C 3 ~ C 40 A cycloalkyl group, a substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear atoms, a substituted or unsubstituted C 1 to C 40 alkylsilyl group, a substituted or unsubstituted C 1 to C 40 alkylboron group, Substituted or unsubstituted C 6 Through C 40 Aryl boron group, Substituted or unsubstituted C 6 Through C 40 Aryl phosphine group, Substituted or unsubstituted C 6 Through C 40 Is selected from the group consisting of an aryl phosphine oxide group and a substituted or unsubstituted C 6 ~ C 40 arylsilyl group, or may be combined with adjacent groups to form a condensed ring,
다만, 상기 R1과 R2는 서로 축합하여 하기 화학식 2 내지 4 중 하나로 표시되는 축합 고리를 형성하거나, 또는 R3 내지 R5 중 하나는 인접하는 기와 축합하여 하기 화학식 5로 표시되는 축합 고리를 형성하며,However, R 1 and R 2 may be condensed together to form a condensed ring represented by one of Formulas 2 to 4, or one of R 3 to R 5 may be condensed with an adjacent group to form a condensed ring represented by Formula 5 below. Forming,
화학식 2
Figure PCTKR2013009778-appb-C000002
Formula 2
Figure PCTKR2013009778-appb-C000002
화학식 3
Figure PCTKR2013009778-appb-C000003
Formula 3
Figure PCTKR2013009778-appb-C000003
화학식 4
Figure PCTKR2013009778-appb-C000004
Formula 4
Figure PCTKR2013009778-appb-C000004
화학식 5
Figure PCTKR2013009778-appb-C000005
Formula 5
Figure PCTKR2013009778-appb-C000005
R6 내지 R11은 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고, 또는 인접하는 기와 결합하여 축합 고리를 형성할 수 있으며,R 6 to R 11 are the same as or different from each other, and each independently hydrogen, deuterium, halogen, cyano, a substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted C 2 to C 40 alkenyl group , Substituted or unsubstituted C 2 -C 40 alkynyl group, substituted or unsubstituted C 6 -C 40 aryl group, substituted or unsubstituted heteroaryl group having 5 to 40 nuclear atoms, substituted or unsubstituted C 6 ~ C 40 aryloxy group, substituted or unsubstituted C 1 ~ C 40 Alkyloxy group, substituted or unsubstituted C 6 ~ C 40 arylamine group, substituted or unsubstituted C 3 ~ C 40 A cycloalkyl group, a substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear atoms, a substituted or unsubstituted C 1 to C 40 alkylsilyl group, a substituted or unsubstituted C 1 to C 40 alkylboron group, Substituted or unsubstituted C 6 Through C 40 Aryl boron group, Substituted or unsubstituted C 6 Through C 40 Aryl phosphine group, Substituted or unsubstituted C 6 Through C 40 Is selected from the group consisting of an aryl phosphine oxide group and a substituted or unsubstituted C 6 ~ C 40 arylsilyl group, or may be combined with adjacent groups to form a condensed ring,
Ar1은 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고,Ar 1 is a substituted or unsubstituted C 1 ~ C 40 alkyl group, a substituted or unsubstituted C 2 ~ C 40 alkenyl group, a substituted or unsubstituted C 2 ~ C 40 alkynyl group, a substituted or unsubstituted C 6 to C 40 aryl group, substituted or unsubstituted heteroaryl group having 5 to 40 nuclear atoms, substituted or unsubstituted C 6 to C 40 aryloxy group, substituted or unsubstituted C 1 to C 40 Alkyloxy group, substituted or unsubstituted C 6 to C 40 arylamine group, substituted or unsubstituted C 3 to C 40 cycloalkyl group, substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear atoms, substituted Or an unsubstituted C 1 to C 40 alkylsilyl group, a substituted or unsubstituted C 1 to C 40 alkylboron group, a substituted or unsubstituted C 6 to C 40 aryl boron group, a substituted or unsubstituted C 6 to C 40 arylphosphine group, substituted or unsubstituted C 6 to C 40 arylphosphine oxide group and substituted or unsubstituted C 6 to C 40 arylsilyl group Selected from the military,
n은 0 내지 4의 정수로서, n이 1 내지 4의 정수이면 하나 이상의 Ra는 각각 독립적으로 중수소, 할로겐, 시아노, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 및 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고, 또는 인접하는 기와 결합하여 축합 고리를 형성할 수 있으며;n is an integer from 0 to 4, and if n is an integer from 1 to 4, at least one Ra is each independently deuterium, halogen, cyano, substituted or unsubstituted C 1 -C 40 alkyl group, substituted or unsubstituted C Alkenyl group of 2 to C 40 , substituted or unsubstituted alkynyl group of C 2 to C 40 , substituted or unsubstituted C 6 to C 40 aryl group, substituted or unsubstituted heteroaryl of 5 to 40 nuclear atoms Groups, substituted or unsubstituted C 6 -C 40 aryloxy group, substituted or unsubstituted C 1 -C 40 alkyloxy group, substituted or unsubstituted C 6 -C 40 arylamine group, substituted or unsubstituted A substituted C 3 to C 40 cycloalkyl group, a substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear atoms, a substituted or unsubstituted C 1 to C 40 alkylsilyl group, a substituted or unsubstituted C 1 to C 40 alkyl boron group, and an aryl phosphonium substituted or unsubstituted C 6 ~ C 40 aryl boron group, a substituted or unsubstituted C 6 ~ C 40 of pingi, substituted Combines groups selected from the group consisting of aryl silyl unsubstituted C 6 ~ C 40 aryl phosphine oxide group, and a substituted or unsubstituted C 6 ~ C 40 is, or adjacent to form a condensed ring;
X는 단일결합이거나, 또는 C(R21)(R22), N(R23), O, 및 S로 이루어진 군에서 선택되고;X is a single bond or is selected from the group consisting of C (R 21 ) (R 22 ), N (R 23 ), O, and S;
R21 내지 R23 은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기 및 치환 또는 비치환된 C6~C40의 아릴아민기로 이루어진 군에서 선택되고;R 21 to R 23 are each independently hydrogen, deuterium, a substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted C 6 to C 40 aryl group, or a substituted or unsubstituted nuclear atom 5 to 5 40 heteroaryl group and substituted or unsubstituted C 6 ~ C 40 arylamine group;
상기 R1 내지 R11, Ra 및 Ar1의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 아릴아민기, 아릴알킬기, 시클로알킬기, 헤테로시클로알킬기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴실릴기;와 R21 내지 R23 의 알킬기, 아릴기, 헤테로아릴기 및 아릴아민기에 각각 도입되는 하나 이상의 치환기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군으로부터 선택되고, 이때 상기 치환기가 복수인 경우, 서로 동일하거나 상이하다.The alkyl group, alkenyl group, alkynyl group, aryl group, heteroaryl group, aryloxy group, alkyloxy group, arylamine group, arylalkyl group, cycloalkyl group, heterocycloalkyl group, alkyl of R 1 to R 11, Ra and Ar 1 A silyl group, an alkyl boron group, an aryl boron group, an aryl phosphine group, an aryl phosphine oxide group and an aryl silyl group; and one or more substituents respectively introduced to the alkyl, aryl, heteroaryl and arylamine groups of R 21 to R 23 . Are each independently deuterium, halogen, cyano group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 40 aryl group, nuclear atom 5 To 40 heteroaryl group, C 6 to C 40 aryloxy group, C 1 to C 40 alkyloxy group, C 6 to C 40 arylamine group, C 3 to C 40 cycloalkyl group, nuclear atom number 3 to 40 heterocycloalkyl group, C 1 ~ C 40 alkyl silyl group, C 1 ~ C 40 alkyl group of boron, C 6 ~ C 40 aryl group of boron, C 6 ~ C 40 aryl group Is selected from the spin group, C 6 ~ C 40 aryl phosphine oxide group, and a C 6 ~ C 40 aryl silyl group of the group consisting of, wherein if the plurality of substituents, the same or different from each other.
또한, 본 발명은 양극, 음극, 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, 상기 1층 이상의 유기물층 중에서 적어도 하나는 상기 화합물을 포함하는 것이 특징인 유기 전계 발광 소자를 제공한다.In addition, the present invention is an organic electroluminescent device comprising an anode, a cathode, and at least one organic layer interposed between the anode and the cathode, wherein at least one of the at least one organic layer comprises the compound. Provided is an organic electroluminescent device.
본 발명의 화학식 1 로 표시되는 화합물은 열적 안정성 및 인광 특성이 우수하기 때문에, 유기 전계 발광 소자의 발광층에 적용될 수 있다.Since the compound represented by Formula 1 of the present invention is excellent in thermal stability and phosphorescence properties, it may be applied to the light emitting layer of the organic EL device.
따라서, 본 발명의 화학식 1로 표시되는 화합물을 인광 호스트 물질로 사용할 경우, 종래 호스트 물질에 비해 우수한 발광 성능, 낮은 구동전압, 높은 효율 및 장수명을 갖는 유기 전계 발광 소자를 제조할 수 있고, 나아가 성능, 수명이 크게 향상된 풀 칼라 디스플레이 패널도 제조할 수 있다. Therefore, when the compound represented by Chemical Formula 1 of the present invention is used as a phosphorescent host material, an organic electroluminescent device having excellent light emission performance, low driving voltage, high efficiency and long life compared to the conventional host material can be manufactured, and further, performance In addition, a full color display panel with a greatly improved lifespan can be manufactured.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명에 따른 신규 화합물은 피롤로아크리딘 모이어티(pyrroloacridine moiety)의 말단에 인돌(indole) 모이어티가 융합(fused)되어 기본 골격을 이루며, 이러한 기본 골격에 다양한 치환체가 결합된 구조로서, 상기 화학식 1로 표시되는 것을 특징으로 한다. 이러한 화학식 1로 표시되는 화합물은 종래 유기 EL 소자용 재료 [예: 4,4-dicarbazolybiphenyl (이하, 'CBP'로 표시함)]보다 분자량이 클 뿐만 아니라, 넓은 에너지 밴드갭을 가지면서, 정공과 전자의 결합력을 높일 수 있다. 따라서, 상기 화학식 1의 화합물을 유기 EL 소자에 이용할 경우, 소자의 구동 전압, 효율(발광효율, 전력효율), 수명 및 휘도 측면이 향상될 수 있다.The novel compound according to the present invention is a structure in which an indole moiety is fused to a terminal of a pyrroloacridine moiety to form a basic skeleton, and various substituents are bonded to the basic skeleton. It is characterized by represented by the formula (1). The compound represented by the formula (1) has a higher molecular weight than the conventional organic EL device material [for example, 4,4-dicarbazolybiphenyl (hereinafter referred to as 'CBP')], and has a wide energy band gap, The bonding force of the electrons can be increased. Therefore, when the compound of Formula 1 is used in an organic EL device, the driving voltage, efficiency (light emitting efficiency, power efficiency), lifetime, and luminance of the device may be improved.
상기 화학식 1로 표시되는 화합물은 피롤로아크리딘 모이어티(pyrroloacridine moiety)의 말단에 전자 공여성이 큰 인돌(indole) 모이어티가 결합된 구조로 넓은 밴드갭을 가질 수 있다. 뿐만 아니라, 상기 화합물은 기본 골격에 전자 흡수성이 큰 전자 끌개기(EWG)가 결합된 다양한 방향족 환(aromatic ring) 치환체로 인해서 분자 전체가 바이폴라(bipolar) 특성을 가지면서, 정공과 전자의 결합력을 높일 수 있다. 따라서, 유기 EL 소자에 상기 화합물을 적용할 경우, 종래 CBP에 비해 발광층의 호스트 재료로서 우수한 특성을 나타낼 수 있기 때문에, 소자의 인광특성이 개선됨과 동시에 정공 주입 능력 및/또는 수송 능력, 발광효율, 구동전압, 수명 특성 등이 개선될 수 있다. 그리고, 상기 치환체에 따라 에너지 레벨이 조절될 수 있어 넓은 밴드갭(sky blue ~ red)을 갖게 되고, 따라서 발광층뿐만 아니라, 정공 수송층, 정공 주입층 등으로도 응용될 수 있다. The compound represented by Chemical Formula 1 may have a wide bandgap in which an indole moiety having a large electron donor is bonded to a terminal of a pyrroloacridine moiety. In addition, the compound has a bipolar characteristic of the entire molecule due to the various aromatic ring substituents in which the electron withdrawal group (EWG) having high electron absorption is bonded to the basic skeleton, and thus the bonding force between the holes and the electrons is improved. It can increase. Therefore, when the compound is applied to the organic EL device, since it can exhibit excellent properties as a host material of the light emitting layer compared to the conventional CBP, the phosphorescence property of the device is improved, and at the same time, the hole injection capacity and / or transport capacity, luminous efficiency, Driving voltage, lifespan characteristics and the like can be improved. In addition, the energy level may be adjusted according to the substituents to have a wide band gap (sky blue to red), and thus may be applied to not only the light emitting layer but also a hole transport layer, a hole injection layer, and the like.
한편, 유기 전계 발광 소자의 인광 발광층에서, 호스트 물질은 호스트의 삼중항 에너지 갭이 도펀트보다 높아야 한다. 즉, 도펀트로부터 효과적으로 인광 발광을 제공하기 위해서는 호스트의 가장 낮은 여기 상태가 도펀트의 가장 낮은 방출 상태보다 에너지가 더 높아야 한다. 본 발명의 화학식 1로 표시되는 화합물은 인돌 모이어티를 중심 골격으로 가지는데 인광 발광에 적합한 삼중항 에너지를 가지고 있다.On the other hand, in the phosphorescent layer of the organic EL device, the host material should have a triplet energy gap of the host higher than the dopant. That is, in order to effectively provide phosphorescence from the dopant, the lowest excited state of the host must be higher in energy than the lowest emitted state of the dopant. The compound represented by Formula 1 of the present invention has an indole moiety as a central skeleton and has triplet energy suitable for phosphorescence emission.
또한, 인돌(indole) 모이어티에 다수 도입된 다양한 방향족 환(aromatic ring) 치환체로 인해 화합물의 분자량이 유의적으로 증대됨으로써, 유리전이온도가 향상될 수 있고, 이로 인해 종래 CBP 보다 높은 열적 안정성을 가질 수 있다. 또한, 상기 피롤로아크리딘 모이어티(pyrroloacridine moiety)의 말단에 결합된 인돌 모이어티(indole moiety)가 융합됨으로써, 화합물의 열적 안정성이 향상될 수 있을 뿐만 아니라, 상기 화학식 1의 화합물을 포함하는 유기층의 결정화 억제에도 효과가 있다. 따라서, 본 발명에 따른 화학식 1의 화합물을 포함하는 소자는 내구성 및 수명 특성을 크게 향상시킬 수 있다. In addition, the molecular weight of the compound is significantly increased due to the various aromatic ring substituents introduced into the indole moiety, so that the glass transition temperature can be improved, thereby having higher thermal stability than the conventional CBP. Can be. In addition, by infusing an indole moiety bound to the terminal of the pyrroloacridine moiety, not only the thermal stability of the compound may be improved, but also the compound of Formula 1 It is also effective in suppressing crystallization of the organic layer. Therefore, the device including the compound of formula 1 according to the present invention can greatly improve the durability and life characteristics.
아울러, 본 발명에 따른 화학식 1의 화합물을 유기 EL 소자의 정공 주입/수송층 재료, 청색, 녹색 및/또는 적색의 인광 호스트 재료로 채택할 경우, 종래 CBP 대비 효율 및 수명 면에서 월등히 우수한 효과를 발휘할 수 있다. 따라서, 본 발명에 따른 화합물은 유기 EL 소자의 성능 개선 및 수명 향상에 크게 기여할 수 있으며, 특히 이러한 소자 수명 향상은 풀 칼라 유기 발광 패널에서의 성능 극대화에도 큰 효과가 있다.In addition, when the compound of Chemical Formula 1 according to the present invention is adopted as a hole injection / transport layer material of an organic EL device, a phosphorescent host material of blue, green and / or red color, the compound having the excellent efficiency and lifespan may be superior to the conventional CBP. Can be. Therefore, the compound according to the present invention can greatly contribute to improving the performance and lifespan of the organic EL device, and in particular, the device life improvement has a great effect on maximizing the performance in the full color organic light emitting panel.
본 발명에 따른 화학식 1로 표시되는 화합물에서, R1 내지 R5는 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고, 또는 인접하는 기와 결합하여 축합 고리를 형성할 수 있다.In the compound represented by Formula 1 according to the present invention, R 1 to R 5 are the same as or different from each other, each independently hydrogen, deuterium, halogen, cyano, substituted or unsubstituted C 1 ~ C 40 alkyl group, substituted Or an unsubstituted C 2 -C 40 alkenyl group, a substituted or unsubstituted C 2 -C 40 alkynyl group, a substituted or unsubstituted C 6 -C 40 aryl group, a substituted or unsubstituted nuclear atom 5 To 40 heteroaryl groups, substituted or unsubstituted C 6 to C 40 aryloxy groups, substituted or unsubstituted C 1 to C 40 alkyloxy groups, substituted or unsubstituted C 6 to C 40 arylamines Groups, substituted or unsubstituted C 3 to C 40 cycloalkyl group, substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear atoms, substituted or unsubstituted C 1 to C 40 alkylsilyl group, substituted or unsubstituted Substituted C 1 to C 40 alkylboron group, substituted or unsubstituted C 6 to C 40 arylboron group, substituted or unsubstituted C 6 to C 40 arylphosphine group, substituted or unsubstituted C 6 ~ C 40 aryl phosphine oxide group and substituted or unsubstituted C 6 ~ C 40 arylsilyl group selected from the group, or in combination with an adjacent group Condensed rings can be formed.
이때, 상기 R1 내지 R5의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 아릴아민기, 아릴알킬기, 시클로알킬기, 헤테로시클로알킬기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴실릴기에 각각 도입되는 하나 이상의 치환기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군으로부터 선택되되, 상기 치환기가 복수인 경우, 서로 동일하거나 상이할 수 있다.At this time, the alkyl group, alkenyl group, alkynyl group, aryl group, heteroaryl group, aryloxy group, alkyloxy group, arylamine group, arylalkyl group, cycloalkyl group, heterocycloalkyl group, alkylsilyl group of the R 1 to R 5 , One or more substituents each introduced into an alkylboron group, an arylboron group, an arylphosphine group, an arylphosphine oxide group and an arylsilyl group are each independently deuterium, halogen, cyano group, C 1 -C 40 alkyl group, C 2 -C 40 alkenyl group, C 2 to C 40 alkynyl group, C 6 to C 40 aryl group, nuclear atom 5 to 40 heteroaryl group, C 6 to C 40 aryloxy group, C 1 to C 40 Alkyloxy group, C 6 -C 40 arylamine group, C 3 -C 40 cycloalkyl group, nuclear atom 3-40 heterocycloalkyl group, C 1 -C 40 alkylsilyl group, C 1 -C 40 boron alkyl group, C 6 ~ C 60 aryl boron group, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 aryl phosphine oxide group, and a C 6 ~ C 40 aryl silyl group Doedoe selected from the group consisting of, in the case where the substituent a plurality, may be identical to or different from each other.
다만, 상기 R1 내지 R5 중에서 R1과 R2가 서로 축합(fused)하여 상기 화학식 2 내지 4 중 하나로 표시되는 축합(fused) 고리를 형성하거나, 또는 R3 내지 R5 중 하나가 인접하는 기와 결합하여 상기 화학식 5로 표시되는 축합 고리를 형성하여야 한다. 예를 들어, 상기 R1 내지 R5 중에서 R3가 인접하는 기 R4와 축합하여 상기 화학식 화학식 5로 표시되는 축합 고리를 형성할 경우, 하기 화학식 6 또는 8로 표시되는 화합물이 형성된다. 또는, 상기 R1 내지 R5 중에서 R1과 R2가 축합하여 상기 화학식 2 내지 4 중 하나로 표시되는 축합 고리를 형성할 경우, 하기 화학식 10 내지 15 중 하나로 표시되는 화합물이 형성된다.However, R 1 and R 2 may be fused to each other in R 1 to R 5 to form a fused ring represented by one of Formulas 2 to 4, or one of R 3 to R 5 may be adjacent to each other. It should be combined with the group to form a condensed ring represented by the formula (5). For example, when R 3 is condensed with an adjacent group R 4 in the R 1 to R 5 to form a condensed ring represented by Chemical Formula 5, a compound represented by the following Chemical Formula 6 or 8 is formed. Alternatively, when R 1 and R 2 are condensed in the R 1 to R 5 to form a condensed ring represented by one of Formulas 2 to 4, a compound represented by one of Formulas 10 to 15 is formed.
상기 화학식 2 내지 5에서, 점선은 화학식 1의 화합물과 축합이 이루어지는 부위를 의미한다.In Chemical Formulas 2 to 5, the dotted line refers to a site where condensation occurs with the compound of Chemical Formula 1.
상기 R6 내지 R11은 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고, 또는 인접하는 기와 결합하여 축합 고리를 형성할 수 있다.R 6 to R 11 are the same as or different from each other, and each independently hydrogen, deuterium, halogen, cyano, a substituted or unsubstituted C 1 -C 40 alkyl group, a substituted or unsubstituted C 2 -C 40 alkene Nyl group, substituted or unsubstituted C 2 to C 40 alkynyl group, substituted or unsubstituted C 6 to C 40 aryl group, substituted or unsubstituted heteroaryl group having 5 to 40 nuclear atoms, substituted or unsubstituted C 6 ~ C 40 aryloxy group, substituted or unsubstituted C 1 ~ C 40 Alkyloxy group, substituted or unsubstituted C 6 ~ C 40 arylamine group, substituted or unsubstituted C 3 ~ C 40 cycloalkyl groups, substituted or unsubstituted heterocycloalkyl groups having 3 to 40 nuclear atoms, substituted or unsubstituted C 1 to C 40 alkylsilyl groups, substituted or unsubstituted C 1 to C 40 alkylboron groups , Substituted or unsubstituted C 6 ~ C 40 arylboron group, substituted or unsubstituted C 6 ~ C 40 arylphosphine group, substituted or unsubstituted C It may be selected from the group consisting of 6 ~ C 40 aryl phosphine oxide group and substituted or unsubstituted C 6 ~ C 40 arylsilyl group, or may be combined with adjacent groups to form a condensed ring.
이때, 상기 R6 내지 R11의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 아릴아민기, 아릴알킬기, 시클로알킬기, 헤테로시클로알킬기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴실릴기에 각각 도입되는 하나 이상의 치환기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군으로부터 선택된다. 다만, 상기 치환기가 복수인 경우, 서로 동일하거나 상이할 수 있다.At this time, the alkyl group, alkenyl group, alkynyl group, aryl group, heteroaryl group, aryloxy group, alkyloxy group, arylamine group, arylalkyl group, cycloalkyl group, heterocycloalkyl group, alkylsilyl group of R 6 to R 11 , One or more substituents each introduced into an alkylboron group, an arylboron group, an arylphosphine group, an arylphosphine oxide group and an arylsilyl group are each independently deuterium, halogen, cyano group, C 1 -C 40 alkyl group, C 2 -C 40 alkenyl group, C 2 to C 40 alkynyl group, C 6 to C 40 aryl group, nuclear atom 5 to 40 heteroaryl group, C 6 to C 40 aryloxy group, C 1 to C 40 Alkyloxy group, C 6 -C 40 arylamine group, C 3 -C 40 cycloalkyl group, nuclear atom 3-40 heterocycloalkyl group, C 1 -C 40 alkylsilyl group, C 1 -C 40 boron alkyl group, C 6 ~ C 60 aryl boron group, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 aryl phosphine oxide group, and a C 6 ~ C 40 aryl silyl group It is selected from the group consisting. However, when there are a plurality of substituents, they may be the same or different from each other.
상기 Ar1은 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고, 바람직하게는 치환 또는 비치환된 C6~C40의 아릴기, 및 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기로 이루어진 군으로부터 선택될 수 있다. Ar 1 is a substituted or unsubstituted C 1 ~ C 40 Alkyl group, a substituted or unsubstituted C 2 ~ C 40 Alkenyl group, a substituted or unsubstituted C 2 ~ C 40 Alkynyl group, a substituted or unsubstituted C 6 ~ C 40 aryl group, substituted or unsubstituted heteroaryl group having 5 to 40 nuclear atoms, substituted or unsubstituted C 6 ~ C 40 aryloxy group, substituted or unsubstituted C 1 ~ C 40 An alkyloxy group, a substituted or unsubstituted C 6 -C 40 arylamine group, a substituted or unsubstituted C 3 -C 40 cycloalkyl group, a substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear atoms, Substituted or unsubstituted C 1 to C 40 alkylsilyl group, substituted or unsubstituted C 1 to C 40 alkylboron group, substituted or unsubstituted C 6 to C 40 arylboron group, substituted or unsubstituted aryl silyl group of C 6 ~ C 40 aryl phosphine group, a substituted or unsubstituted C 6 ~ C 40 aryl phosphine oxide group, and a substituted or unsubstituted C 6 ~ C 40 is Is selected from the group eojin, and preferably may be selected from substituted or unsubstituted aryl group of C 6 ~ C 40 ring, and a substituted or unsubstituted hetero group, the aryl ring of the number of nuclear atoms of 5 to 40.
이때, 상기 Ar1의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 아릴아민기, 아릴알킬기, 시클로알킬기, 헤테로시클로알킬기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴실릴기에 각각 도입되는 하나 이상의 치환기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군으로부터 선택된다. 다만, 상기 치환기가 복수인 경우, 서로 동일하거나 상이할 수 있다.In this case, an alkyl group, an alkenyl group, an alkynyl group, an aryl group of said Ar 1, a heteroaryl group, an aryloxy group, an alkyloxy group, an arylamine group, an aryl group, a cycloalkyl group, a heterocycloalkyl group, alkylsilyl group, an alkyl boronic group , At least one substituent introduced into each of the aryl boron group, aryl phosphine group, aryl phosphine oxide group and aryl silyl group is each independently deuterium, halogen, cyano group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenes group, C 2 ~ C 40 alkynyl group, C 6 ~ C 40 aryl group, an aryloxy group of nuclear atoms aryl of from 5 to 40 heteroaryl group, a C 6 ~ C 40, alkyloxy group of C 1 ~ C 40 of the , C 6 -C 40 arylamine group, C 3 -C 40 cycloalkyl group, nuclear atom 3 to 40 heterocycloalkyl group, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 alkyl boron group , C 6 ~ C 40 aryl boron group, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 aryl phosphine oxide group, and a C 6 ~ C 40 aryl group made of the silyl It is selected from the group true. However, when there are a plurality of substituents, they may be the same or different from each other.
상기 화학식 1의 화합물에서, n은 0 내지 4의 정수이다. 상기 n이 0이면, 수소가 치환기 Ra로 치환되지 않는 것을 의미한다. 또, 상기 n이 1 내지 4의 정수이면, 수소가 치환기 Ra로 치환된 것으로서, 하나 이상의 Ra는 각각 독립적으로 중수소, 할로겐, 시아노, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고, 또는 인접하는 기와 결합하여 축합 고리를 형성할 수 있다.In the compound of Formula 1, n is an integer of 0 to 4. When n is 0, it means that hydrogen is not substituted by the substituent Ra. In addition, when n is an integer of 1 to 4, hydrogen is substituted with a substituent Ra, and at least one Ra is each independently deuterium, halogen, cyano, substituted or unsubstituted C 1 to C 40 alkyl group, substituted or Unsubstituted C 2 to C 40 alkenyl group, substituted or unsubstituted C 2 to C 40 alkynyl group, substituted or unsubstituted C 6 to C 40 aryl group, substituted or unsubstituted nuclear atom 5 to 5 40 heteroaryl groups, substituted or unsubstituted C 6 -C 40 aryloxy groups, substituted or unsubstituted C 1 -C 40 alkyloxy groups, substituted or unsubstituted C 6 -C 40 arylamine groups , Substituted or unsubstituted C 3 to C 40 cycloalkyl group, substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear atoms, substituted or unsubstituted C 1 to C 40 alkylsilyl group, substituted or unsubstituted C 1 ~ C 40 alkyl boron group, substituted or unsubstituted C 6 ~ C 40 aryl boron group, substituted or unsubstituted C 6 ~ C 40 A arylphosphine group, a substituted or unsubstituted C 6 -C 40 arylphosphine oxide group, and a substituted or unsubstituted C 6 -C 40 arylsilyl group, or a condensed ring in combination with an adjacent group Can be formed.
이때, 상기 Ra의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 아릴아민기, 아릴알킬기, 시클로알킬기, 헤테로시클로알킬기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴실릴기에 각각 도입되는 하나 이상의 치환기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군으로부터 선택된다. 다만, 상기 치환기가 복수인 경우, 서로 동일하거나 상이할 수 있다.At this time, the alkyl group, alkenyl group, alkynyl group, aryl group, heteroaryl group, aryloxy group, alkyloxy group, arylamine group of the Ra, arylalkyl group, cycloalkyl group, heterocycloalkyl group, alkylsilyl group, alkyl boron group, One or more substituents introduced into the arylborone group, the arylphosphine group, the arylphosphine oxide group and the arylsilyl group are each independently deuterium, halogen, cyano group, C 1 -C 40 alkyl group, C 2 -C 40 alkenyl group , C 2 ~ C 40 alkynyl group, C 6 ~ C 40 aryl group, an aryloxy group of nuclear atoms aryl of from 5 to 40 heteroaryl group, a C 6 ~ C 40, alkyloxy group of C 1 ~ C 40 of, C 6 ~ C 40 arylamine group, C 3 ~ C 40 cycloalkyl group, C 3 ~ C 40 heterocycloalkyl group, C 1 ~ C 40 Alkylsilyl group, C 1 ~ C 40 Alkyl boron group, C 6 ~ C 40 aryl boron group, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 aryl phosphine oxide group, and a C 6 ~ C 40 aryl group in the silyl done It is selected from the group. However, when there are a plurality of substituents, they may be the same or different from each other.
상기 X는 직접 연결된 단일 결합이거나, 또는 C(R21)(R22), N(R23), O 및 S로 이루어진 군에서 선택되고, 바람직하게는 단일 결합이거나, 또는 C(R21)(R22)일 수 있다. X is a single bond directly connected or is selected from the group consisting of C (R 21 ) (R 22 ), N (R 23 ), O and S, preferably a single bond, or C (R 21 ) ( R 22 ).
상기 R21 내지 R23은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 및 치환 또는 비치환된 C6~C40의 아릴아민기로 이루어진 군에서 선택된다. 본 발명의 일례에 따르면, 상기 X가 C(R21)(R22)인 경우, 상기 R21 및 R22는 수소, 치환 또는 비치환된 C1~C40의 알킬기, 또는 치환 또는 비치환된 C6~C40의 아릴기인 것이 바람직하며, 메틸기 또는 페닐기인 것이 더 바람직하다.R 21 to R 23 are each independently hydrogen, deuterium, a substituted or unsubstituted C 1 -C 40 alkyl group, a substituted or unsubstituted C 6 -C 40 aryl group, a substituted or unsubstituted nuclear atom 5 To 40 heteroaryl groups, and a substituted or unsubstituted C 6 ~ C 40 arylamine group. According to an example of the present invention, when X is C (R 21 ) (R 22 ), R 21 and R 22 are hydrogen, a substituted or unsubstituted C 1 -C 40 alkyl group, or a substituted or unsubstituted group. preferably C 6 ~ C 40 aryl group in it, and it is more preferred that the methyl group or a phenyl group.
이때, 상기 R21 내지 R23의 알킬기, 아릴기, 헤테로아릴기 및 아릴아민기에 각각 도입되는 하나 이상의 치환기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군으로부터 선택된다. 다만, 상기 치환기가 복수인 경우, 서로 동일하거나 상이할 수 있다.At this time, one or more substituents introduced into each of the alkyl group, aryl group, heteroaryl group and arylamine group of R 21 to R 23 are each independently deuterium, halogen, cyano group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 to C 40 alkynyl group, C 6 to C 40 aryl group, nuclear atom 5 to 40 heteroaryl group, C 6 to C 40 aryloxy group, C 1 to C 40 Alkyloxy group, C 6 -C 40 arylamine group, C 3 -C 40 cycloalkyl group, nuclear atom 3-40 heterocycloalkyl group, C 1 -C 40 alkylsilyl group, C 1 -C 40 alkyl boron group, C 6 ~ C group 60 arylboronic of, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 aryl phosphine oxide group, and a C 6 ~ is selected from an aryl silyl group the group consisting of C 40 . However, when there are a plurality of substituents, they may be the same or different from each other.
본 발명에 따른 화학식 1의 화합물에서, 바람직하게는 R1 내지 R11, Ra 및 Ar1은 각각 독립적으로 수소, 또는 하기 치환기 S1 내지 S206으로 이루어진 군에서 선택될 수 있는데, 이에 한정되는 것은 아니다. In the compound of Formula 1 according to the present invention, preferably R 1 to R 11, Ra and Ar 1 may be each independently selected from the group consisting of hydrogen or the following substituents S1 to S206, but is not limited thereto.
Figure PCTKR2013009778-appb-I000001
Figure PCTKR2013009778-appb-I000001
Figure PCTKR2013009778-appb-I000002
Figure PCTKR2013009778-appb-I000002
Figure PCTKR2013009778-appb-I000003
Figure PCTKR2013009778-appb-I000003
Figure PCTKR2013009778-appb-I000004
Figure PCTKR2013009778-appb-I000004
Figure PCTKR2013009778-appb-I000005
Figure PCTKR2013009778-appb-I000005
Figure PCTKR2013009778-appb-I000006
Figure PCTKR2013009778-appb-I000006
Figure PCTKR2013009778-appb-I000007
Figure PCTKR2013009778-appb-I000007
Figure PCTKR2013009778-appb-I000008
Figure PCTKR2013009778-appb-I000008
상기 화학식 1의 화합물에서, 상기 Ar1은 하기 치환기 A1 내지 A64로 이루어진 군에서 선택된 것이 바람직할 수 있다.In the compound of Formula 1, Ar 1 may be preferably selected from the group consisting of the following substituents A1 to A64.
Figure PCTKR2013009778-appb-I000009
Figure PCTKR2013009778-appb-I000009
Figure PCTKR2013009778-appb-I000010
Figure PCTKR2013009778-appb-I000010
Figure PCTKR2013009778-appb-I000011
Figure PCTKR2013009778-appb-I000011
Figure PCTKR2013009778-appb-I000012
Figure PCTKR2013009778-appb-I000012
Figure PCTKR2013009778-appb-I000013
Figure PCTKR2013009778-appb-I000013
Figure PCTKR2013009778-appb-I000014
Figure PCTKR2013009778-appb-I000014
본 발명에 따른 화학식 1로 표시되는 화합물의 예로는, 하기 화학식6 내지 15로 표시되는 화합물 등이 있는데, 이에 한정되지 않는다.Examples of the compound represented by Formula 1 according to the present invention include a compound represented by the following Formulas 6 to 15, but are not limited thereto.
화학식 6
Figure PCTKR2013009778-appb-C000006
Formula 6
Figure PCTKR2013009778-appb-C000006
화학식 7
Figure PCTKR2013009778-appb-C000007
Formula 7
Figure PCTKR2013009778-appb-C000007
화학식 8
Figure PCTKR2013009778-appb-C000008
Formula 8
Figure PCTKR2013009778-appb-C000008
화학식 9
Figure PCTKR2013009778-appb-C000009
Formula 9
Figure PCTKR2013009778-appb-C000009
화학식 10
Figure PCTKR2013009778-appb-C000010
Formula 10
Figure PCTKR2013009778-appb-C000010
화학식 11
Figure PCTKR2013009778-appb-C000011
Formula 11
Figure PCTKR2013009778-appb-C000011
화학식 12
Figure PCTKR2013009778-appb-C000012
Formula 12
Figure PCTKR2013009778-appb-C000012
화학식 13
Figure PCTKR2013009778-appb-C000013
Formula 13
Figure PCTKR2013009778-appb-C000013
화학식 14
Figure PCTKR2013009778-appb-C000014
Formula 14
Figure PCTKR2013009778-appb-C000014
화학식 15
Figure PCTKR2013009778-appb-C000015
Formula 15
Figure PCTKR2013009778-appb-C000015
상기 화학식 6 내지 화학식 15에서, In Chemical Formulas 6 to 15,
R1 내지 R11, Ra, Ar1, X 및 n은 각각 화학식 1에서 정의한 바와 같다.R 1 to R 11 , Ra, Ar 1, X and n are the same as defined in Chemical Formula 1.
상기 화학식 1로 표시되는 화합물의 구체적인 예로는 하기 화학식 INV-1 내지 INV-20로 표시되는 화합물 등이 있는데, 이에 한정되지 않는다:Specific examples of the compound represented by Formula 1 include compounds represented by the following formulas INV-1 to INV-20, but are not limited thereto.
Figure PCTKR2013009778-appb-I000015
Figure PCTKR2013009778-appb-I000015
Figure PCTKR2013009778-appb-I000016
Figure PCTKR2013009778-appb-I000016
Figure PCTKR2013009778-appb-I000017
Figure PCTKR2013009778-appb-I000017
Figure PCTKR2013009778-appb-I000018
Figure PCTKR2013009778-appb-I000018
Figure PCTKR2013009778-appb-I000019
Figure PCTKR2013009778-appb-I000019
Figure PCTKR2013009778-appb-I000020
Figure PCTKR2013009778-appb-I000020
Figure PCTKR2013009778-appb-I000021
Figure PCTKR2013009778-appb-I000021
상기 화학식 INV-1 내지 INV-20에 있어서, In Chemical Formulas INV-1 to INV-20,
R1 내지 R11, Ra, Ar1 및 n은 각각 화학식 1에서 정의한 바와 같다.R 1 to R 11 , Ra, Ar 1 and n are the same as defined in Chemical Formula 1.
상기 화학식 1로 표시되는 화합물의 대표적인 예로는 하기 화합물들이 있으나, 이에 한정되는 것은 아니다.Representative examples of the compound represented by Formula 1 include the following compounds, but are not limited thereto.
Figure PCTKR2013009778-appb-I000022
Figure PCTKR2013009778-appb-I000022
Figure PCTKR2013009778-appb-I000023
Figure PCTKR2013009778-appb-I000023
Figure PCTKR2013009778-appb-I000024
Figure PCTKR2013009778-appb-I000024
Figure PCTKR2013009778-appb-I000025
Figure PCTKR2013009778-appb-I000025
Figure PCTKR2013009778-appb-I000026
Figure PCTKR2013009778-appb-I000026
Figure PCTKR2013009778-appb-I000027
Figure PCTKR2013009778-appb-I000027
Figure PCTKR2013009778-appb-I000028
Figure PCTKR2013009778-appb-I000028
Figure PCTKR2013009778-appb-I000029
Figure PCTKR2013009778-appb-I000029
Figure PCTKR2013009778-appb-I000030
Figure PCTKR2013009778-appb-I000030
본 발명에서 사용되는 "비치환된 알킬"은 탄소수 1 내지 40의 직쇄 또는 측쇄의 포화 탄화수소에서 유래되는 1가의 치환기이며, 이의 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등을 포함한다. As used herein, "unsubstituted alkyl" is a monovalent substituent derived from a straight or branched chain saturated hydrocarbon of 1 to 40 carbon atoms, examples of which are methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso -Amyl, hexyl and the like.
또, 본 발명에서 "비치환된 알케닐(alkenyl)"은 탄소-탄소 이중 결합을 1개 이상 가진, 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기이며, 이의 예로는 비닐(vinyl), 알릴(allyl), 이소프로펜일(isopropenyl), 2-부텐일(2-butenyl) 등이 있으며, 이에 한정되는 것은 아니다. In the present invention, "unsubstituted alkenyl" is a monovalent substituent derived from a C2-C40 straight or branched chain unsaturated hydrocarbon having at least one carbon-carbon double bond, and examples thereof include vinyl. (vinyl), allyl, isopropenyl, 2-butenyl, and the like, but are not limited thereto.
또, 본 발명에서 "비치환된 알키닐(alkynyl)"은 탄소-탄소 삼중 결합을 1개 이상 가진, 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기이며, 이의 예로는 에타인일(ethynyl), 2-프로파인일(2-propynyl) 등이 있는데, 이에 제한되는 것은 아니다.In the present invention, "unsubstituted alkynyl" is a monovalent substituent derived from a C2-C40 straight or branched chain unsaturated hydrocarbon having at least one carbon-carbon triple bond, and examples thereof include eta. Ethynyl, 2-propynyl, and the like, but are not limited thereto.
또, 본 발명에서 "비치환된 아릴"은 단독 고리 또는 2 이상의 고리가 조합된, 탄소수 6 내지 60의 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된(fused) 형태로 부착될 수 있다. 아릴의 예로는 페닐, 나프틸, 페난트릴, 안트릴 등이 포함되며 이에 한정되는 것은 아니다.In addition, in the present invention, "unsubstituted aryl" means a monovalent substituent derived from an aromatic hydrocarbon having 6 to 60 carbon atoms in which a single ring or two or more rings are combined. Two or more rings may be attached in a simple or fused form with one another. Examples of aryl include, but are not limited to, phenyl, naphthyl, phenanthryl, anthryl, and the like.
또, 본 발명에서 "비치환된 헤테로아릴"은 핵원자수 5 내지 40의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로원자로 치환된다. 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된(fused) 형태로 부착될 수 있고, 나아가 아릴기와의 축합된 형태도 포함하는 것으로 해석한다. 헤테로아릴의 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6-원 모노사이클릭 고리; 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리를 포함하고, 2-퓨라닐, N-이미다졸릴, 2-이속사졸릴, 2-피리디닐, 2-피리미디닐 등도 포함하는 것으로 해석한다.In addition, in the present invention, "unsubstituted heteroaryl" means a monovalent substituent derived from monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 40 nuclear atoms. At least one carbon in the ring, preferably 1 to 3 carbons, is substituted with a heteroatom such as N, O, S or Se. It is understood that two or more rings may be attached in a simple or fused form to each other and further include a condensed form with an aryl group. Examples of heteroaryl include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl; Polycyclics such as phenoxathienyl, indolinzinyl, indolyl, purinyl, quinolyl, benzothiazole, carbazolyl It is understood to include a ring and to include 2-furanyl, N-imidazolyl, 2-isoxazolyl, 2-pyridinyl, 2-pyrimidinyl, and the like.
또, 본 발명에서 "비치환된 아릴옥시"는 RO-로 표시되는 1가의 치환기로서, 상기 R은 탄소수 5 내지 60의 아릴이다. 아릴옥시의 예로는 페닐옥시, 나프틸옥시, 디페닐옥시 등이 있다.In the present invention, "unsubstituted aryloxy" is a monovalent substituent represented by RO-, wherein R is aryl having 5 to 60 carbon atoms. Examples of aryloxy include phenyloxy, naphthyloxy, diphenyloxy and the like.
또, 본 발명에서 "비치환된 알킬옥시"는 R'O-로 표시되는 1가의 치환기로서, 상기 R'는 1 내지 40개의 알킬을 의미하며, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함하는 것으로 해석한다. 알킬옥시의 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등이 포함될 수 있으며 이에 한정되지는 않는다. In the present invention, "unsubstituted alkyloxy" is a monovalent substituent represented by R'O-, wherein R 'means 1 to 40 alkyl, and is linear, branched or cyclic. It is interpreted as including a (cyclic) structure. Examples of alkyloxy may include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy and the like.
또, 본 발명에서 "비치환된 아릴아민"은 탄소수 6 내지 60의 아릴로 치환된 아민을 의미한다.In addition, in the present invention, "unsubstituted arylamine" means an amine substituted with aryl having 6 to 60 carbon atoms.
또, 본 발명에서 "비치환된 시클로알킬"은 탄소수 3 내지 40의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이러한 사이클로알킬의 예로는 사이클로프로필, 사이클로펜틸, 사이클로헥실, 놀보닐(norbornyl), 아다만틴(adamantine)등이 포함되지만 이에 한정되는 것은 아니다. In the present invention, "unsubstituted cycloalkyl" means a monovalent substituent derived from a monocyclic or polycyclic non-aromatic hydrocarbon having 3 to 40 carbon atoms. Examples of such cycloalkyls include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine, and the like.
또, 본 발명에서 "비치환된 헤테로시클로알킬"은 핵원자수 3 내지 40의 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O 또는 S와 같은 헤테로 원자로 치환된다. 이의 비-제한적인 예로는 모르폴린, 피페라진 등이 있다.In the present invention, "unsubstituted heterocycloalkyl" means a monovalent substituent derived from a non-aromatic hydrocarbon having 3 to 40 nuclear atoms, and at least one carbon in the ring, preferably 1 to 3 carbons Substituted with a hetero atom such as N, O or S. Non-limiting examples thereof include morpholine, piperazine and the like.
또, 본 발명에서 "알킬실릴"은 탄소수 1 내지 40의 알킬로 치환된 실릴이고, "아릴실릴"은 탄소수 5 내지 40의 아릴로 치환된 실릴을 의미한다.In the present invention, "alkylsilyl" means silyl substituted with alkyl having 1 to 40 carbon atoms, and "arylsilyl" means silyl substituted with aryl having 5 to 40 carbon atoms.
또, 본 발명에서 "축합(fused) 고리"는 축합 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리, 축합 헤테로방향족 고리 또는 이들의 조합된 형태를 의미한다.In the present invention, "fused ring" means a condensed aliphatic ring, a condensed aromatic ring, a condensed heteroaliphatic ring, a condensed heteroaromatic ring, or a combination thereof.
본 발명의 화학식 1의 화합물은 일반적인 합성방법에 따라 합성될 수 있다(Chem. Rev., 60:313 (1960); J. Chem. SOC. 4482 (1955); Chem. Rev. 95: 2457 (1995) 등 참조). 본 발명의 화합물에 대한 상세한 합성 과정은 후술하는 합성예에서 구체적으로 기술하도록 한다. Compounds of formula 1 of the present invention can be synthesized according to general synthetic methods ( Chem. Rev. , 60 : 313 (1960); J. Chem. SOC . 4482 (1955); Chem. Rev. 95: 2457 (1995) ) And so on). Detailed synthesis procedures for the compounds of the present invention will be described in detail in the synthesis examples described below.
한편, 본 발명은 전술한 화학식 1로 표시되는 화합물, 바람직하게는 화학식 6으로 표시되는 화합물 내지 화학식 15로 표시되는 화합물을 포함하는 유기 전계 발광 소자를 제공한다.On the other hand, the present invention provides an organic electroluminescent device comprising a compound represented by the formula (1), preferably a compound represented by the formula (6) to a compound represented by the formula (15).
구체적으로, 본 발명은 양극(anode), 음극(cathode), 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물, 바람직하게는 화학식 6으로 표시되는 화합물 내지 화학식 15로 표시되는 화합물을 포함한다. 이때, 상기 화학식 1의 화합물은 단독으로 또는 2 이상이 혼합되어 사용될 수 있다.Specifically, the present invention is an organic electroluminescent device comprising an anode, a cathode, and at least one organic layer interposed between the anode and the cathode, wherein at least one of the at least one organic layer The compound represented by Chemical Formula 1, preferably, the compound represented by Chemical Formula 6 to the compound represented by Chemical Formula 15 is included. In this case, the compound of Formula 1 may be used alone or in combination of two or more.
상기 1층 이상의 유기물층은 정공주입층, 정공수송층, 발광층, 전자수송층 및 전자주입층 중 어느 하나 이상일 수 있고, 이 중에서 적어도 하나의 유기물층이 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 바람직하게는 상기 화합물 1의 화합물을 포함하는 유기물층은 발광층일 수 있다.The at least one organic material layer may be any one or more of a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer and an electron injection layer, at least one of the organic material layer may include a compound represented by the formula (1). Preferably, the organic material layer including the compound of Compound 1 may be a light emitting layer.
본 발명의 일례에 따르면, 유기 전계 발광 소자의 발광층은 호스트 재료를 포함할 수 있는데, 이때 호스트 재료로서 상기 화학식 1의 화합물을 포함할 수 있다. 이와 같이, 상기 화학식 1의 화합물을 유기 전계 발광 소자의 발광층 재료, 바람직하게는 청색, 녹색, 적색의 인광 호스트로 포함할 경우, 발광층에서 정공과 전자의 결합력이 높아지기 때문에, 유기 전계 발광 소자의 효율(발광효율 및 전력효율), 수명, 휘도 및 구동전압 등이 향상될 수 있다.According to one embodiment of the present invention, the light emitting layer of the organic electroluminescent device may include a host material, wherein the host material may include the compound of formula (1). As such, when the compound of Formula 1 is included as a light emitting layer material of the organic electroluminescent device, preferably a blue, green or red phosphorescent host, the binding force between holes and electrons in the light emitting layer is increased, so that the efficiency of the organic electroluminescent device (Luminescence efficiency and power efficiency), lifetime, brightness and driving voltage can be improved.
전술한 본 발명에 따른 유기 전계 발광 소자의 구조는 특별히 한정되지 않으며, 예컨대 기판, 양극, 정공주입층, 정공수송층, 발광층, 전자수송층 및 음극이 순차적으로 적층된 구조일 수 있다. 이때, 상기 정공주입층, 정공수송층, 발광층, 전자수송층 및 전자주입층 중 하나 이상은 상기 화학식 1로 표시되는 화합물을 포함할 수 있고, 바람직하게는 발광층이 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 특히, 발광층이 상기 화학식 1의 화합물을 포함할 경우, 상기 화합물은 인광 호스트로 이용될 수 있다. 상기 전자수송층 위에는 전자주입층이 추가로 적층될 수 있다. The structure of the organic EL device according to the present invention described above is not particularly limited, and may be, for example, a structure in which a substrate, an anode, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and a cathode are sequentially stacked. In this case, at least one of the hole injection layer, the hole transport layer, the light emitting layer, the electron transport layer and the electron injection layer may include a compound represented by the formula (1), preferably the light emitting layer comprises a compound represented by the formula (1) Can be. In particular, when the light emitting layer includes the compound of Formula 1, the compound may be used as a phosphorescent host. An electron injection layer may be further stacked on the electron transport layer.
또한, 본 발명에 따른 유기 전계 발광 소자의 구조는 양극, 1층 이상의 유기물층 및 음극이 순차적으로 적층될 뿐만 아니라, 전극과 유기물층 계면에 절연층 또는 접착층이 삽입된 구조일 수 있다.In addition, the structure of the organic electroluminescent device according to the present invention may be a structure in which an anode, one or more organic material layers and a cathode are sequentially stacked, and an insulating layer or an adhesive layer is inserted at an interface between the electrode and the organic material layer.
본 발명에 따른 유기 전계 발광 소자는 상기 유기물층 중 1층 이상(예컨대, 발광층)이 상기 화학식 1로 표시되는 화합물을 포함하도록 형성하는 것을 제외하고는, 당 기술 분야에 알려져 있는 재료 및 방법을 이용하여 다른 유기물층 및 전극을 형성하여 제조될 수 있다.The organic electroluminescent device according to the present invention is formed by using materials and methods known in the art, except that at least one layer (eg, a light emitting layer) of the organic material layer is formed to include the compound represented by Chemical Formula 1. It may be prepared by forming another organic layer and an electrode.
상기 유기물층은 진공 증착법이나 용액 도포법에 의하여 형성될 수 있다. 상기 용액 도포법의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등이 있으나, 이들에 한정되지 않는다.The organic material layer may be formed by a vacuum deposition method or a solution coating method. Examples of the solution coating method include, but are not limited to, spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer.
본 발명에서 사용 가능한 기판으로는 특별히 한정되지 않으며, 실리콘 웨이퍼, 석영, 유리판, 금속판, 플라스틱 필름 및 시트 등이 사용될 수 있다.The substrate usable in the present invention is not particularly limited, and silicon wafers, quartz, glass plates, metal plates, plastic films, sheets, and the like may be used.
또, 양극 물질로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 또는 폴리아닐린과 같은 전도성 고분자; 및 카본블랙 등이 있는데, 이에 한정되지 않는다.In addition, examples of the anode material include metals such as vanadium, chromium, copper, zinc and gold or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO); Combinations of metals and oxides such as ZnO: Al or SnO 2 : Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole or polyaniline; And carbon black, but are not limited thereto.
또, 음극 물질로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 또는 납과 같은 금속 또는 이들의 합금; 및 LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있는데, 이에 한정되지 않는다.The negative electrode material may be a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, or lead or an alloy thereof; And multilayer structure materials such as LiF / Al or LiO 2 / Al, and the like.
이하 본 발명을 실시예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to the following Examples. However, the following examples are merely to illustrate the invention, the present invention is not limited by the following examples.
[준비예 1] 화합물 IC-1의 합성Preparation Example 1 Synthesis of Compound IC-1
<단계 1> methyl 2-(4-bromo-1H-indol-1-yl)benzoate의 합성<Step 1> Synthesis of methyl 2- (4-bromo-1H-indol-1-yl) benzoate
Figure PCTKR2013009778-appb-I000031
Figure PCTKR2013009778-appb-I000031
질소 기류 하에서 4-bromo-1H-indole (24.3 g, 0.124 mol), methyl 2-iodobenzoate (97.5 g, 0.372 mmol), Cu powder(1.5 g, 24.8 mmol), K2CO3(34.2 g, 0.248 mmol), Na2SO4(35.3 g, 0.248 mmol) 및 nitrobenzene(1000 ml)를 혼합한 다음, 190 ℃에서 12시간 동안 교반하였다.4-bromo-1H-indole (24.3 g, 0.124 mol), methyl 2-iodobenzoate (97.5 g, 0.372 mmol), Cu powder (1.5 g, 24.8 mmol), K 2 CO 3 (34.2 g, 0.248 mmol) under nitrogen stream ), Na 2 SO 4 (35.3 g, 0.248 mmol) and nitrobenzene (1000 ml) were mixed and then stirred at 190 ° C. for 12 hours.
반응이 종결된 후, nitrobenzene을 제거하고, 메틸렌클로라이드로 유기층을 분리한 다음, MgSO4를 사용하여 물을 제거하였다. 이후, 유기층의 용매를 제거한 후 컬럼크로마토그래피로 정제하여 methyl 2-(4-bromo-1H-indol-1-yl)benzoate (26.6 g, 80.6 mmol, 수율: 65%)을 얻었다.After the reaction was completed, nitrobenzene was removed, the organic layer was separated with methylene chloride, and water was removed using MgSO 4 . Thereafter, the solvent of the organic layer was removed and purified by column chromatography to obtain methyl 2- (4-bromo-1H-indol-1-yl) benzoate (26.6 g, 80.6 mmol, yield: 65%).
1H-NMR: δ 3.83 (s, 3H), 6.52 (d, 1H), 7.23 (m, 2H), 7.31 (d, 1H), 7.53 (m, 2H), 7.76 (m, 3H) 1 H-NMR: δ 3.83 (s, 3H), 6.52 (d, 1H), 7.23 (m, 2H), 7.31 (d, 1H), 7.53 (m, 2H), 7.76 (m, 3H)
<단계 2> 3-bromo-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine의 합성Step 2 Synthesis of 3-bromo-6,6-dimethyl-6H-pyrrolo [3,2,1-de] acridine
Figure PCTKR2013009778-appb-I000032
Figure PCTKR2013009778-appb-I000032
질소 기류 하에서 상기 준비예 1의 <단계 1>에서 얻은 methyl 2-(4-bromo-1H-indol-1-yl)benzoate (23.1 g, 70.0 mmol)을 ether (250 ml)에 넣고, 온도를 - 78 ℃로 유지한 다음, 여기에 Methyl lithium (1.6 M in ether, 110 ml, 0.175 mol)를 넣은 후 1시간 동안 교반시킨 다음, 상온에서 4시간 동안 추가로 교반시켰다. 반응이 종결된 후, 메틸렌클로라이드로 유기층을 분리한 다음, MgSO4를 사용하여 유기층에서 물을 제거하였다. 이후, 상기 유기층에서 용매를 제거한 다음, 컬럼크로마토그래피로 정제하여 중간 화합물을 얻었다.Under nitrogen stream, methyl 2- (4-bromo-1H-indol-1-yl) benzoate (23.1 g, 70.0 mmol) obtained in <Step 1> of Preparation Example 1 was added to ether (250 ml), and the temperature was −. After maintaining at 78 ° C., Methyl lithium (1.6 M in ether, 110 ml, 0.175 mol) was added thereto, followed by stirring for 1 hour, followed by further stirring at room temperature for 4 hours. After the reaction was terminated, the organic layer was separated with methylene chloride, and then water was removed from the organic layer using MgSO 4 . Thereafter, the solvent was removed from the organic layer, and then purified by column chromatography to obtain an intermediate compound.
이어서, 상기 중간 화합물을 인산(150 ml)에 넣고 6 시간 동안 상온에서 교반한 후, 메틸렌클로라이드 및 물을 사용하여 유기층을 분리한 다음, MgSO4를 사용하여 유기층에서 물을 제거하고, 에탄올로 재결정하여 3-bromo-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine (13.5 g, 43.4 mmol, 수율: 62%)을 얻었다.Subsequently, the intermediate compound was added to phosphoric acid (150 ml), stirred at room temperature for 6 hours, the organic layer was separated using methylene chloride and water, and then water was removed from the organic layer using MgSO 4 , and recrystallized from ethanol. 3-bromo-6,6-dimethyl-6H-pyrrolo [3,2,1-de] acridine (13.5 g, 43.4 mmol, yield: 62%) was obtained.
1H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 6.85 (d, 1H), 7.09 (d, 1H), 7.31 (m, 4H), 7.63 (d, 1H) 1 H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 6.85 (d, 1H), 7.09 (d, 1H), 7.31 (m, 4H), 7.63 (d, 1H)
<단계 3> 6,6-dimethyl-3-(2-nitrophenyl)-6H-pyrrolo[3,2,1-de]acridine의 합성Step 3 Synthesis of 6,6-dimethyl-3- (2-nitrophenyl) -6H-pyrrolo [3,2,1-de] acridine
Figure PCTKR2013009778-appb-I000033
Figure PCTKR2013009778-appb-I000033
질소 기류 하에서 준비예 1의 <단계 2>에서 얻은 3-bromo-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine (2.75 g, 8.80 mmol), 2-nitrophenylboronic acid(1.61 g, 9.67 mmol), NaOH (1.06 g, 26.37 mmol)과 THF/H2O (100 ml/50 ml)를 혼합한 후 교반하였다. 이후, 40 ℃에서 Pd(PPh3)4 (0.51 g, 5 mol%)를 상기 혼합물에 넣고, 80 ℃에서 12시간 동안 교반하였다. 반응 종결 후, 메틸렌클로라이드로 추출한 다음, MgSO4를 넣고 필터링하였다. 필터링된 유기층에서 용매를 제거한 다음, 컬럼크로마토그래피를 이용하여 6,6-dimethyl-3-(2-nitrophenyl)-6H-pyrrolo[3,2,1-de]acridine (2.56 g, 7.22 mmol, 수율: 82 %)을 얻었다.3-bromo-6,6-dimethyl-6H-pyrrolo [3,2,1-de] acridine (2.75 g, 8.80 mmol) obtained in <Step 2> of Preparation Example 1 under nitrogen stream, 2-nitrophenylboronic acid (1.61 g, 9.67 mmol), NaOH (1.06 g, 26.37 mmol) and THF / H 2 O (100 ml / 50 ml) were mixed and stirred. Thereafter, Pd (PPh 3 ) 4 (0.51 g, 5 mol%) was added to the mixture at 40 ° C., and stirred at 80 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the filtered organic layer, and then 6,6-dimethyl-3- (2-nitrophenyl) -6H-pyrrolo [3,2,1-de] acridine (2.56 g, 7.22 mmol, yield using column chromatography). : 82%).
1H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.01 (d, 1H), 7.33 (m, 4H), 7.60 (m, 2H), 7.99 (m, 4H) 1 H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.01 (d, 1H), 7.33 (m, 4H), 7.60 (m, 2H), 7.99 (m, 4H)
<단계 4> 화합물 IC-1 의 합성Step 4 Synthesis of Compound IC-1
Figure PCTKR2013009778-appb-I000034
Figure PCTKR2013009778-appb-I000034
질소 기류 하에서 준비예 1의 <단계 3>에서 얻은 6,6-dimethyl-3-(2-nitrophenyl)-6H-pyrrolo[3,2,1-de]acridine (2.56 g, 7.22 mmol), triphenylphosphine (4.73 g, 18.05 mmol), 1,2-dichlorobenzene (30 ml)를 넣은 후, 12 시간 동안 교반하였다. 반응 종료 후, 1,2-dichlorobenzene를 제거한 다음 디클로로메탄으로 유기층을 추출하였다. 추출된 유기층에서 MgSO4로 물을 제거하고, 컬럼크로마토그래피를 이용하여 화합물 IC-1 (1.79 g, 5.56 mmol, 수율: 77 %)을 얻었다.6,6-dimethyl-3- (2-nitrophenyl) -6H-pyrrolo [3,2,1-de] acridine (2.56 g, 7.22 mmol) obtained in <Step 3> of Preparation Example 1 under nitrogen stream, triphenylphosphine ( 4.73 g, 18.05 mmol) and 1,2-dichlorobenzene (30 ml) were added thereto, followed by stirring for 12 hours. After completion of the reaction, 1,2-dichlorobenzene was removed and the organic layer was extracted with dichloromethane. Water was removed from the extracted organic layer with MgSO 4 , and compound IC-1 (1.79 g, 5.56 mmol, yield: 77%) was obtained by column chromatography.
1H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.33 (m, 5H), 7.60 (m, 3H), 8.00 (s, 1H), 8.11(d, 1H), 9.94(s, 1H) 1 H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.33 (m, 5H), 7.60 (m, 3H), 8.00 (s, 1H), 8.11 (d, 1H), 9.94 ( s, 1 H)
[준비예 2] 화합물 IC-2 및 화합물 IC-3의 합성Preparation Example 2 Synthesis of Compound IC-2 and Compound IC-3
<단계 1> methyl 2-(5-bromo-1H-indol-1-yl)benzoate의 합성<Step 1> Synthesis of methyl 2- (5-bromo-1H-indol-1-yl) benzoate
Figure PCTKR2013009778-appb-I000035
Figure PCTKR2013009778-appb-I000035
준비예 1의 <단계 1>에서 사용된 4-bromo-1H-indole 대신 5-bromo-1H-indole (24.3 g, 0.124 mol)을 사용하는 것을 제외하고는, 준비예 1의 <단계 1>과 동일한 과정을 수행하여 methyl 2-(5-bromo-1H-indol-1-yl)benzoate을 얻었다.<Step 1> of Preparation Example 1, except that 5-bromo-1H-indole (24.3 g, 0.124 mol) was used instead of 4-bromo-1H-indole used in <Step 1> of Preparation Example 1 The same procedure was followed to obtain methyl 2- (5-bromo-1H-indol-1-yl) benzoate.
1H-NMR: δ 3.83 (s, 3H), 6.52 (d, 1H), 7.26 (m, 2H), 7.53 (m, 2H), 7.77 (m, 4H) 1 H-NMR: δ 3.83 (s, 3H), 6.52 (d, 1H), 7.26 (m, 2H), 7.53 (m, 2H), 7.77 (m, 4H)
<단계 2> 4-bromo-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine의 합성Step 2 Synthesis of 4-bromo-6,6-dimethyl-6H-pyrrolo [3,2,1-de] acridine
Figure PCTKR2013009778-appb-I000036
Figure PCTKR2013009778-appb-I000036
준비예 1의 <단계 2>에서 사용된 methyl 2-(4-bromo-1H-indol-1-yl)benzoate 대신 methyl 2-(5-bromo-1H-indol-1-yl)benzoate (23.1 g, 70.0 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <단계 2>와 동일한 과정을 수행하여 4-bromo-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine을 얻었다.In place of methyl 2- (4-bromo-1H-indol-1-yl) benzoate used in <Step 2> of Preparation Example 1, methyl 2- (5-bromo-1H-indol-1-yl) benzoate (23.1 g, Except for using 70.0 mmol), 4-bromo-6,6-dimethyl-6H-pyrrolo [3,2,1-de] acridine was obtained in the same manner as in <Step 2> of Preparation Example 1. .
1H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.12 (s, 1H), 7.33 (m, 4H), 7.56 (m, 2H) 1 H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.12 (s, 1H), 7.33 (m, 4H), 7.56 (m, 2H)
<단계 3> 6,6-dimethyl-4-(2-nitrophenyl)-6H-pyrrolo[3,2,1-de]acridine의 합성Step 3 Synthesis of 6,6-dimethyl-4- (2-nitrophenyl) -6H-pyrrolo [3,2,1-de] acridine
Figure PCTKR2013009778-appb-I000037
Figure PCTKR2013009778-appb-I000037
준비예 1의 <단계 3>에서 사용된 3-bromo-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine 대신 4-bromo-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine (2.75 g, 8.80 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6,6-dimethyl-4-(2-nitrophenyl)-6H-pyrrolo[3,2,1-de]acridine을 얻었다.4-bromo-6,6-dimethyl-6H-pyrrolo [3 instead of 3-bromo-6,6-dimethyl-6H-pyrrolo [3,2,1-de] acridine used in <Step 3> of Preparation Example 1 Except for using 2,1-de] acridine (2.75 g, 8.80 mmol), the same procedure as in <Step 3> of Preparation Example 1 was carried out to give 6,6-dimethyl-4- (2-nitrophenyl) -6H-pyrrolo [3,2,1-de] acridine was obtained.
1H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.33 (m, 4H), 7.60 (m, 3H), 8.01 (m, 3H), 8.46(s, 1H) 1 H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.33 (m, 4H), 7.60 (m, 3H), 8.01 (m, 3H), 8.46 (s, 1H)
<단계 4> 화합물 IC-2 및 화합물 IC-3의 합성Step 4 Synthesis of Compound IC-2 and Compound IC-3
Figure PCTKR2013009778-appb-I000038
Figure PCTKR2013009778-appb-I000038
준비예 1의 <단계 4>에서 사용된 6,6-dimethyl-3-(2-nitrophenyl)-6H-pyrrolo[3,2,1-de]acridine 대신 6,6-dimethyl-4-(2-nitrophenyl)-6H-pyrrolo[3,2,1-de]acridine (5.12 g, 14.44 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <단계 4>와 동일한 과정을 수행하여 화합물 IC-2 및 화합물 IC-3를 얻었다.6,6-dimethyl-4- (2- instead of 6,6-dimethyl-3- (2-nitrophenyl) -6H-pyrrolo [3,2,1-de] acridine used in <Step 4> of Preparation Example 1 Except for using nitrophenyl) -6H-pyrrolo [3,2,1-de] acridine (5.12 g, 14.44 mmol), the compound IC-2 and the same procedure as in <Step 4> of Preparation Example 1 Compound IC-3 was obtained.
화합물 IC-2의 1H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.33 (m, 6H), 7.58 (m, 3H), 8.12 (d, 1H), 9.94 (s, 1H) 1 H-NMR of compound IC-2: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.33 (m, 6H), 7.58 (m, 3H), 8.12 (d, 1H), 9.94 (s, 1H)
화합물 IC-3의 1H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.33 (m, 5H), 7.58 (m, 3H), 8.12 (d, 1H), 8.32 (s, 1H), 9.94 (s, 1H) 1 H-NMR of compound IC-3: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.33 (m, 5H), 7.58 (m, 3H), 8.12 (d, 1H), 8.32 (s, 1H), 9.94 (s, 1H)
[준비예 3] 화합물 IC-4의 합성Preparation Example 3 Synthesis of Compound IC-4
<단계 1> methyl 2-(6-bromo-1H-indol-1-yl)benzoate의 합성<Step 1> Synthesis of methyl 2- (6-bromo-1H-indol-1-yl) benzoate
Figure PCTKR2013009778-appb-I000039
Figure PCTKR2013009778-appb-I000039
준비예 1의 <단계 1>에서 사용된 4-bromo-1H-indole 대신 6-bromo-1H-indole (24.3 g, 0.124 mol)을 사용하는 것을 제외하고는, 준비예 1의 <단계 1>과 동일한 과정을 수행하여 methyl 2-(6-bromo-1H-indol-1-yl)benzoate을 얻었다.<Step 1> of Preparation Example 1, except that 6-bromo-1H-indole (24.3 g, 0.124 mol) instead of 4-bromo-1H-indole used in <Step 1> of Preparation Example 1 The same procedure was followed to obtain methyl 2- (6-bromo-1H-indol-1-yl) benzoate.
1H-NMR: δ 3.83 (s, 3H), 6.52 (d, 1H), 7.23 (m, 2H), 7.56 (m, 2H), 7.81 (m, 2H), 8.32 (s, 1H), 8.75 (s, 1H) 1 H-NMR: δ 3.83 (s, 3H), 6.52 (d, 1H), 7.23 (m, 2H), 7.56 (m, 2H), 7.81 (m, 2H), 8.32 (s, 1H), 8.75 ( s, 1 H)
<단계 2> 5-bromo-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine의 합성Step 2 Synthesis of 5-bromo-6,6-dimethyl-6H-pyrrolo [3,2,1-de] acridine
Figure PCTKR2013009778-appb-I000040
Figure PCTKR2013009778-appb-I000040
준비예 1의 <단계 2>에서 사용된 methyl 2-(4-bromo-1H-indol-1-yl)benzoate 대신 methyl 2-(6-bromo-1H-indol-1-yl)benzoate (23.1 g, 70.0 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <단계 2>와 동일한 과정을 수행하여 5-bromo-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine을 얻었다.Methyl 2- (6-bromo-1H-indol-1-yl) benzoate (23.1 g, instead of methyl 2- (4-bromo-1H-indol-1-yl) benzoate used in <Step 2> of Preparation Example 1 Except for using 70.0 mmol), 5-bromo-6,6-dimethyl-6H-pyrrolo [3,2,1-de] acridine was obtained in the same manner as in <Step 2> of Preparation Example 1. .
1H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.10 (d, 1H), 7.33 (m, 4H), 7.60 (d, 1H), 8.13 (d, 1H) 1 H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.10 (d, 1H), 7.33 (m, 4H), 7.60 (d, 1H), 8.13 (d, 1H)
<단계 3> 6,6-dimethyl-5-(2-nitrophenyl)-6H-pyrrolo[3,2,1-de]acridine의 합성Step 3 Synthesis of 6,6-dimethyl-5- (2-nitrophenyl) -6H-pyrrolo [3,2,1-de] acridine
Figure PCTKR2013009778-appb-I000041
Figure PCTKR2013009778-appb-I000041
준비예 1의 <단계 3>에서 사용된 3-bromo-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine 대신 5-bromo-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine (2.75 g, 8.80 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6,6-dimethyl-5-(2-nitrophenyl)-6H-pyrrolo[3,2,1-de]acridine을 얻었다.5-bromo-6,6-dimethyl-6H-pyrrolo [3 instead of 3-bromo-6,6-dimethyl-6H-pyrrolo [3,2,1-de] acridine used in <Step 3> of Preparation Example 1 2,1-de] acridine (2.75 g, 8.80 mmol) was subjected to the same procedure as in <Step 3> of Preparation Example 1 to give 6,6-dimethyl-5- (2-nitrophenyl) -6H-pyrrolo [3,2,1-de] acridine was obtained.
1H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.33 (m, 4H), 7.60 (m, 2H), 8.00 (m, 4H), 8.29 (d, 1H) 1 H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.33 (m, 4H), 7.60 (m, 2H), 8.00 (m, 4H), 8.29 (d, 1H)
<단계 4> 화합물 IC-4의 합성Step 4 Synthesis of Compound IC-4
Figure PCTKR2013009778-appb-I000042
Figure PCTKR2013009778-appb-I000042
준비예 1의 <단계 4>에서 사용된 6,6-dimethyl-3-(2-nitrophenyl)-6H-pyrrolo[3,2,1-de]acridine 대신 6,6-dimethyl-5-(2-nitrophenyl)-6H-pyrrolo[3,2,1-de]acridine (2.56 g, 7.22 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <단계 4>와 동일한 과정을 수행하여 화합물 IC-4를 얻었다.6,6-dimethyl-5- (2- instead of 6,6-dimethyl-3- (2-nitrophenyl) -6H-pyrrolo [3,2,1-de] acridine used in <Step 4> of Preparation Example 1 Compound IC-4 was prepared by the same procedure as in <Step 4> of Preparation Example 1, except that nitrophenyl) -6H-pyrrolo [3,2,1-de] acridine (2.56 g, 7.22 mmol) was used. Got it.
1H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.32 (m, 6H), 7.59 (m, 3H), 8.12 (d, 1H), 9.94 (s, 1H) 1 H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.32 (m, 6H), 7.59 (m, 3H), 8.12 (d, 1H), 9.94 (s, 1H)
[준비예 4] 화합물 IC-5의 합성Preparation Example 4 Synthesis of Compound IC-5
<단계 1> 3-bromopyrrolo[3,2,1-jk]carbazole의 합성Step 1 Synthesis of 3-bromopyrrolo [3,2,1-jk] carbazole
Figure PCTKR2013009778-appb-I000043
Figure PCTKR2013009778-appb-I000043
질소 기류 하에서 4,7-dibromo-1H-indole (24.2 g, 88.0 mmol), 2-bromophenylboronic acid (19.4 g, 96.7 mmol), NaOH (10.6 g, 263.7 mmol) 및 THF/H2O (1000 ml/500 ml)를 혼합한 다음, 교반하였다. 이후, 40 ℃에서 Pd(PPh3)4 (5.1 g, 5 mol%)을 상기 혼합물에 넣은 다음, 80 ℃에서 12 시간 동안 교반하였다. 반응 종결 후, 메틸렌클로라이드로 추출한 다음, MgSO4를 넣고 필터링하였다. 필터링된 유기층에서 용매를 제거한 후, 컬럼크로마토그래피를 이용하여 중간 화합물인 4-bromo-7-(2-bromophenyl)-1H-indole을 획득하였다. 4,7-dibromo-1H-indole (24.2 g, 88.0 mmol), 2-bromophenylboronic acid (19.4 g, 96.7 mmol), NaOH (10.6 g, 263.7 mmol) and THF / H 2 O (1000 ml /) under nitrogen stream 500 ml) were mixed and then stirred. Thereafter, Pd (PPh 3 ) 4 (5.1 g, 5 mol%) was added to the mixture at 40 ° C., followed by stirring at 80 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent from the filtered organic layer, the intermediate compound 4-bromo-7- (2-bromophenyl) -1H-indole was obtained by column chromatography.
상기 중간 화합물 4-bromo-7-(2-bromophenyl)-1H-indole 4-bromo-1H-indole (13.0 g, 0.037 mol)을, Cu powder(0.45 g, 7.44 mmol), K2CO3(10.3 g, 0.074 mmol), Na2SO4(10.6 g, 0.074 mmol) 및 nitrobenzene(300 ml)과 혼합한 다음, 190 ℃에서 12시간 동안 교반하였다. 반응이 종결된 후, nitrobenzene을 제거하고, 메틸렌클로라이드로 유기층을 분리한 다음, MgSO4를 사용하여 유기층에서 물을 제거하였다. 유기층에서 용매를 제거한 다음, 컬럼크로마토그래피로 정제하여 3-bromopyrrolo[3,2,1-jk]carbazole (8.32 g, 30.8 mmol, 수율: 35%)을 얻었다.The intermediate compound 4-bromo-7- (2-bromophenyl) -1H-indole 4-bromo-1H-indole (13.0 g, 0.037 mol), Cu powder (0.45 g, 7.44 mmol), K 2 CO 3 (10.3 g, 0.074 mmol), Na 2 SO 4 (10.6 g, 0.074 mmol) and nitrobenzene (300 ml) were mixed, followed by stirring at 190 ° C. for 12 hours. After the reaction was completed, nitrobenzene was removed, the organic layer was separated with methylene chloride, and then water was removed from the organic layer using MgSO 4 . The solvent was removed from the organic layer, and then purified by column chromatography to obtain 3-bromopyrrolo [3,2,1-jk] carbazole (8.32 g, 30.8 mmol, yield: 35%).
1H-NMR: δ 6.45 (d, 1H), 7.30 (m, 3H), 7.56 (m, 2H), 8.05 (m, 2H) 1 H-NMR: δ 6.45 (d, 1H), 7.30 (m, 3H), 7.56 (m, 2H), 8.05 (m, 2H)
<단계 2> 3-(2-nitrophenyl)pyrrolo[3,2,1-jk]carbazole의 합성Step 2 Synthesis of 3- (2-nitrophenyl) pyrrolo [3,2,1-jk] carbazole
Figure PCTKR2013009778-appb-I000044
Figure PCTKR2013009778-appb-I000044
준비예 1의 <단계 3>에서 사용된 3-bromo-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine 대신 3-bromopyrrolo[3,2,1-jk]carbazole (2.38 g, 8.80 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <단계 3>과 동일한 과정을 수행하여 3-(2-nitrophenyl)pyrrolo[3,2,1-jk]carbazole을 얻었다.3-bromopyrrolo [3,2,1-jk] carbazole (2.38 instead of 3-bromo-6,6-dimethyl-6H-pyrrolo [3,2,1-de] acridine used in <Step 3> of Preparation Example 1 g, 8.80 mmol), except that 3-, 2-nitrophenyl) pyrrolo [3,2,1-jk] carbazole was obtained in the same manner as in <Step 3> of Preparation Example 1.
1H-NMR: δ 6.45 (d, 1H), 7.28 (m, 2H), 7.56 (m, 3H), 7.79(d, 1H), 7.98 (m, 3H), 8.14 (m, 2H) 1 H-NMR: δ 6.45 (d, 1H), 7.28 (m, 2H), 7.56 (m, 3H), 7.79 (d, 1H), 7.98 (m, 3H), 8.14 (m, 2H)
<단계 3> 화합물 IC-5의 합성Step 3 Synthesis of Compound IC-5
Figure PCTKR2013009778-appb-I000045
Figure PCTKR2013009778-appb-I000045
준비예 1의 <단계 4>에서 사용된 6,6-dimethyl-3-(2-nitrophenyl)-6H-pyrrolo[3,2,1-de]acridine 대신 3-(2-nitrophenyl)pyrrolo[3,2,1-jk]carbazole (4.51 g, 14.44 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <단계 4>와 동일한 과정을 수행하여 화합물 IC-5을 얻었다.3- (2-nitrophenyl) pyrrolo [3, instead of 6,6-dimethyl-3- (2-nitrophenyl) -6H-pyrrolo [3,2,1-de] acridine used in <Step 4> of Preparation Example 1 Except for using 2,1-jk] carbazole (4.51 g, 14.44 mmol), Compound IC-5 was obtained by the same procedure as <Step 4> of Preparation Example 1.
1H-NMR: δ 6.45 (d, 1H), 7.28 (m, 3H), 7.57 (m, 5H), 8.12 (m, 2H), 9.94 (s, 1H) 1 H-NMR: δ 6.45 (d, 1H), 7.28 (m, 3H), 7.57 (m, 5H), 8.12 (m, 2H), 9.94 (s, 1H)
[준비예 5] 화합물 IC-6 및 IC-7의 합성Preparation Example 5 Synthesis of Compounds IC-6 and IC-7
<단계 1> 2-bromopyrrolo[3,2,1-jk]carbazole의 합성Step 1 Synthesis of 2-bromopyrrolo [3,2,1-jk] carbazole
Figure PCTKR2013009778-appb-I000046
Figure PCTKR2013009778-appb-I000046
준비예 1의 <단계 1>에서 사용된 4,7-dibromo-1H-indole 대신 5,7-dibromo-1H-indole (24.2 g, 88.0 mmol)을 사용하는 것을 제외하고는, 준비예 4의 <단계 1>과 동일한 과정을 수행하여 2-bromopyrrolo[3,2,1-jk]carbazole을 얻었다.Except for using 5,7-dibromo-1H-indole (24.2 g, 88.0 mmol) instead of 4,7-dibromo-1H-indole used in <step 1> of Preparation Example 1, < The procedure of step 1> was followed to yield 2-bromopyrrolo [3,2,1-jk] carbazole.
1H-NMR: δ 6.45 (d, 1H), 7.28 (m, 2H), 7.59 (m, 3H), 8.09 (m, 2H) 1 H-NMR: δ 6.45 (d, 1H), 7.28 (m, 2H), 7.59 (m, 3H), 8.09 (m, 2H)
<단계 2> 2-(2-nitrophenyl)pyrrolo[3,2,1-jk]carbazole의 합성<Step 2> Synthesis of 2- (2-nitrophenyl) pyrrolo [3,2,1-jk] carbazole
Figure PCTKR2013009778-appb-I000047
Figure PCTKR2013009778-appb-I000047
준비예 1의 <단계 3>에서 사용된 3-bromo-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine 대신 2-bromopyrrolo[3,2,1-jk]carbazole (2.38 g, 8.80 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <단계 3>과 동일한 과정을 수행하여 2-(2-nitrophenyl)pyrrolo[3,2,1-jk]carbazole을 얻었다.Instead of 3-bromo-6,6-dimethyl-6H-pyrrolo [3,2,1-de] acridine used in <Step 3> of Preparation Example 1, 2-bromopyrrolo [3,2,1-jk] carbazole (2.38 g, 8.80 mmol) was used in the same manner as in <Step 3> of Preparation Example 1 to obtain 2- (2-nitrophenyl) pyrrolo [3,2,1-jk] carbazole.
1H-NMR: δ 6.45 (d, 1H), 7.28 (m, 3H), 7.62 (m, 3H), 7.83 (m, 2H), 8.03 (m, 2H), 8.11(d, 1H) 1 H-NMR: δ 6.45 (d, 1H), 7.28 (m, 3H), 7.62 (m, 3H), 7.83 (m, 2H), 8.03 (m, 2H), 8.11 (d, 1H)
<단계 3> 화합물 IC-6 및 IC-7의 합성Step 3 Synthesis of Compounds IC-6 and IC-7
Figure PCTKR2013009778-appb-I000048
Figure PCTKR2013009778-appb-I000048
준비예 1의 <단계 4>에서 사용된 6,6-dimethyl-3-(2-nitrophenyl)-6H-pyrrolo[3,2,1-de]acridine 대신 2-(2-nitrophenyl)pyrrolo[3,2,1-jk]carbazole (4.51 g, 14.44 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <단계 4>와 동일한 과정을 수행하여 화합물 IC-6 및 화합물 IC-7을 얻었다.2- (2-nitrophenyl) pyrrolo [3, instead of 6,6-dimethyl-3- (2-nitrophenyl) -6H-pyrrolo [3,2,1-de] acridine used in <Step 4> of Preparation Example 1 Except for using 2,1-jk] carbazole (4.51 g, 14.44 mmol), the same procedure as in <Step 4> of Preparation Example 1 was carried out to obtain Compound IC-6 and Compound IC-7.
화합물 IC-6의 1H-NMR: δ 6.45 (d, 1H), 7.09(s, 1H), 7.28 (m, 3H), 7.59 (m, 4H), 8.12 (m, 2H), 9.94 (s, 1H) 1 H-NMR of compound IC-6: δ 6.45 (d, 1H), 7.09 (s, 1H), 7.28 (m, 3H), 7.59 (m, 4H), 8.12 (m, 2H), 9.94 (s, 1H)
화합물 IC-7의 1H-NMR: δ 6.45 (d, 1H), 7.28 (m, 3H), 7.58 (m, 5H), 8.12 (m, 2H), 9.94 (s, 1H) 1 H-NMR of compound IC-7: δ 6.45 (d, 1H), 7.28 (m, 3H), 7.58 (m, 5H), 8.12 (m, 2H), 9.94 (s, 1H)
[준비예 6] 화합물 IC-8의 합성Preparation Example 6 Synthesis of Compound IC-8
<단계 1> 1-bromopyrrolo[3,2,1-jk]carbazole의 합성Step 1 Synthesis of 1-bromopyrrolo [3,2,1-jk] carbazole
Figure PCTKR2013009778-appb-I000049
Figure PCTKR2013009778-appb-I000049
준비예 4의 <단계 1>에서 사용된 4,7-dibromo-1H-indole 대신 6,7-dibromo-1H-indole (24.2 g, 88.0 mmol)을 사용하는 것을 제외하고는, 준비예 4의 <단계 1>과 동일한 과정을 수행하여 1-bromopyrrolo[3,2,1-jk]carbazole을 얻었다.6,7-dibromo-1H-indole (24.2 g, 88.0 mmol) was used instead of 4,7-dibromo-1H-indole used in <Step 1> of Preparation Example 4, and < 1-bromopyrrolo [3,2,1-jk] carbazole was obtained in the same manner as in step 1>.
1H-NMR: δ 6.45 (d, 1H), 7.30 (m, 3H), 7.56 (m, 3H), 8.11 (d, 1H) 1 H-NMR: δ 6.45 (d, 1H), 7.30 (m, 3H), 7.56 (m, 3H), 8.11 (d, 1H)
<단계 2> 1-(2-nitrophenyl)pyrrolo[3,2,1-jk]carbazole의 합성Step 2 Synthesis of 1- (2-nitrophenyl) pyrrolo [3,2,1-jk] carbazole
Figure PCTKR2013009778-appb-I000050
Figure PCTKR2013009778-appb-I000050
준비예 1의 <단계 3>에서 사용된 3-bromo-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine 대신 1-bromopyrrolo[3,2,1-jk]carbazole (2.38 g, 8.80 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <단계 3>과 동일한 과정을 수행하여 1-(2-nitrophenyl)pyrrolo[3,2,1-jk]carbazole을 얻었다.1-bromopyrrolo [3,2,1-jk] carbazole (2.38 instead of 3-bromo-6,6-dimethyl-6H-pyrrolo [3,2,1-de] acridine used in <Step 3> of Preparation Example 1 g, 8.80 mmol) was used in the same manner as in <Step 3> of Preparation Example 1 to obtain 1- (2-nitrophenyl) pyrrolo [3,2,1-jk] carbazole.
1H-NMR: δ 6.45 (d, 1H), 7.28 (m, 2H), 7.50 (m, 1H), 7.72 (m, 4H), 8.01 (m, 4H) 1 H-NMR: δ 6.45 (d, 1H), 7.28 (m, 2H), 7.50 (m, 1H), 7.72 (m, 4H), 8.01 (m, 4H)
<단계 3> 화합물 IC-8의 합성Step 3 Synthesis of Compound IC-8
Figure PCTKR2013009778-appb-I000051
Figure PCTKR2013009778-appb-I000051
준비예 1의 <단계 4>에서 사용된 6,6-dimethyl-3-(2-nitrophenyl)-6H-pyrrolo[3,2,1-de]acridine 대신 1-(2-nitrophenyl)pyrrolo[3,2,1-jk]carbazole (4.51 g, 14.44 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <단계 4>와 동일한 과정을 수행하여 화합물 IC-8를 얻었다.1- (2-nitrophenyl) pyrrolo [3, instead of 6,6-dimethyl-3- (2-nitrophenyl) -6H-pyrrolo [3,2,1-de] acridine used in <Step 4> of Preparation Example 1 Except for using 2,1-jk] carbazole (4.51 g, 14.44 mmol), Compound IC-8 was obtained by the same procedure as <Step 4> of Preparation Example 1.
1H-NMR: δ 6.45 (d, 1H), 7.08 (s, 1H), 7.28 (m, 3H), 7.56 (m, 4H), 8.12 (m, 2H), 9.94 (s, 1H) 1 H-NMR: δ 6.45 (d, 1H), 7.08 (s, 1H), 7.28 (m, 3H), 7.56 (m, 4H), 8.12 (m, 2H), 9.94 (s, 1H)
[준비예 7] 화합물 IC-9 및 IC-10의 합성Preparation Example 7 Synthesis of Compounds IC-9 and IC-10
<단계 1> 8,8-dimethyl-8H-indolo[3,2,1-de]acridin-3-amine의 합성Step 1 Synthesis of 8,8-dimethyl-8H-indolo [3,2,1-de] acridin-3-amine
Figure PCTKR2013009778-appb-I000052
Figure PCTKR2013009778-appb-I000052
질소 기류 하에서 3-bromo-8,8-dimethyl-8H-indolo[3,2,1-de]acridine (10.9 g, 30.0 mmol)을 THF(100 ml)에 녹인 후, 28 %의 aqueous ammonia (10.2 ml, 150 mmol) 및 Cu power (0.10 g, 5 mol%)를 넣은 다음, 110 ℃에서 12시간 동안 교반하였다. 반응 종결 후, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터링하였다. 필터링된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 8,8-dimethyl-8H-indolo[3,2,1-de]acridin-3-amine (7.25 g, 24.3 mmol, 수율: 81%)을 얻었다.Under nitrogen stream, 3-bromo-8,8-dimethyl-8H-indolo [3,2,1-de] acridine (10.9 g, 30.0 mmol) was dissolved in THF (100 ml), followed by 28% aqueous ammonia (10.2). ml, 150 mmol) and Cu power (0.10 g, 5 mol%) were added thereto, followed by stirring at 110 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer, 8,8-dimethyl-8H-indolo [3,2,1-de] acridin-3-amine (7.25 g, 24.3 mmol, yield: 81%) was purified using column chromatography. Got it.
1H-NMR: δ 1.73 (s, 6H), 6.24 (s, 2H), 6.78 (d, 1H), 7.32 (m, 6H), 7.65 (m, 2H), 7.94 (d, 1H) -2 1 H-NMR: δ 1.73 (s, 6H), 6.24 (s, 2H), 6.78 (d, 1H), 7.32 (m, 6H), 7.65 (m, 2H), 7.94 (d, 1H) -2
<단계 2> 화합물 IC-9 및 IC-10의 합성Step 2 Synthesis of Compounds IC-9 and IC-10
Figure PCTKR2013009778-appb-I000053
Figure PCTKR2013009778-appb-I000053
질소 기류 하에서 8,8-dimethyl-8H-indolo[3,2,1-de]acridin-3-amine (5.97 g, 20.0 mmol)을 H2O/dioxane (10 ml/90 ml)에 녹인 후, triethanolammonium chloride (0.372 g, 2 mmol), RuCln-H2O (0.052 g, 0.2 mmol), PPh3 (0.158 g, 0.6 mmol), 및 SnCl2-2H2O (0.452 g, 2 mmol)을 넣고, 180 ℃에서 20 시간 동안 교반하였다. 반응 종결 후, 상기 반응물을 5 %의 aqueous HCl solution에 붓고, 메틸렌클로라이드로 추출한 다음 MgSO4를 넣고 필터링하였다. 필터링된 유기층에서 용매를 제거한 후 컬럼크로마토그래피를 이용하여 화합물 IC-9 (1.74 g, 5.4 mmol, 수율: 27%) 및 화합물 IC-10 (1.75 g, 5.4 mmol, 수율: 27%)을 얻었다.Dissolve 8,8-dimethyl-8H-indolo [3,2,1-de] acridin-3-amine (5.97 g, 20.0 mmol) in H 2 O / dioxane (10 ml / 90 ml) under a stream of nitrogen, put triethanolammonium chloride (0.372 g, 2 mmol ), RuCln-H 2 O (0.052 g, 0.2 mmol), PPh 3 (0.158 g, 0.6 mmol), and SnCl 2- 2H 2 O (0.452 g , 2 mmol), Stir at 180 ° C. for 20 hours. After completion of the reaction, the reaction was poured into 5% aqueous HCl solution, extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent from the filtered organic layer using column chromatography to give the compound IC-9 (1.74 g, 5.4 mmol, yield: 27%) and compound IC-10 (1.75 g, 5.4 mmol, yield: 27%).
화합물 IC-9의 1H-NMR: δ 1.73 (s, 6H), 6.43 (d, 1H), 6.95 (d, 1H), 7.17(m, 1H), 7.32 (m, 6H), 7.56 (s, 1H), 8.37 (d, 1H), 9.94 (s, 1H) 1 H-NMR of compound IC-9: δ 1.73 (s, 6H), 6.43 (d, 1H), 6.95 (d, 1H), 7.17 (m, 1H), 7.32 (m, 6H), 7.56 (s, 1H), 8.37 (d, 1H), 9.94 (s, 1H)
화합물 IC-10 의 1H-NMR: δ 1.73 (s, 6H), 6.43 (d, 1H), 6.95 (d, 1H), 7.17(m, 1H), 7.35 (m, 6H), 7.63 (d, 1H), 8.37 (d, 1H), 9.94 (s, 1H) 1 H-NMR of compound IC-10: δ 1.73 (s, 6H), 6.43 (d, 1H), 6.95 (d, 1H), 7.17 (m, 1H), 7.35 (m, 6H), 7.63 (d, 1H), 8.37 (d, 1H), 9.94 (s, 1H)
[준비예 8] 화합물 IC-11 및 IC-12의 합성Preparation Example 8 Synthesis of Compounds IC-11 and IC-12
<단계 1> 4-(5-bromo-2-nitrophenyl)-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine의 합성Step 1 Synthesis of 4- (5-bromo-2-nitrophenyl) -6,6-dimethyl-6H-pyrrolo [3,2,1-de] acridine
Figure PCTKR2013009778-appb-I000054
Figure PCTKR2013009778-appb-I000054
준비예 2의 <단계 3>에서 사용된 2-nitrophenylboronic acid 대신 5-bromo-2-nitrophenylboronic acid (2.38 g, 9.67 mmol)을 사용하는 것을 제외하고는, 준비예 2의 <단계 3>과 동일한 과정을 수행하여 4-(5-bromo-2-nitrophenyl)-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine을 얻었다.The same process as in <Step 3> of Preparation Example 2, except that 5-bromo-2-nitrophenylboronic acid (2.38 g, 9.67 mmol) was used instead of 2-nitrophenylboronic acid used in <Step 3> of Preparation Example 2. Was carried out to obtain 4- (5-bromo-2-nitrophenyl) -6,6-dimethyl-6H-pyrrolo [3,2,1-de] acridine.
1H-NMR: δ 1.71 (s, 6H), 6.54 (d, 1H), 7.34 (m, 4H), 7.60 (m, 2H), 7.74 (s, 1H), 7.98 (d, 1H), 8.24 (m, 2H) 1 H-NMR: δ 1.71 (s, 6H), 6.54 (d, 1H), 7.34 (m, 4H), 7.60 (m, 2H), 7.74 (s, 1H), 7.98 (d, 1H), 8.24 ( m, 2H)
<단계 2> 화합물 IC-11 및 IC-12의 합성Step 2 Synthesis of Compounds IC-11 and IC-12
Figure PCTKR2013009778-appb-I000055
Figure PCTKR2013009778-appb-I000055
준비예 1의 <단계 4>에서 사용된 6,6-dimethyl-3-(2-nitrophenyl)-6H-pyrrolo[3,2,1-de]acridine 대신 4-(5-bromo-2-nitrophenyl)-6,6-dimethyl-6H-pyrrolo[3,2,1-de]acridine (6.26 g, 14.44 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <단계 4>와 동일한 과정을 수행하여 화합물 IC-11 및 IC-12을 얻었다.4- (5-bromo-2-nitrophenyl) instead of 6,6-dimethyl-3- (2-nitrophenyl) -6H-pyrrolo [3,2,1-de] acridine used in <Step 4> of Preparation Example 1 Except for using -6,6-dimethyl-6H-pyrrolo [3,2,1-de] acridine (6.26 g, 14.44 mmol), the compound was carried out in the same manner as in <Step 4> of Preparation Example 1 IC-11 and IC-12 were obtained.
화합물 IC-11의 1H-NMR: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.32 (m, 6H), 7.59 (m, 2H), 8.05 (s, 1H), 10.19 (s, 1H) 1 H-NMR of compound IC-11: δ 1.73 (s, 6H), 6.52 (d, 1H), 7.32 (m, 6H), 7.59 (m, 2H), 8.05 (s, 1H), 10.19 (s, 1H)
화합물 IC-12 의 1H-NMR: δ 1.74 (s, 6H), 6.53 (d, 1H), 7.33 (m, 7H), 8.05 (s, 1H), 8.31 (s, 1H), 10.16 (s, 1H) 1 H-NMR of compound IC-12: δ 1.74 (s, 6H), 6.53 (d, 1H), 7.33 (m, 7H), 8.05 (s, 1H), 8.31 (s, 1H), 10.16 (s, 1H)
[준비예 9] 화합물 IC-13 및 IC-14의 합성Preparation Example 9 Synthesis of Compounds IC-13 and IC-14
<단계 1> 2-(5-bromo-2-nitrophenyl)pyrrolo[3,2,1-jk]carbazole의 합성Synthesis of 2- (5-bromo-2-nitrophenyl) pyrrolo [3,2,1-jk] carbazole
Figure PCTKR2013009778-appb-I000056
Figure PCTKR2013009778-appb-I000056
준비예 4의 <단계 2>에서 사용된 3-bromopyrrolo[3,2,1-jk]carbazole 대신 2-bromopyrrolo[3,2,1-jk]carbazole (2.38 g, 8.80 mmol)를 사용하고, 2-nitrophenylboronic acid 대신 5-bromo-2-nitrophenylboronic acid (2.38 g, 9.67 mmol)을 사용하는 것을 제외하고는, 준비예 4의 <단계 2>와 동일한 과정을 수행하여 2-(5-bromo-2-nitrophenyl)pyrrolo[3,2,1-jk]carbazole을 얻었다.Instead of 3-bromopyrrolo [3,2,1-jk] carbazole used in <Step 2> of Preparation Example 4, 2-bromopyrrolo [3,2,1-jk] carbazole (2.38 g, 8.80 mmol) was used. Except for using 5-bromo-2-nitrophenylboronic acid (2.38 g, 9.67 mmol) instead of -nitrophenylboronic acid, 2- (5-bromo-2- was carried out in the same manner as in <Step 2> of Preparation Example 4 nitrophenyl) pyrrolo [3,2,1-jk] carbazole was obtained.
1H-NMR: δ 6.44 (d, 1H), 7.31 (m, 3H), 7.54 (m, 2H), 7.72 (m, 2H), 7.98 (d, 1H), 8.21 (m, 2H) 1 H-NMR: δ 6.44 (d, 1H), 7.31 (m, 3H), 7.54 (m, 2H), 7.72 (m, 2H), 7.98 (d, 1H), 8.21 (m, 2H)
<단계 2> 화합물 IC-13 및 IC-14의 합성Step 2 Synthesis of Compounds IC-13 and IC-14
Figure PCTKR2013009778-appb-I000057
Figure PCTKR2013009778-appb-I000057
준비예 1의 <단계 4>에서 사용된 6,6-dimethyl-3-(2-nitrophenyl)-6H-pyrrolo[3,2,1-de]acridine 대신 2-(5-bromo-2-nitrophenyl)pyrrolo[3,2,1-jk]carbazole (5.65 g, 14.44 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <단계 4>와 동일한 과정을 수행하여 화합물 IC-13 및 IC-14를 얻었다.2- (5-bromo-2-nitrophenyl) instead of 6,6-dimethyl-3- (2-nitrophenyl) -6H-pyrrolo [3,2,1-de] acridine used in <Step 4> of Preparation Example 1 Except for using pyrrolo [3,2,1-jk] carbazole (5.65 g, 14.44 mmol), the compound IC-13 and IC-14 were obtained by the same procedure as the <Step 4> of Preparation Example 1 .
화합물 IC-13의 1H-NMR: δ 6.43 (d, 1H), 7.08 (s, 1H), 7.29 (m, 2H), 7.49 (m, 4H), 8.06 (m, 2H), 10.21 (s, 1H) 1 H-NMR of compound IC-13: δ 6.43 (d, 1H), 7.08 (s, 1H), 7.29 (m, 2H), 7.49 (m, 4H), 8.06 (m, 2H), 10.21 (s, 1H)
화합물 IC-14의 1H-NMR: δ 6.44 (d, 1H), 7.27 (m, 2H), 7.50 (m, 5H), 8.08 (m, 2H), 10.20 (s, 1H) 1 H-NMR of compound IC-14: δ 6.44 (d, 1H), 7.27 (m, 2H), 7.50 (m, 5H), 8.08 (m, 2H), 10.20 (s, 1H)
[합성예 1] 화합물 C-1의 합성Synthesis Example 1 Synthesis of Compound C-1
Figure PCTKR2013009778-appb-I000058
Figure PCTKR2013009778-appb-I000058
질소 기류 하에서 준비예 1에서 합성된 화합물 IC-1 (4.28 g, 13.29 mmol)을, 2-(4-bromophenyl)triphenylene (10.18 g, 26.57 mmol), Cu powder(0.17 g, 2.66 mmol), K2CO3(3.66 g, 26.57 mmol), Na2SO4(3.78 g, 26.57 mmol) 및 nitrobenzene(100 ml)과 혼합한 다음, 190 ℃에서 12시간 동안 교반하였다. Compound IC-1 (4.28 g, 13.29 mmol), synthesized in Preparation Example 1 under nitrogen stream, 2- (4-bromophenyl) triphenylene (10.18 g, 26.57 mmol), Cu powder (0.17 g, 2.66 mmol), K 2 CO 3 (3.66 g, 26.57 mmol), Na 2 SO 4 (3.78 g, 26.57 mmol) and nitrobenzene (100 ml) were mixed and then stirred at 190 ° C. for 12 hours.
반응이 종결된 후, nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리한 다음, MgSO4를 사용하여 유기층에서 물을 제거하였다. 이후, 유기층에서 용매를 제거한 다음, 컬럼크로마토그래피로 정제하여 화합물 C-1 (5.23 g, 수율: 63%)을 얻었다. After the reaction was completed, nitrobenzene was removed and the organic layer was separated with methylene chloride, and then water was removed from the organic layer using MgSO 4 . Then, the solvent was removed from the organic layer, and then purified by column chromatography to give the compound C-1 (5.23 g, yield: 63%).
GC-Mass (이론치: 624.77 g/mol, 측정치: 624 g/mol)GC-Mass (Theoretical value: 624.77 g / mol, Measured value: 624 g / mol)
[합성예 2] 화합물 C-2의 합성Synthesis Example 2 Synthesis of Compound C-2
Figure PCTKR2013009778-appb-I000059
Figure PCTKR2013009778-appb-I000059
합성예 1에서 사용된 2-(4-bromophenyl)triphenylene 대신 4-(4-bromophenyl)-6-phenyldibenzo[b,d]thiophene(11.02 g, 26.57 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 화합물 C-2 (5.06 g, 수율: 58%)을 얻었다.Synthesis Example 1 except that 4- (4-bromophenyl) -6-phenyldibenzo [b, d] thiophene (11.02 g, 26.57 mmol) was used instead of 2- (4-bromophenyl) triphenylene used in Synthesis Example 1. Compound C-2 (5.06 g, yield: 58%) was obtained by the same process as the same procedure.
GC-Mass (이론치: 656.84 g/mol, 측정치: 656 g/mol)GC-Mass (Theoretical value: 656.84 g / mol, Measured value: 656 g / mol)
[합성예 3] 화합물 C-3의 합성Synthesis Example 3 Synthesis of Compound C-3
Figure PCTKR2013009778-appb-I000060
Figure PCTKR2013009778-appb-I000060
합성예 1에서 사용된 2-(4-bromophenyl)triphenylene 대신 2-bromo-6-phenylpyridine(6.19 g, 26.57 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 화합물 C-3 (4.42 g, 수율: 70%)을 얻었다.Compound C-3 was prepared by the same procedure as in Synthesis Example 1, except that 2-bromo-6-phenylpyridine (6.19 g, 26.57 mmol) was used instead of 2- (4-bromophenyl) triphenylene used in Synthesis Example 1. (4.42 g, yield: 70%) was obtained.
GC-Mass (이론치: 475.58 g/mol, 측정치: 475 g/mol)GC-Mass (Theoretical value: 475.58 g / mol, Measured value: 475 g / mol)
[합성예 4] 화합물 C-4의 합성Synthesis Example 4 Synthesis of Compound C-4
Figure PCTKR2013009778-appb-I000061
Figure PCTKR2013009778-appb-I000061
질소 기류 하에서 준비예 1에서 합성된 화합물 IC-1 (1.89 g, 5.85 mmol)을, 2-chloro-4,6-diphenylpyrimidine (2.09 g, 7.85 mmol), NaH (2.11 g, 8.78 mmol) 및 DMF(80 ml)과 혼합한 다음, 상온에서 3시간 동안 교반하였다. 반응이 종결된 후, 물을 넣고 고체 화합물을 필터링한 다음, 컬럼 크로마토그래피로 정제하여 화합물 C-4 (2.42 g, 수율: 75%)를 얻었다.Compound IC-1 (1.89 g, 5.85 mmol) synthesized in Preparation Example 1 under nitrogen stream was prepared using 2-chloro-4,6-diphenylpyrimidine (2.09 g, 7.85 mmol), NaH (2.11 g, 8.78 mmol), and DMF ( 80 ml) and then stirred at room temperature for 3 hours. After the reaction was terminated, water was added, the solid compound was filtered and purified by column chromatography to give the compound C-4 (2.42 g, yield: 75%).
GC-Mass (이론치: 522.67 g/mol, 측정치: 522 g/mol)GC-Mass (Theoretical value: 522.67 g / mol, Measured value: 522 g / mol)
[합성예 5] 화합물 C-5의 합성Synthesis Example 5 Synthesis of Compound C-5
Figure PCTKR2013009778-appb-I000062
Figure PCTKR2013009778-appb-I000062
합성예 4에서 사용된 2-chloro-4,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine(2.09 g, 7.85 mmol)을 사용하는 것을 제외하고는, 합성예 4와 동일한 과정을 수행하여 화합물 C-5 (2.62 g, 수율 81%)을 얻었다.Except for using 2-chloro-4,6-diphenyl-1,3,5-triazine (2.09 g, 7.85 mmol) instead of 2-chloro-4,6-diphenylpyrimidine used in Synthesis Example 4, Compound C-5 (2.62 g, yield 81%) was obtained in the same manner as the procedure of 4.
GC-Mass (이론치: 553.65 g/mol, 측정치: 553 g/mol)GC-Mass (Theoretical value: 553.65 g / mol, Measured value: 553 g / mol)
[합성예 6] 화합물 C-6의 합성Synthesis Example 6 Synthesis of Compound C-6
Figure PCTKR2013009778-appb-I000063
Figure PCTKR2013009778-appb-I000063
합성예 1에서 사용된 2-(4-bromophenyl)triphenylene 대신 4-bromo-N,N-diphenylaniline(8.61 g, 26.57 mmol)를 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 화합물 C-6 (4.51 g, 수율: 60%)을 얻었다.Compound C was carried out in the same manner as in Synthesis Example 1, except that 4-bromo-N, N-diphenylaniline (8.61 g, 26.57 mmol) was used instead of 2- (4-bromophenyl) triphenylene used in Synthesis Example 1. -6 (4.51 g, yield: 60%) was obtained.
GC-Mass (이론치: 565.70 g/mol, 측정치: 565 g/mol)GC-Mass (Theoretical value: 565.70 g / mol, Measured value: 565 g / mol)
[합성예 7] 화합물 C-7의 합성Synthesis Example 7 Synthesis of Compound C-7
Figure PCTKR2013009778-appb-I000064
Figure PCTKR2013009778-appb-I000064
합성예 1에서 사용된 2-(4-bromophenyl)triphenylene 대신 3-bromo-9-(4,6-diphenyl-1,3,5-triazin-2-yl)-9H-carbazole(12.65 g, 26.57 mmol)를 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 화합물 C-7 (6.02 g, 수율: 63%)을 얻었다.3-bromo-9- (4,6-diphenyl-1,3,5-triazin-2-yl) -9H-carbazole (12.65 g, 26.57 mmol instead of 2- (4-bromophenyl) triphenylene used in Synthesis Example 1 Except for using), the same procedure as in Synthesis Example 1 was carried out to obtain compound C-7 (6.02 g, yield: 63%).
GC-Mass (이론치: 718.85 g/mol, 측정치: 718 g/mol)GC-Mass (Theoretical value: 718.85 g / mol, Measured value: 718 g / mol)
[합성예 8] 화합물 C-8의 합성Synthesis Example 8 Synthesis of Compound C-8
Figure PCTKR2013009778-appb-I000065
Figure PCTKR2013009778-appb-I000065
합성예 1에서 사용된 2-(4-bromophenyl)triphenylene 대신 10-(4-bromophenyl)-9,9-dimethyl-9,10-dihydroacridine(9.64 g, 26.57 mmol)를 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 화합물 C-8 (6.12 g, 수율: 77%)을 얻었다.Synthesis except for using 10- (4-bromophenyl) -9,9-dimethyl-9,10-dihydroacridine (9.64 g, 26.57 mmol) instead of 2- (4-bromophenyl) triphenylene used in Synthesis Example 1 Compound C-8 (6.12 g, yield: 77%) was obtained in the same manner as in Example 1.
GC-Mass (이론치: 605.77 g/mol, 측정치: 605 g/mol)GC-Mass (Theoretical value: 605.77 g / mol, Measured value: 605 g / mol)
[합성예 9] 화합물 C-9의 합성Synthesis Example 9 Synthesis of Compound C-9
Figure PCTKR2013009778-appb-I000066
Figure PCTKR2013009778-appb-I000066
합성예 1에서 사용된 2-(4-bromophenyl)triphenylene 대신 (4-bromophenyl)triphenylsilane(11.0 g, 26.57 mmol)를 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 화합물 C-9 (6.81 g, 수율: 78%)를 얻었다.Except for using (4-bromophenyl) triphenylsilane (11.0 g, 26.57 mmol) instead of 2- (4-bromophenyl) triphenylene used in Synthesis Example 1, the compound C-9 ( 6.81 g, yield: 78%).
GC-Mass (이론치: 656.89 g/mol, 측정치: 656 g/mol)GC-Mass (Theoretical value: 656.89 g / mol, Measured value: 656 g / mol)
[합성예 10] 화합물 C-10의 합성Synthesis Example 10 Synthesis of Compound C-10
Figure PCTKR2013009778-appb-I000067
Figure PCTKR2013009778-appb-I000067
합성예 1에서 사용된 2-(4-bromophenyl)triphenylene 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine(10.28 g, 26.57 mmol)를 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 화합물 C-10 (7.03 g, 수율: 84%)을 얻었다.Except for using 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (10.28 g, 26.57 mmol) instead of 2- (4-bromophenyl) triphenylene used in Synthesis Example 1 , Compound C-10 (7.03 g, yield: 84%) was obtained in the same manner as in Synthesis example 1.
GC-Mass (이론치: 629.75 g/mol, 측정치: 629 g/mol)GC-Mass (Theoretical value: 629.75 g / mol, Measured value: 629 g / mol)
[합성예 11] 화합물 C-11의 합성Synthesis Example 11 Synthesis of Compound C-11
Figure PCTKR2013009778-appb-I000068
Figure PCTKR2013009778-appb-I000068
합성예 1에서 사용된 2-(4-bromophenyl)triphenylene 대신 2-(4'-bromo-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (12.30 g, 26.57 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 화합물 C-11 (6.94 g, 수율: 74%)을 얻었다.2- (4'-bromo- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine instead of 2- (4-bromophenyl) triphenylene used in Synthesis Example 1 Except for using (12.30 g, 26.57 mmol), the same procedure as in Synthesis Example 1 was performed to obtain compound C-11 (6.94 g, yield: 74%).
GC-Mass (이론치: 705.85 g/mol, 측정치: 705 g/mol)GC-Mass (Theoretical value: 705.85 g / mol, Measured value: 705 g / mol)
[합성예 12] 화합물 C-12의 합성Synthesis Example 12 Synthesis of Compound C-12
Figure PCTKR2013009778-appb-I000069
Figure PCTKR2013009778-appb-I000069
합성예 1에서 사용된 2-(4-bromophenyl)triphenylene 대신 2-(3'-bromo-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (12.30 g, 26.57 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 화합물 C-12 (6.47 g, 수율: 69%)를 얻었다.2- (3'-bromo- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine instead of 2- (4-bromophenyl) triphenylene used in Synthesis Example 1 Except for using (12.30 g, 26.57 mmol), the same procedure as in Synthesis Example 1 was performed to obtain compound C-12 (6.47 g, yield: 69%).
GC-Mass (이론치: 705.85 g/mol, 측정치: 705 g/mol)GC-Mass (Theoretical value: 705.85 g / mol, Measured value: 705 g / mol)
[합성예 13] 화합물 C-13의 합성Synthesis Example 13 Synthesis of Compound C-13
Figure PCTKR2013009778-appb-I000070
Figure PCTKR2013009778-appb-I000070
합성예 1에서 사용된 2-(4-bromophenyl)triphenylene 대신 2-(7-bromo-9,9-dimethyl-9H-fluoren-2-yl)-4,6-diphenyl-1,3,5-triazine (13.36 g, 26.57 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 화합물 C-13 (6.14 g, 수율: 62%)을 얻었다.2- (7-bromo-9,9-dimethyl-9H-fluoren-2-yl) -4,6-diphenyl-1,3,5-triazine instead of 2- (4-bromophenyl) triphenylene used in Synthesis Example 1 Compound C-13 (6.14 g, yield: 62%) was obtained in the same manner as the Synthesis Example 1 except for using (13.36 g, 26.57 mmol).
GC-Mass (이론치: 745.91 g/mol, 측정치: 745 g/mol)GC-Mass (Theoretical value: 745.91 g / mol, Measured value: 745 g / mol)
[합성예 14] 화합물 C-14의 합성Synthesis Example 14 Synthesis of Compound C-14
Figure PCTKR2013009778-appb-I000071
Figure PCTKR2013009778-appb-I000071
합성예 1에서 사용된 2-(4-bromophenyl)triphenylene 대신 N-([1,1'-biphenyl]-4-yl)-N-(4-bromophenyl)-[1,1'-biphenyl]-4-amine(12.30 g, 26.57 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 화합물 C-14 (8.39 g, 수율: 88%)를 얻었다.N-([1,1'-biphenyl] -4-yl) -N- (4-bromophenyl)-[1,1'-biphenyl] -4 instead of 2- (4-bromophenyl) triphenylene used in Synthesis Example 1 Except for using -amine (12.30 g, 26.57 mmol), the same procedure as in Synthesis Example 1 was carried out to obtain compound C-14 (8.39 g, yield: 88%).
GC-Mass (이론치: 717.90 g/mol, 측정치: 717 g/mol)GC-Mass (Theoretical value: 717.90 g / mol, Measured value: 717 g / mol)
[합성예 15] 화합물 C-15의 합성Synthesis Example 15 Synthesis of Compound C-15
Figure PCTKR2013009778-appb-I000072
Figure PCTKR2013009778-appb-I000072
합성예 1에서 사용된 2-(4-bromophenyl)triphenylene 대신 N-([1,1'-biphenyl]-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine(13.68 g, 26.57 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 화합물 C-15 (6.55 g, 수율: 65%)를 얻었다.N-([1,1'-biphenyl] -4-yl) -N- (4-bromophenyl) -9,9-dimethyl-9H-fluoren- instead of 2- (4-bromophenyl) triphenylene used in Synthesis Example 1 Except that 2-amine (13.68 g, 26.57 mmol) was used, the same procedure as in Synthesis Example 1 was carried out to obtain Compound C-15 (6.55 g, yield: 65%).
GC-Mass (이론치: 757.96 g/mol, 측정치: 757 g/mol)GC-Mass (Theoretical value: 757.96 g / mol, Measured value: 757 g / mol)
[합성예 16] 화합물 C-16의 합성Synthesis Example 16 Synthesis of Compound C-16
Figure PCTKR2013009778-appb-I000073
Figure PCTKR2013009778-appb-I000073
합성예 1에서 사용된 2-(4-bromophenyl)triphenylene 대신 10-([1,1'-biphenyl]-4-yl)-2-bromo-9,9-dimethyl-7-phenyl-9,10-dihydroacridine (13.68 g, 26.57 mmol)을 사용하는 것을 제외하고는, 합성예 1과 동일한 과정을 수행하여 화합물 C-16 (5.74 g, 수율: 57%)을 얻었다.10-([1,1'-biphenyl] -4-yl) -2-bromo-9,9-dimethyl-7-phenyl-9,10- instead of 2- (4-bromophenyl) triphenylene used in Synthesis Example 1 Except for using dihydroacridine (13.68 g, 26.57 mmol), the same procedure as in Synthesis Example 1 was carried out to obtain compound C-16 (5.74 g, yield: 57%).
GC-Mass (이론치: 757.96 g/mol, 측정치: 757 g/mol)GC-Mass (Theoretical value: 757.96 g / mol, Measured value: 757 g / mol)
[합성예 17] 화합물 C-17의 합성Synthesis Example 17 Synthesis of Compound C-17
Figure PCTKR2013009778-appb-I000074
Figure PCTKR2013009778-appb-I000074
합성예 10에서 사용된 화합물 IC-1 대신 준비예 2에서 합성된 화합물 IC-2 (4.28 g, 13.29 mmol)를 사용하는 것을 제외하고는, 합성예 10과 동일한 과정을 수행하여 화합물 C-17 (5.02 g, 수율: 60%)을 얻었다.Compound C-17 was prepared by the same procedure as in Synthesis Example 10, except that Compound IC-2 (4.28 g, 13.29 mmol) synthesized in Preparation Example 2 was used instead of Compound IC-1 used in Synthesis Example 10. 5.02 g, yield: 60%).
GC-Mass (이론치: 629.75 g/mol, 측정치: 629 g/mol)GC-Mass (Theoretical value: 629.75 g / mol, Measured value: 629 g / mol)
[합성예 18] 화합물 C-18의 합성Synthesis Example 18 Synthesis of Compound C-18
합성예 11에서 사용된 화합물 IC-1 대신 준비예 2에서 합성된 화합물 IC-2 (4.28 g, 13.29 mmol)를 사용하는 것을 제외하고는, 합성예 11과 동일한 과정을 수행하여 화합물 C-18 (7.88 g, 수율: 84%)을 얻었다.Compound C-18 was prepared by the same procedure as in Synthesis Example 11, except that Compound IC-2 (4.28 g, 13.29 mmol) synthesized in Preparation Example 2 was used instead of Compound IC-1 used in Synthesis Example 11. 7.88 g, yield: 84%).
GC-Mass (이론치: 705.85 g/mol, 측정치: 705 g/mol)GC-Mass (Theoretical value: 705.85 g / mol, Measured value: 705 g / mol)
[합성예 19] 화합물 C-19의 합성Synthesis Example 19 Synthesis of Compound C-19
Figure PCTKR2013009778-appb-I000076
Figure PCTKR2013009778-appb-I000076
합성예 12에서 사용된 화합물 IC-1 대신 준비예 2에서 합성된 화합물 IC-2 (4.28 g, 13.29 mmol)를 사용하는 것을 제외하고는, 합성예 12와 동일한 과정을 수행하여 화합물 C-19 (7.69 g, 수율: 82%)을 얻었다.Compound C-19 was prepared by the same procedure as in Synthesis Example 12, except that Compound IC-2 (4.28 g, 13.29 mmol) synthesized in Preparation Example 2 was used instead of Compound IC-1 used in Synthesis Example 12. 7.69 g, yield: 82%) was obtained.
GC-Mass (이론치: 705.85 g/mol, 측정치: 705 g/mol)GC-Mass (Theoretical value: 705.85 g / mol, Measured value: 705 g / mol)
[합성예 20] 화합물 C-20의 합성Synthesis Example 20 Synthesis of Compound C-20
Figure PCTKR2013009778-appb-I000077
Figure PCTKR2013009778-appb-I000077
합성예 10에서 사용된 화합물 IC-1 대신 준비예 2에서 합성된 화합물 IC-3 (4.28 g, 13.29 mmol)를 사용하는 것을 제외하고는, 합성예 10과 동일한 과정을 수행하여 화합물 C-20 (7.45 g, 수율: 89%)을 얻었다.A compound C-20 was prepared by the same procedure as in Synthesis Example 10, except that Compound IC-3 (4.28 g, 13.29 mmol) synthesized in Preparation Example 2 was used instead of Compound IC-1 used in Synthesis Example 10. 7.45 g, yield: 89%).
GC-Mass (이론치: 629.75 g/mol, 측정치: 629 g/mol)GC-Mass (Theoretical value: 629.75 g / mol, Measured value: 629 g / mol)
[합성예 21] 화합물 C-21의 합성Synthesis Example 21 Synthesis of Compound C-21
Figure PCTKR2013009778-appb-I000078
Figure PCTKR2013009778-appb-I000078
합성예 11에서 사용된 화합물 IC-1 대신 준비예 2에서 합성된 화합물 IC-3 (4.28 g, 13.29 mmol)를 사용하는 것을 제외하고는, 합성예 11과 동일한 과정을 수행하여 화합물 C-21 (6.56 g, 수율: 70%)을 얻었다.Compound C-21 was prepared by the same procedure as in Synthesis Example 11, except that Compound IC-3 (4.28 g, 13.29 mmol) synthesized in Preparation Example 2 was used instead of Compound IC-1 used in Synthesis Example 11. 6.56 g, yield: 70%).
GC-Mass (이론치: 705.85 g/mol, 측정치: 705 g/mol)GC-Mass (Theoretical value: 705.85 g / mol, Measured value: 705 g / mol)
[합성예 22] 화합물 C-22의 합성Synthesis Example 22 Synthesis of Compound C-22
Figure PCTKR2013009778-appb-I000079
Figure PCTKR2013009778-appb-I000079
합성예 12에서 사용된 화합물 IC-1 대신 준비예 2에서 합성된 화합물 IC-3 (4.28 g, 13.29 mmol)를 사용하는 것을 제외하고는, 합성예 12와 동일한 과정을 수행하여 화합물 C-22 (7.32 g, 수율: 78%)을 얻었다.Compound C-22 was prepared by the same procedure as in Synthesis Example 12, except that Compound IC-3 (4.28 g, 13.29 mmol) synthesized in Preparation Example 2 was used instead of Compound IC-1 used in Synthesis Example 12. 7.32 g, yield: 78%).
GC-Mass (이론치: 705.85 g/mol, 측정치: 705 g/mol)GC-Mass (Theoretical value: 705.85 g / mol, Measured value: 705 g / mol)
[합성예 23] 화합물 C-23의 합성Synthesis Example 23 Synthesis of Compound C-23
Figure PCTKR2013009778-appb-I000080
Figure PCTKR2013009778-appb-I000080
합성예 10에서 사용된 화합물 IC-1 대신 준비예 3에서 합성된 화합물 IC-4 (4.28 g, 13.29 mmol)를 사용하는 것을 제외하고는, 합성예 10과 동일한 과정을 수행하여 화합물 C-23 (7.28 g, 수율: 87%)을 얻었다.Compound C-23 was prepared in the same manner as in Synthesis Example 10, except that Compound IC-4 (4.28 g, 13.29 mmol) synthesized in Preparation Example 3 was used instead of Compound IC-1 used in Synthesis Example 10. 7.28 g, yield: 87%).
GC-Mass (이론치: 629.75 g/mol, 측정치: 629 g/mol)GC-Mass (Theoretical value: 629.75 g / mol, Measured value: 629 g / mol)
[합성예 24] 화합물 C-24의 합성Synthesis Example 24 Synthesis of Compound C-24
Figure PCTKR2013009778-appb-I000081
Figure PCTKR2013009778-appb-I000081
합성예 11에서 사용된 화합물 IC-1 대신 준비예 3에서 사용된 화합물 IC-4 (4.28 g, 13.29 mmol)를 사용하는 것을 제외하고는, 합성예 11과 동일한 과정을 수행하여 화합물 C-24 (6.75 g, 수율: 72%)을 얻었다.Compound C-24 was carried out in the same manner as in Synthesis Example 11, except that Compound IC-4 (4.28 g, 13.29 mmol) used in Preparation Example 3 was used instead of Compound IC-1 used in Synthesis Example 11. 6.75 g, yield: 72%).
GC-Mass (이론치: 705.85 g/mol, 측정치: 705 g/mol)GC-Mass (Theoretical value: 705.85 g / mol, Measured value: 705 g / mol)
[합성예 25] 화합물 C-25의 합성Synthesis Example 25 Synthesis of Compound C-25
Figure PCTKR2013009778-appb-I000082
Figure PCTKR2013009778-appb-I000082
합성예 12에서 사용된 화합물 IC-1 대신 준비예 3에서 사용된 화합물 IC-4 (4.28 g, 13.29 mmol)를 사용하는 것을 제외하고는, 합성예 12와 동일한 과정을 수행하여 화합물 C-25 (6.19 g, 수율: 66%)를 얻었다.A compound C-25 was prepared by the same procedure as in Synthesis Example 12, except that Compound IC-4 (4.28 g, 13.29 mmol) used in Preparation Example 3 was used instead of Compound IC-1 used in Synthesis Example 12. 6.19 g, yield: 66%).
GC-Mass (이론치: 705.85 g/mol, 측정치: 705 g/mol)GC-Mass (Theoretical value: 705.85 g / mol, Measured value: 705 g / mol)
[합성예 26] 화합물 C-26의 합성Synthesis Example 26 Synthesis of Compound C-26
Figure PCTKR2013009778-appb-I000083
Figure PCTKR2013009778-appb-I000083
합성예 10에서 사용된 화합물 IC-1 대신 준비예 4에서 합성된 화합물 IC-5 (4.28 g, 13.29 mmol)을 사용하는 것을 제외하고는, 합성예 10과 동일한 과정을 수행하여 화합물 C-26 (5.07 g, 수율: 65%)을 얻었다.Compound C-26 was prepared by the same procedure as in Synthesis Example 10, except that Compound IC-5 (4.28 g, 13.29 mmol) synthesized in Preparation Example 4 was used instead of Compound IC-1 used in Synthesis Example 10. 5.07 g, yield: 65%).
GC-Mass (이론치: 587.67 g/mol, 측정치: 587 g/mol)GC-Mass (Theoretical value: 587.67 g / mol, Measured value: 587 g / mol)
[합성예 27] 화합물 C-27의 합성Synthesis Example 27 Synthesis of Compound C-27
Figure PCTKR2013009778-appb-I000084
Figure PCTKR2013009778-appb-I000084
합성예 11에서 사용된 화합물 IC-1 대신 준비예 4에서 합성된 화합물 IC-5 (4.28 g, 13.29 mmol)를 사용하는 것을 제외하고는, 합성예 11과 동일한 과정을 수행하여 화합물 C-27 (5.82 g, 수율: 66%)를 얻었다.Compound C-27 was prepared by the same procedure as in Synthesis Example 11, except that Compound IC-5 (4.28 g, 13.29 mmol) synthesized in Preparation Example 4 was used instead of Compound IC-1 used in Synthesis Example 11. 5.82 g, yield: 66%).
GC-Mass (이론치: 663.77 g/mol, 측정치: 663 g/mol)GC-Mass (Theoretical value: 663.77 g / mol, Measured value: 663 g / mol)
[합성예 28] 화합물 C-28의 합성Synthesis Example 28 Synthesis of Compound C-28
Figure PCTKR2013009778-appb-I000085
Figure PCTKR2013009778-appb-I000085
합성예 12에서 사용된 화합물 IC-1 대신 준비예 4에서 합성된 화합물 IC-5 (4.28 g, 13.29 mmol)를 사용하는 것을 제외하고는, 합성예 12와 동일한 과정을 수행하여 화합물 C-28 (6.35 g, 수율: 72%)을 얻었다.Compound C-28 was prepared by the same procedure as in Synthesis Example 12, except that Compound IC-5 (4.28 g, 13.29 mmol) synthesized in Preparation Example 4 was used instead of Compound IC-1 used in Synthesis Example 12. 6.35 g, yield: 72%).
GC-Mass (이론치: 663.77 g/mol, 측정치: 663 g/mol)GC-Mass (Theoretical value: 663.77 g / mol, Measured value: 663 g / mol)
[합성예 29] 화합물 C-29의 합성Synthesis Example 29 Synthesis of Compound C-29
Figure PCTKR2013009778-appb-I000086
Figure PCTKR2013009778-appb-I000086
합성예 10에서 사용된 화합물 IC-1 대신 준비예 5에서 합성된 화합물 IC-6 (4.28 g, 13.29 mmol)을 사용하는 것을 제외하고는, 합성예 10와 동일한 과정을 수행하여 화합물 C-29 (4.45 g, 수율: 57%)를 얻었다.Compound C-29 was prepared by the same procedure as in Synthesis Example 10, except that Compound IC-6 (4.28 g, 13.29 mmol) synthesized in Preparation Example 5 was used instead of Compound IC-1 used in Synthesis Example 10. 4.45 g, yield: 57%).
GC-Mass (이론치: 587.67 g/mol, 측정치: 587 g/mol)GC-Mass (Theoretical value: 587.67 g / mol, Measured value: 587 g / mol)
[합성예 30] 화합물 C-30의 합성Synthesis Example 30 Synthesis of Compound C-30
Figure PCTKR2013009778-appb-I000087
Figure PCTKR2013009778-appb-I000087
합성예 11에서 사용된 화합물 IC-1 대신 준비예 5에서 합성된 화합물 IC-6(4.28 g, 13.29 mmol)을 사용하는 것을 제외하고는, 합성예 11과 동일한 과정을 수행하여 화합물 C-30 (4.32 g, 수율: 49%)을 얻었다.Compound C-30 was prepared by the same procedure as in Synthesis Example 11, except that Compound IC-6 (4.28 g, 13.29 mmol) synthesized in Preparation Example 5 was used instead of Compound IC-1 used in Synthesis Example 11. 4.32 g, yield: 49%) was obtained.
GC-Mass (이론치: 663.77 g/mol, 측정치: 663 g/mol)GC-Mass (Theoretical value: 663.77 g / mol, Measured value: 663 g / mol)
[합성예 31] 화합물 C-31의 합성Synthesis Example 31 Synthesis of Compound C-31
Figure PCTKR2013009778-appb-I000088
Figure PCTKR2013009778-appb-I000088
합성예 12에서 사용된 화합물 IC-1 대신 준비예 5에서 합성된 화합물 IC-6(4.28 g, 13.29 mmol)을 사용하는 것을 제외하고는, 합성예 12와 동일한 과정을 수행하여 화합물 C-31 (5.55 g, 수율: 63%)을 얻었다.A compound C-31 was prepared in the same manner as in Synthesis Example 12, except that Compound IC-6 (4.28 g, 13.29 mmol) synthesized in Preparation Example 5 was used instead of Compound IC-1 used in Synthesis Example 12. 5.55 g, yield: 63%).
GC-Mass (이론치: 663.77 g/mol, 측정치: 663 g/mol)GC-Mass (Theoretical value: 663.77 g / mol, Measured value: 663 g / mol)
[합성예 32] 화합물 C-32의 합성Synthesis Example 32 Synthesis of Compound C-32
Figure PCTKR2013009778-appb-I000089
Figure PCTKR2013009778-appb-I000089
합성예 10에서 사용된 화합물 IC-1 대신 준비예 5에서 합성된 화합물 IC-7(4.28 g, 13.29 mmol)을 사용하는 것을 제외하고는, 합성예 10과 동일한 과정을 수행하여 화합물 C-32 (6.01 g, 수율: 77%)를 얻었다.Compound C-32 was prepared by the same procedure as in Synthesis Example 10, except that Compound IC-7 (4.28 g, 13.29 mmol) synthesized in Preparation Example 5 was used instead of Compound IC-1 used in Synthesis Example 10. 6.01 g, yield: 77%).
GC-Mass (이론치: 587.67 g/mol, 측정치: 587 g/mol)GC-Mass (Theoretical value: 587.67 g / mol, Measured value: 587 g / mol)
[합성예 33] 화합물 C-33의 합성Synthesis Example 33 Synthesis of Compound C-33
Figure PCTKR2013009778-appb-I000090
Figure PCTKR2013009778-appb-I000090
합성예 11에서 사용된 화합물 IC-1 대신 준비예 5에서 합성된 화합물 IC-7(4.28 g, 13.29 mmol)을 사용하는 것을 제외하고는, 합성예 11과 동일한 과정을 수행하여 화합물 C-33 (7.67 g, 수율: 87%)을 얻었다.Compound C-33 was prepared by the same procedure as in Synthesis Example 11, except that Compound IC-7 (4.28 g, 13.29 mmol) synthesized in Preparation Example 5 was used instead of Compound IC-1 used in Synthesis Example 11. 7.67 g, yield: 87%).
GC-Mass (이론치: 663.77 g/mol, 측정치: 663 g/mol)GC-Mass (Theoretical value: 663.77 g / mol, Measured value: 663 g / mol)
[합성예 34] 화합물 C-34의 합성Synthesis Example 34 Synthesis of Compound C-34
Figure PCTKR2013009778-appb-I000091
Figure PCTKR2013009778-appb-I000091
합성예 12에서 사용된 화합물 IC-1 대신 준비예 5에서 합성된 화합물 IC-7(4.28 g, 13.29 mmol)을 사용하는 것을 제외하고는, 합성예 12와 동일한 과정을 수행하여 화합물 C-34 (6.53 g, 수율: 74%)을 얻었다.A compound C-34 was prepared in the same manner as in Synthesis Example 12, except that Compound IC-7 (4.28 g, 13.29 mmol) synthesized in Preparation Example 5 was used instead of Compound IC-1 used in Synthesis Example 12. 6.53 g, yield: 74%).
GC-Mass (이론치: 663.77 g/mol, 측정치: 663 g/mol)GC-Mass (Theoretical value: 663.77 g / mol, Measured value: 663 g / mol)
[합성예 35] 화합물 C-35의 합성Synthesis Example 35 Synthesis of Compound C-35
Figure PCTKR2013009778-appb-I000092
Figure PCTKR2013009778-appb-I000092
합성예 10에서 사용된 화합물 IC-1 대신 준비예 6에서 합성된 화합물 IC-8(4.28 g, 13.29 mmol)을 사용하는 것을 제외하고는, 합성예 10과 동일한 과정을 수행하여 화합물 C-35 (6.71 g, 수율: 86%)를 얻었다.Compound C-35 was prepared in the same manner as in Synthesis Example 10, except that Compound IC-8 (4.28 g, 13.29 mmol) synthesized in Preparation Example 6 was used instead of Compound IC-1 used in Synthesis Example 10. 6.71 g, yield: 86%).
GC-Mass (이론치: 587.67 g/mol, 측정치: 587 g/mol)GC-Mass (Theoretical value: 587.67 g / mol, Measured value: 587 g / mol)
[합성예 36] 화합물 C-36의 합성Synthesis Example 36 Synthesis of Compound C-36
Figure PCTKR2013009778-appb-I000093
Figure PCTKR2013009778-appb-I000093
합성예 11에서 사용된 화합물 IC-1 대신 준비예 6에서 합성된 화합물 IC-8(4.28 g, 13.29 mmol)을 사용하는 것을 제외하고는, 합성예 11과 동일한 과정을 수행하여 화합물 C-36 (5.64 g, 수율: 64%)을 얻었다.Compound C-36 was prepared by the same procedure as in Synthesis Example 11, except that Compound IC-8 (4.28 g, 13.29 mmol) synthesized in Preparation Example 6 was used instead of Compound IC-1 used in Synthesis Example 11. 5.64 g, yield: 64%).
GC-Mass (이론치: 663.77 g/mol, 측정치: 663 g/mol)GC-Mass (Theoretical value: 663.77 g / mol, Measured value: 663 g / mol)
[합성예 37] 화합물 C-37의 합성Synthesis Example 37 Synthesis of Compound C-37
Figure PCTKR2013009778-appb-I000094
Figure PCTKR2013009778-appb-I000094
합성예 12에서 사용된 화합물 IC-1 대신 준비예 6에서 합성된 화합물 IC-8(4.28 g, 13.29 mmol)을 사용하는 것을 제외하고는, 합성예 12와 동일한 과정을 수행하여 화합물 C-37 (6.88 g, 수율: 78%)을 얻었다.Compound C-37 was prepared by the same procedure as in Synthesis Example 12, except that Compound IC-8 (4.28 g, 13.29 mmol) synthesized in Preparation Example 6 was used instead of Compound IC-1 used in Synthesis Example 12. 6.88 g, yield: 78%).
GC-Mass (이론치: 663.77 g/mol, 측정치: 663 g/mol)GC-Mass (Theoretical value: 663.77 g / mol, Measured value: 663 g / mol)
[합성예 38] 화합물 C-38의 합성Synthesis Example 38 Synthesis of Compound C-38
Figure PCTKR2013009778-appb-I000095
Figure PCTKR2013009778-appb-I000095
합성예 10에서 사용된 화합물 IC-1 대신 준비예 7에서 합성된 화합물 IC-9(4.28 g, 13.29 mmol)를 사용하는 것을 제외하고는, 합성예 10과 동일한 과정을 수행하여 화합물 C-38 (6.44 g, 수율: 77%)를 얻었다.Compound C-38 was prepared by the same procedure as in Synthesis Example 10, except that Compound IC-9 (4.28 g, 13.29 mmol) synthesized in Preparation Example 7 was used instead of Compound IC-1 used in Synthesis Example 10. 6.44 g, yield: 77%).
GC-Mass (이론치: 629.75 g/mol, 측정치: 629 g/mol)GC-Mass (Theoretical value: 629.75 g / mol, Measured value: 629 g / mol)
[합성예 39] 화합물 C-39의 합성Synthesis Example 39 Synthesis of Compound C-39
Figure PCTKR2013009778-appb-I000096
Figure PCTKR2013009778-appb-I000096
합성예 11에서 사용된 화합물 IC-1 대신 준비예 7에서 합성된 화합물 IC-9(4.28 g, 13.29 mmol)를 사용하는 것을 제외하고는, 합성예 11과 동일한 과정을 수행하여 화합물 C-39 (5.63 g, 수율: 60%)을 얻었다.Compound C-39 was prepared by the same procedure as in Synthesis Example 11, except that Compound IC-9 (4.28 g, 13.29 mmol) synthesized in Preparation Example 7 was used instead of Compound IC-1 used in Synthesis Example 11. 5.63 g, yield: 60%).
GC-Mass (이론치: 705.85 g/mol, 측정치: 705 g/mol)GC-Mass (Theoretical value: 705.85 g / mol, Measured value: 705 g / mol)
[합성예 40] 화합물 C-40의 합성Synthesis Example 40 Synthesis of Compound C-40
Figure PCTKR2013009778-appb-I000097
Figure PCTKR2013009778-appb-I000097
합성예 12에서 사용된 화합물 IC-1 대신 준비예 7에서 합성된 화합물 IC-9(4.28 g, 13.29 mmol)를 사용하는 것을 제외하고는, 합성예 12와 동일한 과정을 수행하여 화합물 C-40 (4.97 g, 수율: 53%)을 얻었다.A compound C-40 was prepared by the same procedure as in Synthesis Example 12, except that Compound IC-9 (4.28 g, 13.29 mmol) synthesized in Preparation Example 7 was used instead of Compound IC-1 used in Synthesis Example 12. 4.97 g, yield: 53%) was obtained.
GC-Mass (이론치: 705.85 g/mol, 측정치: 705 g/mol)GC-Mass (Theoretical value: 705.85 g / mol, Measured value: 705 g / mol)
[합성예 41] 화합물 C-41의 합성Synthesis Example 41 Synthesis of Compound C-41
Figure PCTKR2013009778-appb-I000098
Figure PCTKR2013009778-appb-I000098
합성예 10에서 사용된 화합물 IC-1 대신 준비예 7에서 합성된 화합물 IC-10(4.28 g, 13.29 mmol)을 사용하는 것을 제외하고는, 합성예 10과 동일한 과정을 수행하여 화합물 C-41 (6.27 g, 수율: 75%)을 얻었다.A compound C-41 was prepared in the same manner as in Synthesis Example 10, except that Compound IC-10 (4.28 g, 13.29 mmol) synthesized in Preparation Example 7 was used instead of Compound IC-1 used in Synthesis Example 10. 6.27 g, yield: 75%).
GC-Mass (이론치: 629.75 g/mol, 측정치: 629 g/mol)GC-Mass (Theoretical value: 629.75 g / mol, Measured value: 629 g / mol)
[합성예 42] 화합물 C-42의 합성Synthesis Example 42 Synthesis of Compound C-42
Figure PCTKR2013009778-appb-I000099
Figure PCTKR2013009778-appb-I000099
합성예 11에서 사용된 화합물 IC-1 대신 준비예 7에서 합성된 화합물 IC-10(4.28 g, 13.29 mmol)을 사용하는 것을 제외하고는, 합성예 11과 동일한 과정을 수행하여 화합물 C-42 (6.75 g, 수율: 72%)을 얻었다.Compound C-42 was prepared by the same procedure as in Synthesis Example 11, except that Compound IC-10 (4.28 g, 13.29 mmol) synthesized in Preparation Example 7 was used instead of Compound IC-1 used in Synthesis Example 11. 6.75 g, yield: 72%).
GC-Mass (이론치: 705.85 g/mol, 측정치: 705 g/mol)GC-Mass (Theoretical value: 705.85 g / mol, Measured value: 705 g / mol)
[합성예 43] 화합물 C-43의 합성Synthesis Example 43 Synthesis of Compound C-43
Figure PCTKR2013009778-appb-I000100
Figure PCTKR2013009778-appb-I000100
합성예 12에서 사용된 화합물 IC-1 대신 준비예 7에서 합성된 화합물 IC-10(4.28 g, 13.29 mmol)을 사용하는 것을 제외하고는, 합성예 12와 동일한 과정을 수행하여 화합물 C-43 (5.90 g, 수율: 63%)을 얻었다.Compound C-43 was prepared by the same procedure as in Synthesis Example 12, except that Compound IC-10 (4.28 g, 13.29 mmol) synthesized in Preparation Example 7 was used instead of Compound IC-1 used in Synthesis Example 12. 5.90 g, yield: 63%).
GC-Mass (이론치: 705.85 g/mol, 측정치: 705 g/mol)GC-Mass (Theoretical value: 705.85 g / mol, Measured value: 705 g / mol)
[합성예 44] 화합물 C-44의 합성Synthesis Example 44 Synthesis of Compound C-44
Figure PCTKR2013009778-appb-I000101
Figure PCTKR2013009778-appb-I000101
질소 기류 하에서 준비예 8에서 합성된 화합물 IC-11 (3.49 g, 7.31 mmol), 2,4-diphenyl-6-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,3,5-triazine (3.81 g, 8.77 mmol), NaOH (0.87 g, 21.93 mmol), Pd(PPh3)4 (0.25 g, 0.21 mmol) 및 1,4-dioxane, H2O (30 ml, 8 ml)를 혼합한 다음, 100 ℃에서 12시간 동안 교반하였다. 반응 종결 후, 에틸아세테이트로 추출한 다음, MgSO4를 넣고 필터링하였다. 필터링된 유기층에서 용매를 제거한 후 컬럼크로마토그래피를 이용하여 화합물 C-44 (2.37 g, 수율: 46%)를 얻었다. Compound IC-11 (3.49 g, 7.31 mmol), 2,4-diphenyl-6- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan, synthesized in Preparation Example 8 under nitrogen stream -2-yl) phenyl) -1,3,5-triazine (3.81 g, 8.77 mmol), NaOH (0.87 g, 21.93 mmol), Pd (PPh 3 ) 4 (0.25 g, 0.21 mmol) and 1,4- dioxane, H 2 O (30 ml, 8 ml) was mixed and then stirred at 100 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with ethyl acetate, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer to give a compound C-44 (2.37 g, yield: 46%) by column chromatography.
GC-Mass (이론치: 705.85 g/mol, 측정치: 705 g/mol)GC-Mass (Theoretical value: 705.85 g / mol, Measured value: 705 g / mol)
[합성예 45] 화합물 C-45의 합성Synthesis Example 45 Synthesis of Compound C-45
Figure PCTKR2013009778-appb-I000102
Figure PCTKR2013009778-appb-I000102
합성예 44에서 사용된 2,4-diphenyl-6-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,3,5-triazine 대신 N-([1,1'-biphenyl]-4-yl)-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-[1,1'-biphenyl]-4-amine(4.58 g, 8.77 mmol)을 사용하는 것을 제외하고는, 합성예 44와 동일한 과정을 수행하여 화합물 C-45 (2.26 g, 수율: 39%)을 얻었다.2,4-diphenyl-6- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -1,3,5-triazine used in Synthesis Example 44 N-([1,1'-biphenyl] -4-yl) -N- (4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl)-[ Compound C-45 (2.26 g, yield: 39%) was obtained in the same manner as Synthesis Example 44 except for using 1,1'-biphenyl] -4-amine (4.58 g, 8.77 mmol). .
GC-Mass (이론치: 793.99 g/mol, 측정치: 793 g/mol)GC-Mass (Theoretical value: 793.99 g / mol, Measured value: 793 g / mol)
[합성예 46] 화합물 C-46의 합성Synthesis Example 46 Synthesis of Compound C-46
Figure PCTKR2013009778-appb-I000103
Figure PCTKR2013009778-appb-I000103
합성예 44에서 사용된 2,4-diphenyl-6-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,3,5-triazine 대신 N-([1,1'-biphenyl]-4-yl)-9,9-dimethyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-9H-fluoren-2-amine(4.94 g, 8.77 mmol)을 사용하는 것을 제외하고는, 합성예 44와 동일한 과정을 수행하여 화합물 C-46 (2.19 g, 수율: 36%)을 얻었다.2,4-diphenyl-6- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -1,3,5-triazine used in Synthesis Example 44 Instead N-([1,1'-biphenyl] -4-yl) -9,9-dimethyl-N- (4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- Except for using yl) phenyl) -9H-fluoren-2-amine (4.94 g, 8.77 mmol), the compound C-46 (2.19 g, yield: 36%) was obtained by the same procedure as in Synthesis Example 44. Got it.
GC-Mass (이론치: 834.06 g/mol, 측정치: 833 g/mol)GC-Mass (Theoretical value: 834.06 g / mol, Measured value: 833 g / mol)
[합성예 47] 화합물 C-47의 합성Synthesis Example 47 Synthesis of Compound C-47
Figure PCTKR2013009778-appb-I000104
Figure PCTKR2013009778-appb-I000104
합성예 44에서 사용된 2,4-diphenyl-6-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,3,5-triazine 대신 10-([1,1'-biphenyl]-4-yl)-9,9-dimethyl-2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9,10-dihydroacridine(4.94 g, 8.77 mmol)을 사용하는 것을 제외하고는, 합성예 44와 동일한 과정을 수행하여 화합물 C-47 (3.17 g, 수율: 52%)을 얻었다.2,4-diphenyl-6- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) -1,3,5-triazine used in Synthesis Example 44 Instead of 10-([1,1'-biphenyl] -4-yl) -9,9-dimethyl-2-phenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2 Compound C-47 (3.17 g, yield: 52%) was obtained in the same manner as Synthesis Example 44 except for using -yl) -9,10-dihydroacridine (4.94 g, 8.77 mmol).
GC-Mass (이론치: 834.06 g/mol, 측정치: 833 g/mol)GC-Mass (Theoretical value: 834.06 g / mol, Measured value: 833 g / mol)
[합성예 48] 화합물 C-48의 합성Synthesis Example 48 Synthesis of Compound C-48
Figure PCTKR2013009778-appb-I000105
Figure PCTKR2013009778-appb-I000105
합성예 44에서 사용된 화합물 IC-11 대신 준비예 8에서 합성된 화합물 IC-12(3.49 g, 7.31 mmol)를 사용하는 것을 제외하고는, 합성예 44와 동일한 과정을 수행하여 화합물 C-48 (2.83 g, 수율: 55%)을 얻었다.Compound C-48 was prepared by the same procedure as in Synthesis Example 44, except that Compound IC-12 (3.49 g, 7.31 mmol) synthesized in Preparation Example 8 was used instead of Compound IC-11 used in Synthesis Example 44. 2.83 g, yield: 55%).
GC-Mass (이론치: 705.85 g/mol, 측정치: 705 g/mol)GC-Mass (Theoretical value: 705.85 g / mol, Measured value: 705 g / mol)
[합성예 49] 화합물 C-49의 합성Synthesis Example 49 Synthesis of Compound C-49
Figure PCTKR2013009778-appb-I000106
Figure PCTKR2013009778-appb-I000106
합성예 45에서 사용된 화합물 IC-11 대신 준비예 8에서 합성된 화합물 IC-12(3.49 g, 7.31 mmol)를 사용하는 것을 제외하고는, 합성예 45와 동일한 과정을 수행하여 화합물 C-49 (2.38 g, 수율: 41%)을 얻었다.A compound C-49 was prepared in the same manner as in Synthesis Example 45, except that Compound IC-12 (3.49 g, 7.31 mmol) synthesized in Preparation Example 8 was used instead of Compound IC-11 used in Synthesis Example 45. 2.38 g, yield: 41%).
GC-Mass (이론치: 793.99 g/mol, 측정치: 793 g/mol)GC-Mass (Theoretical value: 793.99 g / mol, Measured value: 793 g / mol)
[합성예 50] 화합물 C-50의 합성Synthesis Example 50 Synthesis of Compound C-50
Figure PCTKR2013009778-appb-I000107
Figure PCTKR2013009778-appb-I000107
합성예 46에서 사용된 화합물 IC-11 대신 준비예 8에서 합성된 화합물 IC-12(3.49 g, 7.31 mmol)를 사용하는 것을 제외하고는, 합성예 46과 동일한 과정을 수행하여 화합물 C-50 (2.44 g, 수율: 40%)을 얻었다.A compound C-50 was prepared in the same manner as in Synthesis Example 46, except that Compound IC-12 (3.49 g, 7.31 mmol) synthesized in Preparation Example 8 was used instead of Compound IC-11 used in Synthesis Example 46. 2.44 g, yield: 40%).
GC-Mass (이론치: 834.06 g/mol, 측정치: 833 g/mol)GC-Mass (Theoretical value: 834.06 g / mol, Measured value: 833 g / mol)
[합성예 51] 화합물 C-51의 합성Synthesis Example 51 Synthesis of Compound C-51
Figure PCTKR2013009778-appb-I000108
Figure PCTKR2013009778-appb-I000108
합성예 47에서 사용된 화합물 IC-11 대신 준비예 8에서 합성된 화합물 IC-12(3.49 g, 7.31 mmol)를 사용하는 것을 제외하고는, 합성예 47과 동일한 과정을 수행하여 화합물 C-51 (2.01 g, 수율: 33%)을 얻었다.Compound C-51 was prepared by the same procedure as in Synthesis Example 47, except that Compound IC-12 (3.49 g, 7.31 mmol) synthesized in Preparation Example 8 was used instead of Compound IC-11 used in Synthesis Example 47. 2.01 g, yield: 33%).
GC-Mass (이론치: 834.06 g/mol, 측정치: 833 g/mol)GC-Mass (Theoretical value: 834.06 g / mol, Measured value: 833 g / mol)
[실시예 1] 녹색 유기 EL 소자의 제조Example 1 Manufacture of Green Organic EL Device
합성예 1에서 합성된 화합물 C-1을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후, 하기와 같이 녹색 유기 EL 소자를 제조하였다.After compound C-1 synthesized in Synthesis Example 1 was subjected to high purity sublimation purification by a conventionally known method, a green organic EL device was manufactured as follows.
ITO (Indium tin oxide)가 1500 Å 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면, 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음, UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.A glass substrate coated with ITO (Indium tin oxide) to a thickness of 1500 Å was washed with distilled water ultrasonically. After washing the distilled water, ultrasonic cleaning with a solvent such as isopropyl alcohol, acetone, methanol, dried and transferred to a UV OZONE cleaner (Power sonic 405, Hwasin Tech), and then wash the substrate using UV for 5 minutes The substrate was transferred to a vacuum evaporator.
상기와 같이 준비된 ITO 투명 전극 위에, 합성예 1의 화합물 C-1을 호스트 물질로 이용하여, m-MTDATA(60 nm) / TCTA(80 nm) / 화합물 C-1 + 10 % Ir(ppy)3(300nm) / BCP(10 nm) / Alq3(30 nm) / LiF(1 nm) / Al(200 nm) 순으로 적층하여 유기 EL 소자를 제작하였다. On the prepared ITO transparent electrode, using Compound C-1 of Synthesis Example 1 as a host material, m-MTDATA (60 nm) / TCTA (80 nm) / Compound C-1 + 10% Ir (ppy) 3 An organic EL device was fabricated by stacking (300 nm) / BCP (10 nm) / Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm) in this order.
사용된 m-MTDATA, TCTA, Ir(ppy)3, CBP 및 BCP의 구조는 하기와 같다.The structures of m-MTDATA, TCTA, Ir (ppy) 3 , CBP and BCP used are as follows.
Figure PCTKR2013009778-appb-I000109
Figure PCTKR2013009778-appb-I000109
Figure PCTKR2013009778-appb-I000110
Figure PCTKR2013009778-appb-I000110
[실시예 2 ~ 51] - 유기 EL 소자의 제조[Examples 2 to 51]-Fabrication of Organic EL Device
실시예 1에서 발광층의 형성시 호스트 물질로서 사용된 화합물 C-1 대신 합성예 2 내지 51에서 각각 합성된 화합물 C-2 내지 C-51을 사용하는 것을 제외하고는, 실시예 1과 동일하게 수행하여 유기 EL 소자를 제조하였다.Except for using the compounds C-2 to C-51 synthesized in Synthesis Examples 2 to 51 instead of the compound C-1 used as a host material in the formation of the emission layer in Example 1, the same as in Example 1 To an organic EL device.
[비교예 1] 녹색 유기 EL 소자의 제조Comparative Example 1 Fabrication of Green Organic EL Device
실시예 1에서 발광층의 형성시 호스트 물질로서 사용된 화합물 C-1 대신 CBP를 사용하는 것을 제외하고는, 실시예 1과 동일하게 수행하여 녹색 유기 EL 소자를 제작하였다. 사용된 CBP의 구조는 하기와 같다.A green organic EL device was manufactured in the same manner as in Example 1, except that CBP was used instead of Compound C-1 used as a host material in forming the emission layer in Example 1. The structure of CBP used is as follows.
Figure PCTKR2013009778-appb-I000111
Figure PCTKR2013009778-appb-I000111
[실험예]Experimental Example
실시예 1 내지 51, 및 비교예 1에서 각각 제조된 녹색 유기 EL 소자에 대하여, 전류밀도 10 mA/㎠에서의 구동전압, 전류효율 및 발광 피크를 측정하였고, 그 결과를 하기 표 1에 나타내었다.For green organic EL devices prepared in Examples 1 to 51 and Comparative Example 1, driving voltage, current efficiency and emission peak at a current density of 10 mA / cm 2 were measured, and the results are shown in Table 1 below. .
표 1
샘플 호스트 구동 전압 (V) 전류효율 (cd/A)
실시예 1 화합물 C-1 6.50 41.0
실시예 2 화합물 C-2 6.45 41.2
실시예 3 화합물 C-3 6.55 41.1
실시예 4 화합물 C-4 6.50 40.9
실시예 5 화합물 C-5 6.60 41.3
실시예 6 화합물 C-6 6.55 41.0
실시예 7 화합물 C-7 6.50 41.4
실시예 8 화합물 C-8 6.46 41.9
실시예 9 화합물 C-9 6.55 41.5
실시예 10 화합물 C-10 6.45 41.3
실시예 11 화합물 C-11 6.60 41.8
실시예 12 화합물 C-12 6.55 42.1
실시예 13 화합물 C-13 6.60 41.2
실시예 14 화합물 C-14 6.54 41.7
실시예 15 화합물 C-15 6.65 42.1
실시예 16 화합물 C-16 6.60 41.5
실시예 17 화합물 C-17 6.59 41.8
실시예 18 화합물 C-18 6.50 41.7
실시예 19 화합물 C-19 6.45 41.8
실시예 20 화합물 C-20 6.51 41.3
실시예 21 화합물 C-21 6.55 40.9
실시예 22 화합물 C-22 6.60 41.2
실시예 23 화합물 C-23 6.49 41.5
실시예 24 화합물 C-24 6.52 40.8
실시예 25 화합물 C-25 6.55 40.9
실시예 26 화합물 C-26 6.59 41.7
실시예 27 화합물 C-27 6.60 42.3
실시예 28 화합물 C-28 6.50 41.6
실시예 29 화합물 C-29 6.55 41.4
실시예 30 화합물 C-30 6.50 41.7
실시예 31 화합물 C-31 6.60 40.8
실시예 32 화합물 C-32 6.58 41.0
실시예 33 화합물 C-33 6.55 41.2
실시예 34 화합물 C-34 6.51 41.5
실시예 35 화합물 C-35 6.65 42.1
실시예 36 화합물 C-36 6.60 41.5
실시예 37 화합물 C-37 6.62 40.9
실시예 38 화합물 C-38 6.55 41.7
실시예 39 화합물 C-39 6.60 40.6
실시예 40 화합물 C-40 6.52 41.3
실시예 41 화합물 C-41 6.50 40.5
실시예 42 화합물 C-42 6.55 41.5
실시예 43 화합물 C-43 6.45 41.7
실시예 44 화합물 C-44 6.52 40.8
실시예 45 화합물 C-45 6.55 41.0
실시예 46 화합물 C-46 6.58 41.3
실시예 47 화합물 C-47 6.60 41.1
실시예 48 화합물 C-48 6.53 40.9
실시예 49 화합물 C-49 6.55 41.0
실시예 50 화합물 C-50 6.50 41.5
실시예 51 화합물 C-51 6.45 40.8
비교예 1 CBP 6.93 38.2
Table 1
Sample Host Driving voltage (V) Current efficiency (cd / A)
Example 1 Compound C-1 6.50 41.0
Example 2 Compound C-2 6.45 41.2
Example 3 Compound c-3 6.55 41.1
Example 4 Compound c-4 6.50 40.9
Example 5 Compound C-5 6.60 41.3
Example 6 Compound c-6 6.55 41.0
Example 7 Compound c-7 6.50 41.4
Example 8 Compound c-8 6.46 41.9
Example 9 Compound c-9 6.55 41.5
Example 10 Compound C-10 6.45 41.3
Example 11 Compound C-11 6.60 41.8
Example 12 Compound c-12 6.55 42.1
Example 13 Compound C-13 6.60 41.2
Example 14 Compound c-14 6.54 41.7
Example 15 Compound c-15 6.65 42.1
Example 16 Compound c-16 6.60 41.5
Example 17 Compound c-17 6.59 41.8
Example 18 Compound c-18 6.50 41.7
Example 19 Compound c-19 6.45 41.8
Example 20 Compound C-20 6.51 41.3
Example 21 Compound c-21 6.55 40.9
Example 22 Compound c-22 6.60 41.2
Example 23 Compound c-23 6.49 41.5
Example 24 Compound c-24 6.52 40.8
Example 25 Compound C-25 6.55 40.9
Example 26 Compound C-26 6.59 41.7
Example 27 Compound c-27 6.60 42.3
Example 28 Compound c-28 6.50 41.6
Example 29 Compound c-29 6.55 41.4
Example 30 Compound C-30 6.50 41.7
Example 31 Compound c-31 6.60 40.8
Example 32 Compound c-32 6.58 41.0
Example 33 Compound c-33 6.55 41.2
Example 34 Compound c-34 6.51 41.5
Example 35 Compound C-35 6.65 42.1
Example 36 Compound c-36 6.60 41.5
Example 37 Compound c-37 6.62 40.9
Example 38 Compound c-38 6.55 41.7
Example 39 Compound C-39 6.60 40.6
Example 40 Compound c-40 6.52 41.3
Example 41 Compound c-41 6.50 40.5
Example 42 Compound c-42 6.55 41.5
Example 43 Compound c-43 6.45 41.7
Example 44 Compound c-44 6.52 40.8
Example 45 Compound c-45 6.55 41.0
Example 46 Compound c-46 6.58 41.3
Example 47 Compound c-47 6.60 41.1
Example 48 Compound c-48 6.53 40.9
Example 49 Compound c-49 6.55 41.0
Example 50 Compound C-50 6.50 41.5
Example 51 Compound c-51 6.45 40.8
Comparative Example 1 CBP 6.93 38.2
실험 결과, 본 발명에 따른 화학식 1로 표시되는 화합물(화합물 C-1 내지 C-51)을 발광층의 호스트 물질로 사용하는 실시예 1 내지 51의 녹색 유기 EL 소자는, 종래 CBP를 사용하는 비교예 1의 녹색 유기 EL 소자보다 전류효율 및 구동전압 면에서 우수한 성능을 나타내는 것을 확인할 수 있었다.As a result of the experiment, the green organic EL devices of Examples 1 to 51 using the compounds represented by the formula (1) according to the present invention (Compounds C-1 to C-51) as the host material of the light emitting layer were comparative examples using conventional CBP. It was confirmed that the green organic EL device of 1 exhibited better performance in terms of current efficiency and driving voltage.
이상을 통해 본 발명의 바람직한 실시예에 대하여 설명하였지만, 본 발명은 이에 한정되는 것이 아니고 특허청구범위와 발명의 상세한 설명의 범위 안에서 여러 가지로 변형하여 실시하는 것이 가능하고 이 또한 발명의 범주에 속하는 것은 당연하다.Although the preferred embodiments of the present invention have been described above, the present invention is not limited thereto, and various modifications and changes can be made within the scope of the claims and the detailed description of the invention, which also fall within the scope of the invention. It is natural.

Claims (8)

  1. 하기 화학식 1로 표시되는 화합물: Compound represented by the following formula (1):
    [화학식 1][Formula 1]
    Figure PCTKR2013009778-appb-I000112
    Figure PCTKR2013009778-appb-I000112
    (상기 화학식 1에서,(In Formula 1,
    R1 내지 R5는 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고, 또는 인접하는 기와 결합하여 축합 고리를 형성할 수 있으며,R 1 to R 5 are the same as or different from each other, and each independently hydrogen, deuterium, halogen, cyano, a substituted or unsubstituted C 1 -C 40 alkyl group, a substituted or unsubstituted C 2 -C 40 alkenyl group , Substituted or unsubstituted C 2 -C 40 alkynyl group, substituted or unsubstituted C 6 -C 40 aryl group, substituted or unsubstituted heteroaryl group having 5 to 40 nuclear atoms, substituted or unsubstituted C 6 ~ C 40 aryloxy group, substituted or unsubstituted C 1 ~ C 40 Alkyloxy group, substituted or unsubstituted C 6 ~ C 40 arylamine group, substituted or unsubstituted C 3 ~ C 40 A cycloalkyl group, a substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear atoms, a substituted or unsubstituted C 1 to C 40 alkylsilyl group, a substituted or unsubstituted C 1 to C 40 alkylboron group, Substituted or unsubstituted C 6 Through C 40 Aryl boron group, Substituted or unsubstituted C 6 Through C 40 Aryl phosphine group, Substituted or unsubstituted C 6 Through C 40 Is selected from the group consisting of an aryl phosphine oxide group and a substituted or unsubstituted C 6 ~ C 40 arylsilyl group, or may be combined with adjacent groups to form a condensed ring,
    다만, 상기 R1과 R2는 서로 축합하여 하기 화학식 2 내지 4 중 하나로 표시되는 축합 고리를 형성하거나, 또는 R3 내지 R5 중 하나는 인접하는 기와 축합하여 하기 화학식 5로 표시되는 축합 고리를 형성하며;However, R 1 and R 2 may be condensed together to form a condensed ring represented by one of Formulas 2 to 4, or one of R 3 to R 5 may be condensed with an adjacent group to form a condensed ring represented by Formula 5 below. Form;
    [화학식 2][Formula 2]
    Figure PCTKR2013009778-appb-I000113
    Figure PCTKR2013009778-appb-I000113
    [화학식 3][Formula 3]
    Figure PCTKR2013009778-appb-I000114
    Figure PCTKR2013009778-appb-I000114
    [화학식 4][Formula 4]
    Figure PCTKR2013009778-appb-I000115
    Figure PCTKR2013009778-appb-I000115
    [화학식 5][Formula 5]
    Figure PCTKR2013009778-appb-I000116
    Figure PCTKR2013009778-appb-I000116
    R6 내지 R11은 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고, 또는 인접하는 기와 결합하여 축합 고리를 형성할 수 있으며;R 6 to R 11 are the same as or different from each other, and each independently hydrogen, deuterium, halogen, cyano, a substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted C 2 to C 40 alkenyl group , Substituted or unsubstituted C 2 -C 40 alkynyl group, substituted or unsubstituted C 6 -C 40 aryl group, substituted or unsubstituted heteroaryl group having 5 to 40 nuclear atoms, substituted or unsubstituted C 6 ~ C 40 aryloxy group, substituted or unsubstituted C 1 ~ C 40 Alkyloxy group, substituted or unsubstituted C 6 ~ C 40 arylamine group, substituted or unsubstituted C 3 ~ C 40 A cycloalkyl group, a substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear atoms, a substituted or unsubstituted C 1 to C 40 alkylsilyl group, a substituted or unsubstituted C 1 to C 40 alkylboron group, Substituted or unsubstituted C 6 Through C 40 Aryl boron group, Substituted or unsubstituted C 6 Through C 40 Aryl phosphine group, Substituted or unsubstituted C 6 Through C 40 An arylphosphine oxide group and a substituted or unsubstituted C 6 to C 40 arylsilyl group, or may be combined with an adjacent group to form a condensed ring;
    Ar1은 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고;Ar 1 is a substituted or unsubstituted C 1 ~ C 40 alkyl group, a substituted or unsubstituted C 2 ~ C 40 alkenyl group, a substituted or unsubstituted C 2 ~ C 40 alkynyl group, a substituted or unsubstituted C 6 to C 40 aryl group, substituted or unsubstituted heteroaryl group having 5 to 40 nuclear atoms, substituted or unsubstituted C 6 to C 40 aryloxy group, substituted or unsubstituted C 1 to C 40 Alkyloxy group, substituted or unsubstituted C 6 to C 40 arylamine group, substituted or unsubstituted C 3 to C 40 cycloalkyl group, substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear atoms, substituted Or an unsubstituted C 1 to C 40 alkylsilyl group, a substituted or unsubstituted C 1 to C 40 alkylboron group, a substituted or unsubstituted C 6 to C 40 aryl boron group, a substituted or unsubstituted C 6 to C 40 arylphosphine group, substituted or unsubstituted C 6 to C 40 arylphosphine oxide group and substituted or unsubstituted C 6 to C 40 arylsilyl group Selected from the group;
    n은 0 내지 4의 정수로서, n이 1 내지 4의 정수이면 하나 이상의 Ra는 각각 독립적으로 중수소, 할로겐, 시아노, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 및 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고, 또는 인접하는 기와 결합하여 축합 고리를 형성할 수 있으며;n is an integer from 0 to 4, and if n is an integer from 1 to 4, at least one Ra is each independently deuterium, halogen, cyano, substituted or unsubstituted C 1 -C 40 alkyl group, substituted or unsubstituted C Alkenyl group of 2 to C 40 , substituted or unsubstituted alkynyl group of C 2 to C 40 , substituted or unsubstituted C 6 to C 40 aryl group, substituted or unsubstituted heteroaryl of 5 to 40 nuclear atoms Groups, substituted or unsubstituted C 6 -C 40 aryloxy group, substituted or unsubstituted C 1 -C 40 alkyloxy group, substituted or unsubstituted C 6 -C 40 arylamine group, substituted or unsubstituted A substituted C 3 to C 40 cycloalkyl group, a substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear atoms, a substituted or unsubstituted C 1 to C 40 alkylsilyl group, a substituted or unsubstituted C 1 to C 40 alkyl boron group, and an aryl phosphonium substituted or unsubstituted C 6 ~ C 40 aryl boron group, a substituted or unsubstituted C 6 ~ C 40 of pingi, substituted Combines groups selected from the group consisting of aryl silyl unsubstituted C 6 ~ C 40 aryl phosphine oxide group, and a substituted or unsubstituted C 6 ~ C 40 is, or adjacent to form a condensed ring;
    X는 단일결합이거나, 또는 C(R21)(R22), N(R23), O 및 S로 이루어진 군에서 선택되고;X is a single bond or is selected from the group consisting of C (R 21 ) (R 22 ), N (R 23 ), O and S;
    R21 내지 R23 은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기 및 치환 또는 비치환된 C6~C40의 아릴아민기로 이루어진 군에서 선택되고;R 21 to R 23 are each independently hydrogen, deuterium, a substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted C 6 to C 40 aryl group, or a substituted or unsubstituted nuclear atom 5 to 5 40 heteroaryl group and substituted or unsubstituted C 6 ~ C 40 arylamine group;
    상기 R1 내지 R11, Ra 및 Ar1의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 아릴아민기, 아릴알킬기, 시클로알킬기, 헤테로시클로알킬기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴실릴기와, R21 내지 R23 의 알킬기, 아릴기, 헤테로아릴기 및 아릴아민기에 각각 도입되는 하나 이상의 치환기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군으로부터 선택되고, 이때 상기 치환기가 복수인 경우, 서로 동일하거나 상이할 수 있음).The alkyl group, alkenyl group, alkynyl group, aryl group, heteroaryl group, aryloxy group, alkyloxy group, arylamine group, arylalkyl group, cycloalkyl group, heterocycloalkyl group, alkyl of R 1 to R 11, Ra and Ar 1 One or more substituents introduced into the silyl group, the alkyl boron group, the aryl boron group, the arylphosphine group, the arylphosphine oxide group and the arylsilyl group, and the alkyl group, the aryl group, the heteroaryl group and the arylamine group of R 21 to R 23 , respectively Deuterium, halogen, cyano group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 40 aryl group, 5 to 5 nuclear atoms each independently 40 heteroaryl groups, C 6 to C 40 aryloxy groups, C 1 to C 40 alkyloxy groups, C 6 to C 40 arylamine groups, C 3 to C 40 cycloalkyl groups, nuclear atoms 3 to 40 heterocycloalkyl group, C 1 ~ C 40 alkyl silyl group, C 1 ~ C 40 alkyl group of boron, C 6 ~ C 40 aryl group of boron, C 6 ~ C 40 aryl group Spin group, C 6 ~ C 40 aryl phosphine oxide is selected from the pin group and an aryl silyl group the group consisting of a C 6 ~ C 40 of, wherein if the plurality of substituents, may be the same or different from each other).
  2. 제1항에 있어서, 상기 X는 단일결합이거나, 또는 C(R21)(R22)인 것이 특징인 화합물.The compound of claim 1, wherein X is a single bond or C (R 21 ) (R 22 ).
  3. 제1항에 있어서, 상기 Ar1 은 치환 또는 비치환된 C6~C40의 아릴기, 및 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기로 이루어진 군으로부터 선택되고,The method of claim 1, wherein Ar 1 is selected from the group consisting of a substituted or unsubstituted C 6 ~ C 40 aryl group, and a substituted or unsubstituted heteroaryl group having 5 to 40 nuclear atoms,
    이때 Ar1의 아릴기 및 헤테로아릴기에 각각 도입되는 하나 이상의 치환기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군으로부터 선택되고, 다만 상기 치환기가 복수개인 경우, 서로 동일하거나 상이한 것이 특징인 화합물.In this case one or more substituents to be introduced, each aryl group, and heteroaryl of Ar 1 are each independently a heavy hydrogen, a halogen, cyano group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 of the Alkynyl group, C 6 ~ C 40 aryl group, C 5 ~ C 40 heteroaryl group, C 6 ~ C 40 aryloxy group, C 1 ~ C 40 Alkyloxy group, C 6 ~ C 40 aryl An amine group, a C 3 to C 40 cycloalkyl group, a C 3 to C 40 heterocycloalkyl group, a C 1 to C 40 alkylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 40 aryl is selected from boron group, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 aryl phosphine oxide group, and a C 6 ~ C 40 aryl silyl group the group consisting of, but if the substituent multiple individual, equal to each other Or are characterized by being different.
  4. 제1항에 있어서, 상기 Ar1은 하기 치환기 A1 내지 A64로 이루어진 군에서 선택된 것이 특징인 화합물:The compound of claim 1, wherein Ar 1 is selected from the group consisting of the following substituents A1 to A64:
    Figure PCTKR2013009778-appb-I000117
    Figure PCTKR2013009778-appb-I000117
    Figure PCTKR2013009778-appb-I000118
    Figure PCTKR2013009778-appb-I000118
    Figure PCTKR2013009778-appb-I000119
    Figure PCTKR2013009778-appb-I000119
    Figure PCTKR2013009778-appb-I000120
    Figure PCTKR2013009778-appb-I000120
    Figure PCTKR2013009778-appb-I000121
    Figure PCTKR2013009778-appb-I000121
    Figure PCTKR2013009778-appb-I000122
    Figure PCTKR2013009778-appb-I000122
  5. 제1항에 있어서, 하기 화학식 6 내지 15로 표시되는 화합물로 이루어진 군에서 선택되는 화합물: The compound of claim 1 selected from the group consisting of compounds represented by the following Chemical Formulas 6 to 15:
    [화학식 6][Formula 6]
    Figure PCTKR2013009778-appb-I000123
    Figure PCTKR2013009778-appb-I000123
    [화학식 7][Formula 7]
    Figure PCTKR2013009778-appb-I000124
    Figure PCTKR2013009778-appb-I000124
    [화학식 8][Formula 8]
    Figure PCTKR2013009778-appb-I000125
    Figure PCTKR2013009778-appb-I000125
    [화학식 9][Formula 9]
    Figure PCTKR2013009778-appb-I000126
    Figure PCTKR2013009778-appb-I000126
    [화학식 10][Formula 10]
    Figure PCTKR2013009778-appb-I000127
    Figure PCTKR2013009778-appb-I000127
    [화학식 11][Formula 11]
    Figure PCTKR2013009778-appb-I000128
    Figure PCTKR2013009778-appb-I000128
    [화학식 12][Formula 12]
    Figure PCTKR2013009778-appb-I000129
    Figure PCTKR2013009778-appb-I000129
    [화학식 13][Formula 13]
    Figure PCTKR2013009778-appb-I000130
    Figure PCTKR2013009778-appb-I000130
    [화학식 14][Formula 14]
    Figure PCTKR2013009778-appb-I000131
    Figure PCTKR2013009778-appb-I000131
    [화학식 15][Formula 15]
    Figure PCTKR2013009778-appb-I000132
    Figure PCTKR2013009778-appb-I000132
    (상기 화학식 6 내지 화학식 15에서, (In Chemical Formula 6 to Formula 15,
    R1 내지 R11, Ra, Ar1, X 및 n 은 각각 제1항에서 정의한 바와 같음)R 1 to R 11 , Ra, Ar 1, X and n are each as defined in claim 1)
  6. 제1항에 있어서, 하기 화학식 INV-1 내지 INV-20로 표시되는 화합물로 이루어진 군에서 선택되는 화합물: The compound of claim 1 selected from the group consisting of compounds represented by the following formulas INV-1 to INV-20:
    Figure PCTKR2013009778-appb-I000133
    Figure PCTKR2013009778-appb-I000133
    Figure PCTKR2013009778-appb-I000134
    Figure PCTKR2013009778-appb-I000134
    Figure PCTKR2013009778-appb-I000135
    Figure PCTKR2013009778-appb-I000135
    Figure PCTKR2013009778-appb-I000136
    Figure PCTKR2013009778-appb-I000136
    Figure PCTKR2013009778-appb-I000137
    Figure PCTKR2013009778-appb-I000137
    Figure PCTKR2013009778-appb-I000138
    Figure PCTKR2013009778-appb-I000138
    Figure PCTKR2013009778-appb-I000139
    Figure PCTKR2013009778-appb-I000139
    (상기 화학식 INV-1 내지 INV-20에 있어서, (In the above formulas INV-1 to INV-20,
    R1 내지 R11, Ra, Ar1 및 n은 각각 제1항에서 정의한 바와 같음).R 1 to R 11 , Ra, Ar 1 and n are each as defined in claim 1).
  7. 양극, 음극, 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자에 있어서,In an organic electroluminescent device comprising an anode, a cathode, and at least one organic layer interposed between the anode and the cathode,
    상기 1층 이상의 유기물층 중 적어도 하나는 제1항 내지 제6항 중 어느 한 항에 기재된 화합물을 포함하는 것이 특징인 유기 전계 발광 소자. At least one of the one or more organic material layers comprises the compound according to any one of claims 1 to 6.
  8. 제7항에 있어서, 상기 화합물을 포함하는 유기물층은 발광층인 것이 특징인 유기 전계 발광 소자.The organic electroluminescent device according to claim 7, wherein the organic material layer including the compound is a light emitting layer.
PCT/KR2013/009778 2012-11-20 2013-10-31 Organic compound, and organic electro-luminescence device comprising same WO2014081131A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2012-0131975 2012-11-20
KR20120131975 2012-11-20
KR1020130105613A KR101571600B1 (en) 2012-11-20 2013-09-03 Organic compounds and organic electro luminescence device comprising the same
KR10-2013-0105613 2013-09-03

Publications (1)

Publication Number Publication Date
WO2014081131A1 true WO2014081131A1 (en) 2014-05-30

Family

ID=50776269

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2013/009778 WO2014081131A1 (en) 2012-11-20 2013-10-31 Organic compound, and organic electro-luminescence device comprising same

Country Status (1)

Country Link
WO (1) WO2014081131A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150087700A (en) * 2014-01-22 2015-07-30 주식회사 두산 Organic compounds and organic electro luminescence device comprising the same
KR101810788B1 (en) 2016-10-12 2017-12-19 주식회사 두산 Organic compounds and organic electro luminescence device comprising the same
US10199584B2 (en) 2016-08-10 2019-02-05 Samsung Electronics Co., Ltd. Organometallic compound and organic light-emitting device including the same
US10658594B2 (en) 2017-12-06 2020-05-19 Idemitsu Kosan Co., Ltd. Organic electroluminescence device and novel compound

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120015883A (en) * 2010-08-13 2012-02-22 주식회사 엘지화학 New compounds and organic electronic device using the same
WO2012069121A1 (en) * 2010-11-24 2012-05-31 Merck Patent Gmbh Materials for organic electroluminescent devices
JP2012121867A (en) * 2010-12-10 2012-06-28 Canon Inc Indolophenoxazine compound, and organic light-emitting device using the same
KR20120122897A (en) * 2011-04-29 2012-11-07 에스에프씨 주식회사 New compounds and organic light-emitting diode including the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120015883A (en) * 2010-08-13 2012-02-22 주식회사 엘지화학 New compounds and organic electronic device using the same
WO2012069121A1 (en) * 2010-11-24 2012-05-31 Merck Patent Gmbh Materials for organic electroluminescent devices
JP2012121867A (en) * 2010-12-10 2012-06-28 Canon Inc Indolophenoxazine compound, and organic light-emitting device using the same
KR20120122897A (en) * 2011-04-29 2012-11-07 에스에프씨 주식회사 New compounds and organic light-emitting diode including the same

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150087700A (en) * 2014-01-22 2015-07-30 주식회사 두산 Organic compounds and organic electro luminescence device comprising the same
KR101641408B1 (en) 2014-01-22 2016-07-20 주식회사 두산 Organic compounds and organic electro luminescence device comprising the same
US10199584B2 (en) 2016-08-10 2019-02-05 Samsung Electronics Co., Ltd. Organometallic compound and organic light-emitting device including the same
KR101810788B1 (en) 2016-10-12 2017-12-19 주식회사 두산 Organic compounds and organic electro luminescence device comprising the same
US10658594B2 (en) 2017-12-06 2020-05-19 Idemitsu Kosan Co., Ltd. Organic electroluminescence device and novel compound
US10672989B2 (en) 2017-12-06 2020-06-02 Idemitsu Kosan Co., Ltd. Organic electroluminescence device and novel compound
US10680181B2 (en) 2017-12-06 2020-06-09 Idemitsu Kosan Co., Ltd. Organic electroluminescence device and novel compound
US11557730B2 (en) 2017-12-06 2023-01-17 Idemitsu Kosan Co., Ltd. Organic electroluminescence device and novel compound
US11569449B2 (en) 2017-12-06 2023-01-31 Idemitsu Kosan Co., Ltd. Organic electroluminescence device and novel compound

Similar Documents

Publication Publication Date Title
WO2017179809A1 (en) Organic light-emitting compound and organic electroluminescent element using same
WO2015190718A1 (en) Organic electroluminescent device
WO2013094999A2 (en) Organic compound, and organic electroluminescent device using same
WO2018038400A1 (en) Organic compound and organic electroluminescence device including same
WO2014142488A1 (en) Organic compound and organic electroluminescent element including same
WO2014010810A1 (en) Novel compound and electroluminescent device including same
WO2014092354A1 (en) Organic compound and organic electroluminescent element comprising same
WO2014025209A1 (en) Novel compound and organic electroluminescence device comprising same
WO2016105123A2 (en) Organic compound and organic electroluminescent device comprising same
WO2020218680A1 (en) Organic compound and organic electroluminescent diode using same
WO2016105054A2 (en) Organic light emitting compound and organic electroluminescent element using same
WO2017209488A1 (en) Organic compound and organic electroluminescent device comprising same
WO2020027463A1 (en) Organic compound and organic electroluminescent device using same
WO2015125986A1 (en) Organic compound and organic electroluminescent device comprising same
WO2015111943A1 (en) Organic compound, and organic electroluminescent device containing same
WO2015133804A1 (en) Organic compound and organic electroluminescent device comprising same
WO2016122178A2 (en) Organic light-emitting compound and organic electroluminescent element using same
WO2014046392A1 (en) Organic compound and electroluminescent element having same
WO2015111942A2 (en) Organic compound and organic electroluminescent element comprising same
WO2017095086A1 (en) Organic light-emitting compound and organic electroluminescent device using same
WO2017111389A1 (en) Organic compound and organic electroluminescent diode including same
WO2014081134A1 (en) Novel compound and organic electroluminescent element comprising same
WO2015133808A1 (en) Organic compound and organic electroluminescent device comprising same
WO2014025114A1 (en) Organic light-emitting compound and organic electroluminescent device using same
WO2014081131A1 (en) Organic compound, and organic electro-luminescence device comprising same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13857553

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 04/09/2015)

122 Ep: pct application non-entry in european phase

Ref document number: 13857553

Country of ref document: EP

Kind code of ref document: A1